Neurofibromatosis	S-ALL
2	O
-LRB-	O
NF2	O
-RRB-	O
is	O
a	O
dominantly	B-ALL
inherited	E-ALL
disorder	O
characterized	O
by	O
multiple	O
tumors	B-ALL
of	I-ALL
the	I-ALL
central	I-ALL
nervous	I-ALL
system	E-ALL
,	O
predominantly	O
bilateral	B-ALL
vestibular	B-ALL
schwannomas	S-ALL
.	O

We	O
compared	O
epilepsy	S-ALL
phenotypes	O
with	O
genotypes	O
of	O
Angelman	O
syndrome	O
-LRB-	O
AS	O
-RRB-	O
,	O
including	O
chromosome	O
15q11	O
-	O
13	O
deletions	O
-LRB-	O
class	O
I	O
-RRB-	O
,	O
uniparental	O
disomy	O
-LRB-	O
class	O
II	O
-RRB-	O
,	O
methylation	O
imprinting	O
abnormalities	O
-LRB-	O
class	O
III	O
-RRB-	O
,	O
and	O
mutation	O
in	O
the	O
UBE3A	O
gene	O
-LRB-	O
class	O
IV	O
-RRB-	O
.	O

Patients	O
from	O
all	O
genotypic	O
classes	O
had	O
characteristic	B-ALL
EEGs	E-ALL
with	O
diffuse	O
bifrontally	O
dominant	S-ALL
high	O
-	O
amplitude	O
1	O
-	O
to	O
3	O
-	O
Hz	O
notched	O
or	O
triphasic	O
or	O
polyphasic	O
slow	O
waves	O
,	O
or	O
slow	O
and	O
sharp	O
waves	O
.	O

Class	O
I	O
patients	O
had	O
severe	O
intractable	B-ALL
epilepsy	S-ALL
,	O
most	O
frequently	O
with	O
atypical	B-ALL
absences	E-ALL
and	O
myoclonias	S-ALL
and	O
less	O
frequently	O
with	O
generalized	B-ALL
extensor	I-ALL
tonic	I-ALL
seizures	S-ALL
or	O
flexor	B-ALL
spasms	E-ALL
.	O

Epileptic	B-ALL
spasms	E-ALL
were	O
recorded	O
in	O
AS	O
patients	O
as	O
old	O
as	O
41	O
years	O
.	O

Aged	O
-	O
matched	O
class	O
II	O
,	O
III	O
,	O
and	O
IV	O
patients	O
had	O
either	O
no	O
epilepsy	S-ALL
or	O
drug	O
-	O
responsive	O
mild	O
epilepsy	S-ALL
with	O
relatively	O
infrequent	O
atypical	B-ALL
absences	E-ALL
,	O
myoclonias	S-ALL
,	O
or	O
atonic	B-ALL
seizures	S-ALL
.	O

In	O
conclusion	O
,	O
maternally	O
inherited	O
chromosome	O
15q11	O
-	O
13	O
deletions	O
produce	O
severe	O
epilepsy	S-ALL
.	O

Loss	O
-	O
of	O
-	O
function	O
UBE3A	O
mutations	O
,	O
uniparental	O
disomy	O
,	O
or	O
methylation	O
imprint	O
abnormalities	O
in	O
AS	O
are	O
associated	O
with	O
relatively	O
mild	O
epilepsy	S-ALL
.	O

Involvement	O
of	O
other	O
genes	O
in	O
the	O
chromosome	O
15q11	O
-	O
13	O
deletion	O
,	O
such	O
as	O
GABRB3	O
,	O
may	O
explain	O
severe	O
epilepsy	S-ALL
in	O
AS	O
.	O

A	O
retrospective	O
review	O
of	O
29	O
consecutive	O
unselected	O
patients	O
referred	O
for	O
neuro	O
-	O
ophthalmic	O
evaluation	O
after	O
the	O
diagnosis	O
of	O
neurofibromatosis	S-ALL
type	O
2	O
-LRB-	O
NF2	O
-RRB-	O
showed	O
that	O
four	O
of	O
them	O
had	O
a	O
monocular	B-ALL
elevator	I-ALL
paresis	E-ALL
.	O

In	O
two	O
of	O
the	O
four	O
MRI	O
demonstrated	O
lesions	O
,	O
presumed	O
to	O
be	O
schwannomas	B-ALL
,	I-ALL
of	I-ALL
the	I-ALL
third	I-ALL
nerve	E-ALL
.	O

These	O
findings	O
indicate	O
that	O
monocular	B-ALL
elevator	I-ALL
paresis	E-ALL
is	O
a	O
common	O
neuro	O
-	O
ophthalmic	O
finding	O
in	O
NF2	O
,	O
which	O
the	O
authors	O
suspect	O
is	O
probably	O
a	O
sign	O
of	O
third	O
nerve	O
infiltration	O
or	O
compression	O
by	O
a	O
schwannoma	S-ALL
.	O

We	O
report	O
on	O
2	O
children	O
with	O
Townes	O
-	O
Brocks	O
syndrome	O
-LRB-	O
TBS	O
-RRB-	O
and	O
mental	B-ALL
retardation	S-ALL
.	O

One	O
child	O
had	O
mild	O
hearing	B-ALL
loss	E-ALL
,	O
but	O
the	O
other	O
only	O
had	O
hearing	B-ALL
loss	E-ALL
at	O
8000	O
Hz	O
.	O

These	O
cases	O
suggest	O
that	O
there	O
may	O
be	O
an	O
increased	O
incidence	O
of	O
mental	B-ALL
retardation	S-ALL
in	O
individuals	O
with	O
TBS	O
.	O

Cell	O
cultures	O
grown	O
from	O
peripheral	O
neurofibromas	S-ALL
of	O
three	O
patients	O
suffering	O
from	O
sporadic	S-ALL
peripheral	O
neurofibromatosis	S-ALL
-LRB-	O
NF	O
-RRB-	O
were	O
analysed	O
cytogenetically	O
at	O
early	O
in	O
vitro	O
passages	O
.	O

The	O
role	O
of	O
monosomy	O
22	O
in	O
tumorigenesis	O
of	O
meningiomas	S-ALL
and	O
neurofibromas	S-ALL
is	O
discussed	O
.	O

They	O
both	O
have	O
orbital	B-ALL
haemangiomatous	I-ALL
cysts	E-ALL
,	O
which	O
is	O
a	O
previously	O
unreported	O
feature	O
.	O

This	O
disorder	O
has	O
been	O
reported	O
showing	O
autosomal	B-ALL
dominant	S-ALL
transmission	E-ALL
so	O
this	O
family	O
could	O
represent	O
either	O
an	O
autosomal	B-ALL
recessive	E-ALL
form	E-ALL
or	O
germline	B-ALL
mosaicism	E-ALL
for	O
the	O
dominant	S-ALL
gene	O
.	O

To	O
report	O
new	O
ocular	B-ALL
manifestations	E-ALL
of	O
branchio	O
-	O
oculo	O
-	O
facial	O
-LRB-	O
BOF	O
-RRB-	O
syndrome	O
.	O

A	O
10	O
-	O
year	O
-	O
old	O
girl	O
with	O
known	O
BOF	O
syndrome	O
was	O
referred	O
because	O
of	O
a	O
fundus	B-ALL
lesion	E-ALL
in	O
her	O
left	O
eye	O
.	O

She	O
had	O
undergone	O
excision	O
of	O
a	O
left	B-ALL
orbital	I-ALL
dermoid	I-ALL
cyst	E-ALL
at	O
age	O
18	O
months	O
and	O
a	O
branchial	S-ALL
cleft	I-ALL
fistula	E-ALL
from	O
the	O
right	O
side	O
of	O
neck	O
at	O
age	O
4	O
years	O
.	O

In	O
the	O
right	O
eye	O
,	O
an	O
iris	B-ALL
pigment	I-ALL
epithelial	I-ALL
cyst	E-ALL
was	O
confirmed	O
with	O
ultrasound	O
biomicroscopy	O
.	O

In	O
the	O
left	O
eye	O
,	O
there	O
was	O
a	O
combined	O
hamartoma	B-ALL
of	I-ALL
the	I-ALL
retina	E-ALL
and	O
retina	B-ALL
pigment	I-ALL
epithelium	E-ALL
.	O

BOF	O
syndrome	O
can	O
display	O
mild	O
to	O
severe	O
craniofacial	B-ALL
,	I-ALL
auricular	B-ALL
,	I-ALL
oral	B-ALL
,	I-ALL
and	I-ALL
ophthalmic	B-ALL
anomalies	E-ALL
.	O

In	O
this	O
case	O
,	O
the	O
ophthalmic	O
manifestations	O
included	O
lacrimal	B-ALL
sac	I-ALL
fistula	E-ALL
,	O
orbital	B-ALL
dermoid	I-ALL
cyst	E-ALL
,	O
iris	B-ALL
pigment	I-ALL
epithelial	I-ALL
cyst	E-ALL
,	O
and	O
combined	O
hamartoma	B-ALL
of	I-ALL
the	I-ALL
retina	E-ALL
and	O
retinal	B-ALL
pigment	I-ALL
epithelium	E-ALL
.	O

This	O
is	O
a	O
report	O
on	O
a	O
child	O
with	O
sensorineural	B-ALL
deafness	S-ALL
,	O
imperforate	B-ALL
anus	E-ALL
with	O
rectovaginal	B-ALL
fistula	E-ALL
,	O
hypoplastic	B-ALL
thumb	E-ALL
,	O
and	O
congenital	B-ALL
heart	I-ALL
defect	E-ALL
.	O

It	O
is	O
proposed	O
that	O
the	O
clinical	O
spectrum	O
of	O
the	O
Townes	O
-	O
Brocks	O
syndrome	O
must	O
be	O
extended	O
to	O
include	O
congenital	B-ALL
heart	I-ALL
defect	E-ALL
,	O
auricular	B-ALL
changes	E-ALL
differing	O
from	O
those	O
previously	O
described	O
,	O
and	O
anomalies	O
of	O
other	O
internal	B-ALL
organs	E-ALL
.	O

The	O
syndrome	O
is	O
an	O
autosomal	B-ALL
dominant	S-ALL
trait	E-ALL
.	O

The	O
present	O
case	O
may	O
represent	O
a	O
de	B-ALL
novo	I-ALL
mutation	E-ALL
.	O

Dysmorphogenesis	S-ALL
and	O
/	O
or	O
mental	B-ALL
retardation	S-ALL
provide	O
clinical	O
clues	O
for	O
uniparental	O
disomy	O
in	O
apparently	O
balanced	O
offspring	O
of	O
translocation	O
carriers	O
.	O

Research	O
strategies	O
for	O
assessing	O
frequency	O
and	O
implications	O
of	O
uniparental	O
disomy	O
in	O
translocation	O
carriers	O
include	O
a	O
genetic	O
register	O
approach	O
,	O
study	O
of	O
abortuses	O
from	O
balanced	O
translocation	O
carriers	O
,	O
and	O
parent	O
-	O
of	O
-	O
origin	O
studies	O
on	O
de	B-ALL
novo	E-ALL
homologous	O
Robertsonian	O
translocations	O
.	O

However	O
,	O
a	O
number	O
of	O
other	O
clinical	O
entities	O
have	O
also	O
been	O
associated	O
with	O
similar	O
,	O
if	O
not	O
identical	O
,	O
cytogenetic	O
defects	O
,	O
arguing	O
for	O
clinical	B-ALL
heterogeneity	S-ALL
associated	O
with	O
abnormalities	O
in	O
this	O
region	O
of	O
chromosome	O
15	O
.	O

The	O
first	O
patient	O
is	O
a	O
child	O
with	O
Williams	O
syndrome	O
,	O
the	O
second	O
,	O
Angelman	O
-LRB-	O
Happy	O
Puppet	O
-RRB-	O
syndrome	O
,	O
and	O
the	O
third	O
is	O
a	O
child	O
with	O
hypotonia	S-ALL
of	I-ALL
infancy	S-ALL
,	O
obesity	S-ALL
,	O
and	O
developmental	B-ALL
delay	E-ALL
,	O
but	O
who	O
does	O
not	O
meet	O
specific	O
diagnostic	O
criteria	O
for	O
the	O
Prader	O
-	O
Willi	O
syndrome	O
.	O

Nevoid	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
syndrome	O
-LRB-	O
NBCC	O
;	O
Gorlin	O
syndrome	O
-RRB-	O
,	O
an	O
autosomal	B-ALL
dominant	S-ALL
disorder	E-ALL
linked	O
to	O
9q22	O
.	O
3	O
-	O
q31	O
,	O
and	O
caused	O
by	O
mutations	O
in	O
PTC	O
,	O
the	O
human	O
homologue	O
of	O
the	O
Drosophila	O
patched	O
gene	O
,	O
comprises	O
multiple	O
basal	B-ALL
cell	I-ALL
carcinomas	E-ALL
,	O
keratocysts	B-ALL
of	I-ALL
the	I-ALL
jaw	E-ALL
,	O
palmar	B-ALL
/	I-ALL
plantar	B-ALL
pits	S-ALL
,	O
spine	B-ALL
and	I-ALL
rib	B-ALL
anomalies	E-ALL
and	O
calcification	B-ALL
of	I-ALL
the	I-ALL
falx	I-ALL
cerebri	E-ALL
.	O

Eighty	O
percent	O
of	O
whites	O
-LRB-	O
71	O
/	O
90	O
-RRB-	O
and	O
38	O
%	O
-LRB-	O
5	O
/	O
13	O
-RRB-	O
of	O
African	O
-	O
Americans	O
had	O
at	O
least	O
one	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
-LRB-	O
BCC	O
-RRB-	O
,	O
with	O
the	O
first	O
tumor	S-ALL
occurring	O
at	O
a	O
mean	O
age	O
of	O
23	O
-LRB-	O
median	O
20	O
-RRB-	O
years	O
and	O
21	O
-LRB-	O
median	O
20	O
-RRB-	O
years	O
,	O
respectively	O
.	O

Jaw	B-ALL
cysts	E-ALL
occurred	O
in	O
78	O
/	O
105	O
-LRB-	O
74	O
%	O
-RRB-	O
with	O
the	O
first	O
tumor	S-ALL
occurring	O
in	O
80	O
%	O
by	O
the	O
age	O
of	O
20	O
years	O
.	O

The	O
number	O
of	O
total	O
jaw	B-ALL
cysts	E-ALL
ranged	O
from	O
1	O
to	O
28	O
-LRB-	O
median	O
3	O
-RRB-	O
.	O

Palmar	B-ALL
pits	S-ALL
and	O
plantar	B-ALL
pits	S-ALL
were	O
seen	O
in	O
87	O
%	O
.	O

Ovarian	B-ALL
fibromas	E-ALL
were	O
diagnosed	O
by	O
ultrasound	O
in	O
9	O
/	O
52	O
-LRB-	O
17	O
%	O
-RRB-	O
at	O
a	O
mean	O
age	O
of	O
30	O
years	O
.	O

Medulloblastoma	S-ALL
occurred	O
in	O
4	O
patients	O
at	O
a	O
mean	O
age	O
of	O
2	O
.	O
3	O
years	O
.	O

Three	O
patients	O
had	O
cleft	B-ALL
lip	E-ALL
or	I-ALL
palate	E-ALL
.	O

Physical	O
findings	O
include	O
``	O
coarse	B-ALL
face	E-ALL
''	O
in	O
54	O
%	O
,	O
relative	B-ALL
macrocephaly	E-ALL
in	O
50	O
%	O
,	O
hypertelorism	S-ALL
in	O
42	O
%	O
,	O
frontal	B-ALL
bossing	E-ALL
in	O
27	O
%	O
,	O
pectus	B-ALL
deformity	E-ALL
in	O
13	O
%	O
,	O
and	O
Sprengel	B-ALL
deformity	E-ALL
in	O
11	O
%	O
.	O

Important	O
radiological	O
signs	O
included	O
calcification	B-ALL
of	I-ALL
the	I-ALL
falx	I-ALL
cerebri	E-ALL
in	O
65	O
%	O
,	O
of	O
the	O
tentorium	O
cerebelli	O
in	O
20	O
%	O
,	O
bridged	B-ALL
sella	E-ALL
in	O
68	O
%	O
,	O
bifid	B-ALL
ribs	E-ALL
in	O
26	O
%	O
,	O
hemivertebrae	S-ALL
in	O
15	O
%	O
,	O
fusion	B-ALL
of	I-ALL
the	I-ALL
vertebral	I-ALL
bodies	E-ALL
in	O
10	O
%	O
,	O
and	O
flame	O
shaped	O
lucencies	O
of	O
the	O
phalanges	O
,	O
metacarpal	O
,	O
and	O
carpal	O
bones	O
of	O
the	O
hands	O
in	O
30	O
%	O
.	O

Several	O
traits	O
previously	O
considered	O
components	O
of	O
the	O
syndrome	O
-LRB-	O
including	O
short	B-ALL
fourth	I-ALL
metacarpal	E-ALL
,	O
scoliosis	S-ALL
,	O
cervical	B-ALL
ribs	E-ALL
and	O
spina	B-ALL
bifida	E-ALL
occulta	E-ALL
-RRB-	O
were	O
not	O
found	O
to	O
be	O
significantly	O
increased	O
in	O
the	O
affected	O
individuals	O
.	O

We	O
present	O
an	O
8	O
-	O
year	O
-	O
old	O
African	O
-	O
American	O
boy	O
with	O
medulloblastoma	S-ALL
and	O
nevoid	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
syndrome	O
-LRB-	O
NBCCS	O
-RRB-	O
who	O
exhibited	O
the	O
radiosensitive	B-ALL
response	E-ALL
of	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
-LRB-	O
BCC	O
-RRB-	O
formation	O
in	O
the	O
area	O
irradiated	O
for	O
medulloblastoma	S-ALL
.	O

Such	O
a	O
response	O
is	O
well	O
-	O
documented	O
in	O
Caucasian	O
NBCCS	O
patients	O
with	O
medulloblastoma	S-ALL
.	O

The	O
propositus	O
was	O
diagnosed	O
with	O
medulloblastoma	S-ALL
at	O
the	O
age	O
of	O
2	O
years	O
and	O
underwent	O
surgery	O
,	O
chemotherapy	O
,	O
and	O
craniospinal	O
irradiation	O
.	O

At	O
the	O
age	O
of	O
6	O
years	O
,	O
he	O
was	O
diagnosed	O
with	O
NBCCS	O
following	O
his	O
presentation	O
with	O
a	O
large	O
odontogenic	B-ALL
keratocyst	E-ALL
of	I-ALL
the	I-ALL
mandible	E-ALL
,	O
pits	B-ALL
of	I-ALL
the	I-ALL
palms	I-ALL
and	I-ALL
soles	E-ALL
and	O
numerous	O
BCCs	O
in	O
the	O
area	O
of	O
the	O
back	O
and	O
neck	O
that	O
had	O
been	O
irradiated	O
previously	O
for	O
medulloblastoma	S-ALL
.	O

This	O
case	O
illustrates	O
complex	O
gene	O
-	O
environment	O
interaction	O
,	O
in	O
that	O
increased	B-ALL
skin	I-ALL
pigmentation	E-ALL
in	O
African	O
-	O
Americans	O
is	O
presumably	O
protective	O
against	O
ultraviolet	O
,	O
but	O
not	O
ionizing	O
,	O
radiation	O
.	O

This	O
case	O
and	O
other	O
similar	O
cases	O
in	O
the	O
literature	O
show	O
the	O
importance	O
of	O
considering	O
NBCCS	O
in	O
the	O
differential	O
diagnosis	O
of	O
any	O
patient	O
who	O
presents	O
with	O
a	O
medulloblastoma	S-ALL
,	O
especially	O
before	O
the	O
age	O
of	O
5	O
years	O
,	O
and	O
of	O
examining	O
other	O
close	O
relatives	O
for	O
signs	O
of	O
NBCCS	O
to	O
determine	O
the	O
patient	O
's	O
at	O
-	O
risk	O
status	O
.	O

Finally	O
,	O
for	O
individuals	O
who	O
are	O
radiosensitive	S-ALL
,	O
protocols	O
that	O
utilize	O
chemotherapy	O
in	O
lieu	O
of	O
radiotherapy	O
should	O
be	O
considered	O
.	O

A	O
clinical	O
and	O
genetic	O
study	O
of	O
type	O
2	O
neurofibromatosis	S-ALL
-LRB-	O
NF2	O
-RRB-	O
has	O
been	O
carried	O
out	O
in	O
the	O
United	O
Kingdom	O
.	O

The	O
autosomal	B-ALL
dominant	S-ALL
inheritance	E-ALL
of	O
NF2	O
was	O
confirmed	O
,	O
49	O
%	O
of	O
cases	O
were	O
assessed	O
as	O
representing	O
new	O
mutations	O
,	O
and	O
the	O
mutation	O
rate	O
was	O
estimated	O
to	O
be	O
6	O
.	O
5	O
x	O
10	O
-LRB-	O
-	O
6	O
-RRB-	O
.	O

Data	O
are	O
presented	O
which	O
suggest	O
that	O
there	O
are	O
two	O
types	O
of	O
NF2	O
,	O
one	O
with	O
later	O
onset	O
and	O
bilateral	B-ALL
vestibular	B-ALL
schwannomas	S-ALL
as	O
the	O
only	O
usual	O
feature	O
,	O
and	O
the	O
other	O
with	O
earlier	O
onset	O
and	O
multiple	O
other	O
tumours	S-ALL
.	O

Her	O
mother	O
had	O
severe	O
brachycephaly	S-ALL
,	O
sensorineural	B-ALL
hearing	B-ALL
loss	E-ALL
,	O
speech	B-ALL
impediment	E-ALL
,	O
and	O
mild	B-ALL
ataxia	S-ALL
.	O

CT	O
brain	O
scans	O
showed	O
an	O
enlarged	B-ALL
foramen	I-ALL
magnum	E-ALL
in	O
the	O
mother	O
and	O
daughter	O
but	O
magnetic	O
resonance	O
imaging	O
-LRB-	O
MRI	O
-RRB-	O
showed	O
no	O
brainstem	B-ALL
abnormality	E-ALL
in	O
either	O
.	O

This	O
family	O
demonstrates	O
that	O
some	O
Angelman	O
syndrome	O
cases	O
may	O
be	O
dominantly	B-ALL
transmitted	E-ALL
with	O
variable	S-ALL
expression	E-ALL
and	O
associated	O
with	O
abnormal	O
or	O
cytogenetically	O
apparently	O
normal	O
chromosome	O
15	O
.	O

We	O
report	O
the	O
prenatal	O
diagnosis	O
of	O
distal	B-ALL
arthrogryposis	S-ALL
type	O
I	O
by	O
ultrasound	O
at	O
18	O
wk	O
gestation	O
in	O
a	O
family	O
with	O
two	O
other	O
affected	O
members	O
-LRB-	O
mother	O
and	O
sister	O
of	O
the	O
fetus	O
-RRB-	O
.	O

A	O
literature	O
survey	O
of	O
prenatally	B-ALL
diagnosed	I-ALL
cases	E-ALL
of	O
multiple	B-ALL
joint	B-ALL
contractures	S-ALL
is	O
presented	O
.	O

This	O
is	O
the	O
first	O
report	O
of	O
the	O
prenatal	O
diagnosis	O
of	O
distal	B-ALL
arthrogryposis	S-ALL
type	O
I	O
.	O

It	O
helps	O
to	O
illustrate	O
the	O
variability	S-ALL
and	O
prenatal	O
natural	O
history	O
of	O
the	O
condition	O
and	O
the	O
subtlety	O
of	O
the	O
prenatal	O
ultrasound	O
findings	O
.	O

Four	O
sets	O
of	O
clinical	O
diagnostic	O
criteria	O
for	O
neurofibromatosis	S-ALL
2	O
-LRB-	O
NF2	O
-RRB-	O
have	O
been	O
developed	O
by	O
groups	O
of	O
expert	O
clinicians	O
,	O
but	O
sensitivity	O
has	O
never	O
been	O
formally	O
assessed	O
.	O

The	O
sets	O
of	O
criteria	O
differ	O
for	O
people	O
without	O
bilateral	B-ALL
vestibular	B-ALL
schwannomas	S-ALL
,	O
which	O
are	O
pathognomonic	O
for	O
NF2	O
.	O

The	O
study	O
was	O
based	O
on	O
163	O
of	O
403	O
people	O
in	O
the	O
United	O
Kingdom	O
NF2	O
registry	O
-LRB-	O
41	O
%	O
-RRB-	O
who	O
presented	O
without	O
bilateral	B-ALL
vestibular	B-ALL
schwannomas	S-ALL
.	O

None	O
of	O
the	O
existing	O
sets	O
of	O
criteria	O
are	O
adequate	O
at	O
initial	O
assessment	O
for	O
diagnosing	O
people	O
who	O
present	O
without	O
bilateral	B-ALL
vestibular	B-ALL
schwannomas	S-ALL
as	O
having	O
NF2	O
,	O
particularly	O
people	O
with	O
a	O
negative	O
family	O
history	O
of	O
NF2	O
.	O

Several	O
pedigrees	O
with	O
19	O
new	O
cases	O
of	O
the	O
earpits	S-ALL
-	O
deafness	S-ALL
syndrome	O
-LRB-	O
McK	O
+	O
12510	O
-RRB-	O
-	O
LSB	O
-	O
28	O
-	O
RSB	O
-	O
are	O
presented	O
.	O

The	O
earpits	S-ALL
-	O
deafness	S-ALL
syndrome	O
is	O
an	O
autosomal	B-ALL
dominant	S-ALL
disorder	E-ALL
in	O
which	O
affected	O
individuals	O
may	O
have	O
sensorineural	B-ALL
,	I-ALL
conductive	B-ALL
or	I-ALL
mixed	B-ALL
hearing	B-ALL
loss	E-ALL
,	O
preauricular	B-ALL
pits	S-ALL
,	O
structural	O
defects	B-ALL
of	I-ALL
the	I-ALL
outer	I-ALL
,	I-ALL
middle	I-ALL
and	I-ALL
inner	I-ALL
ear	E-ALL
,	O
lacrimal	B-ALL
duct	I-ALL
stenosis	E-ALL
,	O
branchial	B-ALL
fistulas	S-ALL
or	I-ALL
cysts	E-ALL
of	O
the	O
second	O
branchial	S-ALL
arch	O
,	O
and	O
renal	B-ALL
anomalies	E-ALL
ranging	O
from	O
mild	O
hypoplasia	O
to	O
complete	O
absence	O
.	O

Pits	S-ALL
,	O
branchial	S-ALL
clefts	S-ALL
and	O
hearing	B-ALL
loss	E-ALL
are	O
frequently	O
expressed	O
.	O

The	O
incidence	O
of	O
renal	B-ALL
malformation	E-ALL
is	O
higher	O
,	O
as	O
mentioned	O
earlier	O
in	O
the	O
literature	O
.	O

On	O
the	O
basis	O
of	O
personal	O
observations	O
as	O
well	O
as	O
in	O
view	O
of	O
data	O
from	O
the	O
literature	O
it	O
is	O
maintained	O
that	O
the	O
BOR	O
-LRB-	O
branchio	O
-	O
oto	O
-	O
renal	B-ALL
dysplasia	E-ALL
-RRB-	O
syndrome	O
-	O
LSB	O
-	O
12	O
,	O
30	O
-	O
32	O
-	O
RSB	O
-	O
and	O
the	O
BO	O
-LRB-	O
branchio	O
-	O
oto	O
dysplasia	O
-RRB-	O
syndrome	O
are	O
in	O
fact	O
the	O
same	O
affection	O
.	O

It	O
is	O
also	O
maintained	O
that	O
no	O
separate	O
syndromes	O
can	O
be	O
distinguished	O
on	O
the	O
basis	O
of	O
the	O
type	O
of	O
hearing	B-ALL
loss	E-ALL
.	O

The	O
phenotype	O
of	O
Gorlin	O
-	O
Goltz	O
syndrome	O
or	O
basal	B-ALL
cell	I-ALL
nevus	I-ALL
syndrome	E-ALL
-LRB-	O
BCNS	O
,	O
#	O
109400	O
,	O
OMIM	O
-RRB-	O
,	O
a	O
Mendelian	O
trait	O
due	O
to	O
PTCH	O
mutations	O
has	O
been	O
reported	O
in	O
a	O
few	O
cases	O
of	O
interstitial	O
deletion	O
of	O
chromosome	O
9q	O
.	O

We	O
present	O
an	O
11	O
-	O
year	O
-	O
old	O
girl	O
with	O
clinical	O
features	O
consistent	O
with	O
BCNS	O
including	O
bridging	B-ALL
of	I-ALL
sella	I-ALL
turcica	E-ALL
,	O
biparietal	B-ALL
bossing	E-ALL
,	O
downward	B-ALL
slanting	I-ALL
palpebral	I-ALL
fissures	E-ALL
,	O
mandible	B-ALL
prognathism	S-ALL
,	O
pectus	B-ALL
excavatum	E-ALL
,	O
thumb	B-ALL
abnormalities	E-ALL
,	O
occult	B-ALL
spina	B-ALL
bifida	E-ALL
at	O
L5	O
-	O
S4	O
,	O
numerous	B-ALL
basal	B-ALL
cell	I-ALL
nevi	E-ALL
,	O
and	O
single	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
.	O

Interestingly	O
,	O
some	O
features	O
of	O
our	O
proband	O
-LRB-	O
e	O
.	O
g	O
.	O
,	O
bilateral	O
patellar	B-ALL
dysplasia	E-ALL
and	O
abnormal	B-ALL
clavicular	I-ALL
shape	E-ALL
-RRB-	O
,	O
as	O
well	O
as	O
her	O
healthy	O
sister	O
who	O
carries	O
the	O
same	O
translocation	O
,	O
are	O
also	O
found	O
in	O
patients	O
with	O
NPS	O
.	O

In	O
two	O
patients	O
studied	O
,	O
somatic	B-ALL
mosaicism	E-ALL
was	O
proven	O
by	O
molecular	O
and	O
cellular	O
cloning	O
,	O
respectively	O
.	O

In	O
conclusion	O
,	O
we	O
suggest	O
that	O
the	O
role	O
of	O
mosaic	O
imprinting	O
defects	O
in	O
mental	B-ALL
retardation	S-ALL
is	O
underestimated	O
.	O

Mutations	O
of	O
the	O
human	O
Patched	O
gene	O
-LRB-	O
PTCH	O
-RRB-	O
have	O
been	O
identified	O
in	O
individuals	O
with	O
the	O
nevoid	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
syndrome	O
-LRB-	O
NBCCS	O
-RRB-	O
as	O
well	O
as	O
in	O
sporadic	S-ALL
basal	B-ALL
cell	I-ALL
carcinomas	E-ALL
and	O
medulloblastomas	S-ALL
.	O

We	O
have	O
characterized	O
the	O
genomic	O
structure	O
of	O
PTCH2	O
and	O
have	O
used	O
single	O
-	O
stranded	O
conformational	O
polymorphism	O
analysis	O
to	O
search	O
for	O
mutations	O
in	O
PTCH2	O
in	O
NBCCS	O
patients	O
,	O
basal	B-ALL
cell	I-ALL
carcinomas	E-ALL
and	O
in	O
medulloblastomas	S-ALL
.	O

To	O
date	O
,	O
we	O
have	O
identified	O
one	O
truncating	O
mutation	O
in	O
a	O
medulloblastoma	S-ALL
and	O
a	O
change	O
in	O
a	O
splice	O
donor	O
site	O
in	O
a	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
,	O
suggesting	O
that	O
the	O
gene	O
plays	O
a	O
role	O
in	O
the	O
development	O
of	O
some	O
tumours	S-ALL
.	O

Brachydactyly	B-ALL
type	I-ALL
A1	E-ALL
-LRB-	O
BDA1	S-ALL
-RRB-	O
was	O
the	O
first	O
disorder	O
described	O
in	O
terms	O
of	O
autosomal	B-ALL
dominant	S-ALL
Mendelian	O
inheritance	O
.	O

Both	O
families	O
demonstrate	O
significant	O
intrafamilial	B-ALL
phenotypic	E-ALL
heterogeneity	S-ALL
among	O
the	O
affected	O
individuals	O
.	O

Branchio	O
-	O
oto	O
-	O
renal	O
syndrome	O
-LRB-	O
BOR	O
-RRB-	O
is	O
an	O
autosomal	B-ALL
dominant	S-ALL
disorder	E-ALL
with	O
variable	S-ALL
clinical	O
manifestations	B-ALL
affecting	I-ALL
branchial	S-ALL
,	I-ALL
renal	I-ALL
and	I-ALL
auditory	I-ALL
development	E-ALL
.	O

However	O
,	O
the	O
possibility	O
of	O
genetic	B-ALL
heterogeneity	S-ALL
as	O
the	O
cause	O
of	O
clinical	B-ALL
variability	S-ALL
can	O
not	O
be	O
resolved	O
until	O
the	O
gene	O
-LRB-	O
s	O
-RRB-	O
causing	O
BOR	O
syndrome	O
are	O
mapped	O
.	O

DNA	O
from	O
four	O
generations	O
of	O
a	O
family	O
with	O
autosomal	B-ALL
dominant	S-ALL
BOR	O
syndrome	O
have	O
been	O
typed	O
with	O
a	O
series	O
of	O
genetic	O
markers	O
on	O
the	O
long	O
arm	O
of	O
chromosome	O
8	O
.	O

The	O
gene	O
predisposing	O
to	O
neurofibromatosis	S-ALL
type	O
2	O
-LRB-	O
NF2	O
-RRB-	O
on	O
human	O
chromosome	O
22	O
has	O
revealed	O
a	O
wide	O
variety	O
of	O
different	O
mutations	O
in	O
NF2	O
individuals	O
.	O

These	O
patients	O
display	O
a	O
marked	O
variability	S-ALL
in	O
clinical	O
presentation	O
,	O
ranging	O
from	O
very	O
severe	O
disease	O
with	O
numerous	B-ALL
tumors	S-ALL
at	O
a	O
young	B-ALL
age	E-ALL
to	O
a	O
relatively	O
mild	B-ALL
condition	I-ALL
much	I-ALL
later	I-ALL
in	I-ALL
life	E-ALL
.	O

To	O
investigate	O
whether	O
this	O
phenotypic	O
heterogeneity	S-ALL
is	O
determined	O
by	O
the	O
type	O
of	O
mutation	O
in	O
NF2	O
,	O
we	O
have	O
collected	O
clinical	O
information	O
on	O
111	O
NF2	O
cases	O
from	O
73	O
different	O
families	O
on	O
whom	O
we	O
have	O
performed	O
mutation	O
screening	O
in	O
this	O
gene	O
.	O

Seventeen	O
of	O
these	O
mutations	O
are	O
novel	O
,	O
whereas	O
the	O
remaining	O
19	O
have	O
been	O
described	O
previously	O
in	O
other	O
NF2	O
individuals	O
or	O
sporadic	S-ALL
tumors	S-ALL
.	O

Townes	O
-	O
Brocks	O
syndrome	O
-LRB-	O
TBS	O
-RRB-	O
has	O
been	O
recognized	O
as	O
a	O
dominant	B-ALL
inherited	E-ALL
syndrome	O
.	O

Case	O
1	O
was	O
operated	O
on	O
for	O
imperforate	B-ALL
anus	E-ALL
.	O

Triphalangeal	B-ALL
thumb	E-ALL
and	O
ear	B-ALL
anomalies	E-ALL
were	O
remarkable	O
.	O

Deafness	S-ALL
was	O
diagnosed	O
when	O
the	O
patient	O
was	O
6	O
months	O
old	O
.	O

Anomalies	B-ALL
of	I-ALL
the	I-ALL
semicircular	I-ALL
canals	I-ALL
and	I-ALL
the	I-ALL
incus	E-ALL
with	O
inculomalleolar	B-ALL
fusion	E-ALL
were	O
shown	O
when	O
the	O
patient	O
was	O
3	O
.	O
5	O
years	O
old	O
.	O

During	O
childhood	S-ALL
,	O
recurrent	O
episodes	B-ALL
of	I-ALL
abdominal	B-ALL
pain	S-ALL
appeared	O
.	O

The	O
diagnosis	O
of	O
hereditary	O
angioneurotic	O
edema	S-ALL
-LRB-	O
HANE	O
-RRB-	O
was	O
made	O
.	O

The	O
parents	O
of	O
case	O
2	O
,	O
a	O
female	O
,	O
are	O
both	O
mildly	B-ALL
mentally	B-ALL
retarded	S-ALL
.	O

This	O
was	O
the	O
first	O
pregnancy	O
of	O
the	O
mother	O
who	O
had	O
short	B-ALL
stature	E-ALL
.	O

The	O
child	O
had	O
an	O
antepositioned	B-ALL
anus	E-ALL
,	O
bifid	B-ALL
right	I-ALL
thumb	E-ALL
,	O
large	B-ALL
toes	E-ALL
,	O
low	B-ALL
set	I-ALL
ears	E-ALL
,	O
microretrognathia	S-ALL
and	O
deafness	S-ALL
.	O

We	O
report	O
on	O
44	O
patients	O
-LRB-	O
18	O
with	O
additional	O
affected	O
family	O
members	O
-RRB-	O
,	O
with	O
congenital	B-ALL
distal	B-ALL
limb	B-ALL
contractures	S-ALL
identified	O
from	O
a	O
large	O
study	O
of	O
over	O
350	O
patients	O
with	O
congenital	B-ALL
joint	B-ALL
contractures	S-ALL
.	O

Fourteen	O
propositi	O
-LRB-	O
seven	O
familial	B-ALL
cases	E-ALL
,	O
seven	O
isolated	B-ALL
cases	E-ALL
-RRB-	O
had	O
a	O
newly	O
recognized	O
form	O
of	O
arthrogryposis	S-ALL
,	O
which	O
we	O
have	O
designated	O
distal	B-ALL
arthrogryposis	S-ALL
type	O
1	O
,	O
with	O
the	O
predominant	O
manifestations	O
of	O
autosomal	B-ALL
dominant	S-ALL
inheritance	E-ALL
;	O
tightly	B-ALL
clenched	I-ALL
fists	E-ALL
at	O
birth	O
,	O
with	O
medially	B-ALL
overlapping	B-ALL
fingers	E-ALL
,	O
ulnar	B-ALL
deviation	E-ALL
,	O
and	O
camptodactyly	S-ALL
in	O
adults	O
;	O
and	O
positional	B-ALL
foot	B-ALL
deformities	E-ALL
.	O

Contractures	S-ALL
at	O
other	O
major	O
joints	O
are	O
variable	S-ALL
.	O

There	O
are	O
no	O
associated	O
visceral	B-ALL
anomalies	E-ALL
;	O
intelligence	O
is	O
normal	O
.	O

There	O
can	O
be	O
marked	O
intrafamilial	B-ALL
and	I-ALL
interfamilial	B-ALL
variability	S-ALL
.	O

Twenty	O
-	O
two	O
propositi	O
with	O
similar	O
distal	B-ALL
contractures	S-ALL
had	O
additional	O
findings	O
and	O
were	O
classified	O
into	O
five	O
subcategories	O
of	O
distal	B-ALL
arthrogryposis	S-ALL
-LRB-	O
type	O
IIA	O
-	O
E	O
-RRB-	O
.	O

Among	O
type	O
II	O
patients	O
cleft	B-ALL
palate	E-ALL
,	O
cleft	B-ALL
lip	E-ALL
,	O
small	B-ALL
tongue	E-ALL
,	O
trismus	S-ALL
,	O
ptosis	S-ALL
,	O
epicanthal	B-ALL
folds	E-ALL
,	O
keratoconus	S-ALL
,	O
short	B-ALL
stature	E-ALL
,	O
scoliosis	S-ALL
,	O
a	O
unique	B-ALL
hand	I-ALL
position	E-ALL
,	O
and	O
dull	O
normal	O
intelligence	O
were	O
seen	O
.	O

The	O
remaining	O
eight	O
propositi	O
were	O
recognized	O
to	O
have	O
previously	O
described	O
conditions	O
with	O
distal	B-ALL
contractures	S-ALL
and	O
autosomal	B-ALL
dominant	S-ALL
inheritance	E-ALL
,	O
ie	O
,	O
the	O
Freeman	O
-	O
Sheldon	O
syndrome	O
,	O
trismus	S-ALL
-	O
pseudo	O
-	O
camptodactyly	S-ALL
syndrome	O
,	O
congenital	O
contractural	B-ALL
arachnodactyly	S-ALL
,	O
and	O
familial	O
camptodactyly	S-ALL
.	O

A	O
17	O
-	O
year	O
-	O
old	O
girl	O
presented	O
with	O
an	O
enlarged	B-ALL
cardiac	I-ALL
silhouette	E-ALL
on	O
routine	O
chest	O
roentgenogram	O
.	O

After	O
clinical	O
evaluation	O
,	O
echocardiography	O
,	O
and	O
pericardiocentesis	O
failed	O
to	O
provide	O
a	O
diagnosis	O
,	O
exploratory	O
thoracotomy	O
and	O
biopsy	O
revealed	O
an	O
unresectable	O
left	B-ALL
ventricular	I-ALL
fibroma	E-ALL
.	O

The	O
tumor	S-ALL
continued	O
to	O
enlarge	O
and	O
began	O
causing	O
ventricular	B-ALL
arrhythmia	E-ALL
.	O

Angelman	O
syndrome	O
is	O
a	O
neuro	B-ALL
-	I-ALL
developmental	I-ALL
disorder	E-ALL
caused	O
by	O
genetic	O
abnormalities	O
affecting	O
the	O
maternal	O
gene	O
expression	O
in	O
the	O
chromosome	O
region	O
15q11	O
-	O
q13	O
.	O

We	O
studied	O
the	O
seizure	S-ALL
and	O
polygraphic	O
patterns	O
of	O
18	O
patients	O
with	O
Angelman	O
's	O
syndrome	O
.	O

All	O
patients	O
showed	O
movement	B-ALL
problems	E-ALL
.	O

Eleven	O
patients	O
were	O
also	O
reported	O
to	O
have	O
long	O
-	O
lasting	O
periods	O
of	O
jerky	B-ALL
movements	E-ALL
.	O

The	O
polygraphic	O
recording	O
showed	O
a	O
myoclonic	S-ALL
status	B-ALL
epilepticus	E-ALL
in	O
nine	O
of	O
them	O
.	O

Seven	O
patients	O
had	O
partial	B-ALL
seizures	S-ALL
with	O
eye	B-ALL
deviation	E-ALL
and	O
vomiting	S-ALL
,	O
similar	O
to	O
those	O
of	O
childhood	S-ALL
occipital	O
epilepsies	S-ALL
.	O

These	O
seizures	S-ALL
and	O
electroencephalographic	B-ALL
patterns	E-ALL
suggest	O
that	O
Angelman	O
's	O
syndrome	O
occurs	O
in	O
most	O
of	O
the	O
patients	O
as	O
a	O
nonprogressive	B-ALL
,	I-ALL
age	I-ALL
-	I-ALL
dependent	I-ALL
myoclonic	I-ALL
encephalopathy	S-ALL
with	O
a	O
prominent	O
occipital	O
involvement	O
.	O

These	O
findings	O
indicate	O
that	O
,	O
whereas	O
ataxia	S-ALL
is	O
a	O
constant	O
symptom	O
in	O
Angelman	O
's	O
syndrome	O
,	O
the	O
occurrence	O
of	O
a	O
transient	O
myoclonic	B-ALL
status	B-ALL
epilepticus	E-ALL
may	O
account	O
for	O
the	O
recurrence	O
of	O
different	O
abnormal	B-ALL
movements	I-ALL
,	I-ALL
namely	I-ALL
the	I-ALL
jerky	I-ALL
ones	E-ALL
.	O

This	O
technique	O
has	O
allowed	O
the	O
diagnosis	O
of	O
small	O
-LRB-	O
less	O
than	O
8	O
mm	O
-RRB-	O
acoustic	B-ALL
neuromas	E-ALL
in	O
two	O
asymptomatic	O
children	O
-LRB-	O
age	O
7	O
and	O
11	O
-RRB-	O
,	O
one	O
of	O
whom	O
had	O
normal	O
audiometric	O
and	O
brainstem	O
-	O
evoked	O
response	O
testing	O
.	O

It	O
is	O
possible	O
that	O
acoustic	B-ALL
neuromas	E-ALL
develop	O
at	O
an	O
early	B-ALL
age	E-ALL
more	O
commonly	O
than	O
recognized	O
previously	O
.	O

The	O
early	O
diagnosis	O
of	O
acoustic	B-ALL
neuromas	E-ALL
with	O
the	O
use	O
of	O
gadolinium	O
-	O
enhanced	O
MRI	O
may	O
lead	O
to	O
better	O
outcome	O
following	O
surgery	O
.	O

Six	O
children	O
had	O
no	O
history	O
of	O
seizures	S-ALL
at	O
the	O
time	O
of	O
the	O
first	O
EEG	O
.	O

One	O
or	O
more	O
of	O
the	O
following	O
EEG	B-ALL
abnormalities	E-ALL
were	O
seen	O
in	O
all	O
patients	O
:	O
1	O
.	O

Persistent	B-ALL
rhythmic	I-ALL
4	I-ALL
-	I-ALL
6	I-ALL
/	I-ALL
s	I-ALL
activities	E-ALL
reaching	O
more	O
than	O
200	O
microV	O
not	O
associated	O
with	O
drowsiness	S-ALL
.	O

Two	O
and	O
sometimes	O
three	O
of	O
these	O
EEG	O
features	O
could	O
be	O
present	O
in	O
the	O
same	O
record	O
particularly	O
at	O
a	O
young	S-ALL
age	E-ALL
.	O

The	O
EEG	O
features	O
of	O
Angelman	O
syndrome	O
appear	O
to	O
be	O
sufficiently	O
characteristic	O
to	O
help	O
identify	O
patients	O
at	O
an	O
early	B-ALL
age	E-ALL
before	O
the	O
clinical	O
features	O
become	O
obvious	O
and	O
at	O
a	O
time	O
when	O
genetic	O
counselling	O
may	O
be	O
particularly	O
important	O
.	O

Two	O
siblings	O
with	O
the	O
``	O
happy	B-ALL
puppet	E-ALL
''	O
syndrome	O
are	O
presented	O
.	O

These	O
features	O
include	O
severe	B-ALL
mental	B-ALL
retardation	S-ALL
,	O
epileptic	B-ALL
seizures	S-ALL
,	O
easily	B-ALL
provoked	I-ALL
and	I-ALL
prolonged	I-ALL
paroxysms	B-ALL
of	I-ALL
laughter	S-ALL
,	O
atactic	B-ALL
jerky	B-ALL
movements	E-ALL
,	O
hypotonia	S-ALL
,	O
large	B-ALL
mandible	B-ALL
with	I-ALL
prognathia	S-ALL
,	O
and	O
2	B-ALL
-	I-ALL
3	I-ALL
cps	I-ALL
spike	I-ALL
and	I-ALL
wave	I-ALL
activity	I-ALL
in	I-ALL
the	I-ALL
EEG	E-ALL
.	O

The	O
occurrence	O
of	O
this	O
syndrome	O
in	O
the	O
two	O
siblings	O
suggests	O
a	O
genetic	O
etiology	O
possible	O
as	O
an	O
autosomal	B-ALL
recessive	E-ALL
trait	O
.	O

Branchio	O
-	O
oto	O
-	O
renal	O
-LRB-	O
BOR	O
-RRB-	O
syndrome	O
is	O
an	O
autosomal	B-ALL
dominant	S-ALL
disorder	E-ALL
characterized	O
by	O
branchial	S-ALL
abnormality	E-ALL
,	O
hearing	B-ALL
loss	E-ALL
,	O
and	O
renal	B-ALL
anomalies	E-ALL
.	O

All	O
cases	O
were	O
sporadic	S-ALL
.	O

All	O
patients	O
were	O
ataxic	S-ALL
,	O
severely	B-ALL
retarded	S-ALL
,	O
and	O
lacking	B-ALL
recognisable	I-ALL
speech	I-ALL
.	E-ALL

At	O
last	O
review	O
HC	O
was	O
around	O
the	O
50th	O
centile	O
in	O
three	O
patients	O
-LRB-	O
12	O
center	O
dot	O
5	O
%	O
-RRB-	O
while	O
15	O
had	O
poor	B-ALL
postnatal	I-ALL
head	I-ALL
growth	E-ALL
.	O

Short	B-ALL
stature	E-ALL
was	O
not	O
invariable	O
,	O
5	O
/	O
26	O
-LRB-	O
19	O
%	O
-RRB-	O
were	O
on	O
or	O
above	O
the	O
50th	O
centile	O
.	O

Hypotonia	B-ALL
at	I-ALL
birth	E-ALL
was	O
recorded	O
in	O
15	O
/	O
24	O
-LRB-	O
63	O
%	O
-RRB-	O
and	O
neonatal	B-ALL
feeding	B-ALL
difficulties	E-ALL
were	O
recorded	O
in	O
20	O
/	O
26	O
-LRB-	O
77	O
%	O
-RRB-	O
.	O

Epilepsy	S-ALL
was	O
present	O
in	O
26	O
/	O
27	O
-LRB-	O
96	O
%	O
-RRB-	O
with	O
onset	O
by	O
the	O
third	O
year	O
of	O
life	O
in	O
20	O
patients	O
-LRB-	O
83	O
%	O
-RRB-	O
.	O

Improvement	O
in	O
epilepsy	S-ALL
was	O
reported	O
in	O
11	O
/	O
16	O
patients	O
-LRB-	O
69	O
%	O
-RRB-	O
with	O
age	O
.	O

An	O
abnormal	B-ALL
EEG	E-ALL
was	O
reported	O
in	O
25	O
/	O
25	O
patients	O
.	O

Hypopigmentation	S-ALL
was	O
present	O
in	O
19	O
/	O
26	O
-LRB-	O
73	O
%	O
-RRB-	O
.	O

One	O
patient	O
had	O
oculocutaneous	B-ALL
albinism	S-ALL
.	O

Five	O
patients	O
could	B-ALL
not	I-ALL
walk	I-ALL
independently	E-ALL
.	O

Disrupted	B-ALL
sleep	I-ALL
patterns	E-ALL
were	O
present	O
in	O
18	O
/	O
21	O
patients	O
-LRB-	O
86	O
%	O
-RRB-	O
,	O
with	O
improvement	O
in	O
9	O
/	O
12	O
patients	O
-LRB-	O
75	O
%	O
-RRB-	O
over	O
10	O
years	O
of	O
age	O
.	O

In	O
our	O
group	O
of	O
deletional	O
cases	O
,	O
100	O
%	O
showed	O
severe	B-ALL
mental	B-ALL
retardation	S-ALL
,	O
ataxic	S-ALL
movements	E-ALL
,	O
absent	B-ALL
language	E-ALL
,	O
abnormal	B-ALL
EEG	E-ALL
,	O
happy	B-ALL
disposition	E-ALL
-LRB-	O
noted	O
in	O
infancy	S-ALL
in	O
95	O
%	O
-RRB-	O
,	O
normal	O
birth	O
weight	O
and	O
head	O
circumference	O
at	O
birth	O
,	O
and	O
a	O
large	O
,	O
wide	B-ALL
mouth	E-ALL
.	O

The	O
disorder	O
is	O
an	O
autosomal	B-ALL
dominant	B-ALL
form	E-ALL
of	O
cleft	B-ALL
lip	I-ALL
and	I-ALL
palate	E-ALL
with	O
lip	B-ALL
pits	S-ALL
,	O
and	O
is	O
the	O
most	O
common	O
syndromic	O
form	O
of	O
cleft	B-ALL
lip	E-ALL
or	I-ALL
palate	E-ALL
.	O

Popliteal	B-ALL
pterygium	S-ALL
syndrome	O
-LRB-	O
PPS	O
;	O
OMIM	O
119500	O
-RRB-	O
is	O
a	O
disorder	O
with	O
a	O
similar	O
orofacial	O
phenotype	O
that	O
also	O
includes	O
skin	B-ALL
and	I-ALL
genital	B-ALL
anomalies	E-ALL
.	O

Our	O
observations	O
demonstrate	O
that	O
haploinsufficiency	O
of	O
IRF6	O
disrupts	O
orofacial	O
development	O
and	O
are	O
consistent	O
with	O
dominant	S-ALL
-	O
negative	O
mutations	O
disturbing	O
development	O
of	O
the	O
skin	O
and	O
genitalia	O
.	O

Neurofibromatosis	S-ALL
type	O
2	O
-LRB-	O
NF2	O
-RRB-	O
is	O
a	O
highly	O
penetrant	O
autosomal	B-ALL
dominant	S-ALL
condition	O
predisposing	O
affected	O
individuals	O
to	O
schwannomas	S-ALL
and	O
meningiomas	S-ALL
.	O

The	O
proportion	O
of	O
children	O
presenting	O
with	O
meningioma	S-ALL
or	O
schwannoma	S-ALL
who	O
have	O
NF2	O
is	O
not	O
well	O
described	O
,	O
and	O
neither	O
is	O
the	O
mode	O
of	O
presentation	O
in	O
most	O
children	O
with	O
the	O
inherited	O
disease	O
.	O

To	O
determine	O
the	O
frequency	O
of	O
childhood	S-ALL
meningioma	S-ALL
and	O
schwannoma	S-ALL
cases	O
caused	O
by	O
NF2	O
and	O
the	O
mode	O
of	O
presentation	O
.	O

The	O
records	O
of	O
the	O
Manchester	O
Children	O
's	O
Tumour	S-ALL
Registry	O
from	O
1954	O
were	O
searched	O
for	O
cases	O
of	O
meningioma	S-ALL
and	O
schwannoma	S-ALL
.	O

18	O
%	O
-LRB-	O
61	O
/	O
334	O
-RRB-	O
of	O
patients	O
with	O
NF2	O
on	O
the	O
UK	O
database	O
presented	O
in	O
the	O
paediatric	O
age	O
group	O
-LRB-	O
0	O
-	O
15	O
years	O
-RRB-	O
,	O
frequently	O
with	O
the	O
symptoms	O
of	O
an	O
isolated	O
tumour	S-ALL
.	O

Three	O
of	O
22	O
children	O
presenting	O
with	O
a	O
meningioma	S-ALL
on	O
the	O
Manchester	O
Children	O
's	O
Tumour	S-ALL
Registry	O
have	O
gone	O
on	O
to	O
develop	O
classic	O
features	O
of	O
NF2	O
.	O

Clinicians	O
should	O
suspect	O
NF2	O
in	O
children	O
presenting	O
with	O
meningioma	S-ALL
,	O
schwannoma	S-ALL
,	O
and	O
skin	B-ALL
features	E-ALL
,	O
such	O
as	O
neurofibromas	S-ALL
/	O
schwannomas	S-ALL
,	O
but	O
fewer	O
than	O
6	O
caf?	B-ALL
au	I-ALL
lait	I-ALL
patches	I-ALL
,	E-ALL
who	O
thus	O
fall	O
short	O
of	O
a	O
diagnosis	O
of	O
neurofibromatosis	S-ALL
type	O
1	O
.	O

To	O
determine	O
the	O
spectrum	O
of	O
manifestations	O
in	O
neurofibromatosis	S-ALL
2	O
-LRB-	O
NF2	O
-RRB-	O
and	O
to	O
assess	O
possible	O
heterogeneity	S-ALL
,	O
we	O
evaluated	O
63	O
affected	O
individuals	O
from	O
32	O
families	O
.	O

Mean	O
age	O
-	O
at	O
-	O
onset	O
in	O
58	O
individuals	O
was	O
20	O
.	O
3	O
years	O
;	O
initial	O
symptoms	O
resulted	O
from	O
vestibular	B-ALL
schwannomas	S-ALL
-LRB-	O
44	O
.	O
4	O
%	O
-RRB-	O
,	O
other	O
CNS	B-ALL
tumors	S-ALL
-LRB-	O
22	O
.	O
2	O
%	O
-RRB-	O
,	O
skin	B-ALL
tumors	S-ALL
-LRB-	O
12	O
.	O
7	O
%	O
-RRB-	O
,	O
and	O
ocular	B-ALL
manifestations	E-ALL
including	O
cataracts	S-ALL
and	O
retinal	B-ALL
hamartomas	E-ALL
-LRB-	O
12	O
.	O
7	O
%	O
-RRB-	O
.	O

Vestibular	B-ALL
schwannomas	S-ALL
were	O
documented	O
in	O
62	O
individuals	O
-LRB-	O
98	O
.	O
4	O
%	O
-RRB-	O
;	O
other	O
findings	O
included	O
cataracts	S-ALL
-LRB-	O
81	O
.	O
0	O
%	O
-RRB-	O
,	O
skin	B-ALL
tumors	S-ALL
-LRB-	O
67	O
.	O
7	O
%	O
-RRB-	O
,	O
spinal	B-ALL
tumors	S-ALL
-LRB-	O
67	O
.	O
4	O
%	O
-RRB-	O
,	O
and	O
meningiomas	S-ALL
-LRB-	O
49	O
.	O
2	O
%	O
-RRB-	O
.	O

To	O
assess	O
possible	O
heterogeneity	S-ALL
,	O
we	O
assigned	O
affected	O
individuals	O
to	O
three	O
proposed	O
subtypes	O
-LRB-	O
representing	O
mild	O
,	O
intermediate	O
,	O
and	O
severe	O
NF2	O
-RRB-	O
based	O
on	O
age	O
-	O
at	O
-	O
onset	O
,	O
presence	O
or	O
absence	O
of	O
CNS	B-ALL
tumors	S-ALL
other	O
than	O
vestibular	B-ALL
schwannomas	S-ALL
,	O
and	O
presence	O
or	O
absence	O
of	O
retinal	B-ALL
hamartomas	E-ALL
.	O

A	O
syndrome	O
of	O
brachydactyly	S-ALL
-LRB-	O
absence	B-ALL
of	I-ALL
some	I-ALL
middle	I-ALL
or	I-ALL
distal	I-ALL
phalanges	E-ALL
-RRB-	O
,	O
aplastic	B-ALL
or	I-ALL
hypoplastic	B-ALL
nails	E-ALL
,	O
symphalangism	S-ALL
-LRB-	O
ankylois	B-ALL
of	I-ALL
proximal	I-ALL
interphalangeal	I-ALL
joints	E-ALL
-RRB-	O
,	O
synostosis	B-ALL
of	I-ALL
some	I-ALL
carpal	I-ALL
and	I-ALL
tarsal	I-ALL
bones	E-ALL
,	O
craniosynostosis	S-ALL
,	O
and	O
dysplastic	B-ALL
hip	I-ALL
joints	E-ALL
is	O
reported	O
in	O
five	O
members	O
of	O
an	O
Italian	O
family	O
.	O

It	O
may	O
represent	O
a	O
previously	O
undescribed	O
autosomal	B-ALL
dominant	B-ALL
trait	E-ALL
.	O

We	O
report	O
a	O
girl	O
aged	O
11	O
and	O
her	O
brother	O
aged	O
five	O
,	O
both	O
with	O
the	O
typical	O
features	O
of	O
Angelman	O
syndrome	O
,	O
and	O
three	O
isolated	B-ALL
cases	E-ALL
.	O

The	O
possible	O
effect	O
of	O
voluntary	O
restriction	O
of	O
family	O
size	O
after	O
the	O
birth	O
of	O
an	O
affected	O
child	O
is	O
discussed	O
in	O
relation	O
to	O
the	O
possibility	O
of	O
autosomal	B-ALL
recessive	E-ALL
inheritance	E-ALL
,	O
but	O
a	O
recurrence	O
risk	O
of	O
5	O
%	O
is	O
appropriate	O
for	O
use	O
in	O
the	O
genetic	O
clinic	O
.	O

We	O
describe	O
a	O
14	O
-	O
month	O
-	O
old	O
girl	O
with	O
unilateral	O
congenital	O
cholesteatoma	S-ALL
and	O
anomalies	B-ALL
of	I-ALL
the	I-ALL
facial	I-ALL
nerve	E-ALL
in	O
addition	O
to	O
the	O
more	O
common	O
branchial	S-ALL
arch	I-ALL
,	I-ALL
otic	B-ALL
,	I-ALL
and	I-ALL
renal	B-ALL
malformations	E-ALL
comprising	O
the	O
branchio	O
-	O
oto	O
-	O
renal	O
-LRB-	O
BOR	O
-RRB-	O
syndrome	O
.	O

Her	O
mother	O
also	O
has	O
the	O
BOR	O
syndrome	O
and	O
unilateral	B-ALL
duplication	I-ALL
of	I-ALL
the	I-ALL
facial	I-ALL
nerve	E-ALL
.	O

This	O
is	O
the	O
first	O
study	O
of	O
a	O
BOR	O
patient	O
with	O
congenital	O
cholesteatoma	S-ALL
and	O
the	O
second	O
family	O
in	O
which	O
cholesteatoma	S-ALL
and	O
anomalies	B-ALL
of	I-ALL
the	I-ALL
facial	I-ALL
nerve	E-ALL
are	O
described	O
in	O
patients	O
with	O
the	O
BO	O
/	O
BOR	O
syndrome	O
.	O

We	O
review	O
the	O
congenital	O
cholesteatoma	S-ALL
literature	O
and	O
discuss	O
hypotheses	O
for	O
the	O
pathogenesis	O
of	O
this	O
entity	O
in	O
light	O
of	O
this	O
new	O
report	O
.	O

Five	O
new	O
cases	O
are	O
presented	O
of	O
a	O
syndrome	O
characterized	O
mainly	O
by	O
severe	B-ALL
mental	B-ALL
retardation	S-ALL
,	O
epilepsy	S-ALL
,	O
puppet	B-ALL
-	I-ALL
like	I-ALL
ataxic	B-ALL
movements	E-ALL
,	O
microbrachycephaly	S-ALL
,	O
prognathism	S-ALL
,	O
tongue	B-ALL
protrusion	E-ALL
,	O
and	O
inappropriate	B-ALL
paroxysms	B-ALL
of	I-ALL
laughter	S-ALL
.	O

To	O
evaluate	O
patients	O
with	O
multiple	O
endocrine	B-ALL
neoplasia	S-ALL
type	O
1	O
-LRB-	O
MEN	O
1	O
-RRB-	O
for	O
cutaneous	B-ALL
manifestations	E-ALL
.	O

A	O
consecutive	O
sample	O
of	O
32	O
individuals	O
with	O
previously	O
diagnosed	O
MEN1	O
who	O
were	O
not	O
preselected	O
for	O
the	O
presence	O
of	O
skin	B-ALL
lesions	E-ALL
were	O
examined	O
for	O
cutaneous	B-ALL
abnormalities	E-ALL
.	O

To	O
determine	O
the	O
frequency	O
of	O
skin	B-ALL
lesions	E-ALL
in	O
patients	O
with	O
MEN1	O
.	O

Multiple	O
facial	B-ALL
angiofibromas	S-ALL
were	O
observed	O
in	O
28	O
-LRB-	O
88	O
%	O
-RRB-	O
of	O
the	O
patients	O
with	O
MEN1	O
,	O
with	O
16	O
patients	O
-LRB-	O
50	O
%	O
-RRB-	O
having	O
5	O
or	O
more	O
.	O

Angiofibromas	S-ALL
were	O
clinically	O
and	O
histologically	O
identical	O
to	O
those	O
in	O
individuals	O
with	O
tuberous	O
sclerosis	O
.	O

Collagenomas	S-ALL
were	O
observed	O
in	O
23	O
patients	O
-LRB-	O
72	O
%	O
-RRB-	O
.	O

Also	O
observed	O
were	O
cafe	B-ALL
au	I-ALL
lait	I-ALL
macules	E-ALL
in	O
12	O
patients	O
-LRB-	O
38	O
%	O
-RRB-	O
,	O
lipomas	S-ALL
in	O
11	O
patients	O
-LRB-	O
34	O
%	O
-RRB-	O
,	O
confetti	B-ALL
-	I-ALL
like	I-ALL
hypopigmented	I-ALL
macules	E-ALL
in	O
2	O
patients	O
-LRB-	O
6	O
%	O
-RRB-	O
,	O
and	O
multiple	O
gingival	B-ALL
papules	E-ALL
in	O
2	O
patients	O
-LRB-	O
6	O
%	O
-RRB-	O
.	O

Multiple	O
angiofibromas	S-ALL
,	O
collagenomas	S-ALL
,	O
lipomas	S-ALL
,	O
confetti	B-ALL
-	I-ALL
like	I-ALL
hypopigmented	I-ALL
macules	E-ALL
and	O
multiple	O
gingival	B-ALL
papules	E-ALL
are	O
cutaneous	B-ALL
manifestations	E-ALL
of	O
MEN1	O
and	O
should	O
be	O
looked	O
for	O
in	O
both	O
family	O
members	O
of	O
patients	O
with	O
MEN1	O
and	O
individuals	O
with	O
hyperparathyroidism	S-ALL
of	O
other	O
MEN1	O
-	O
associated	O
tumors	S-ALL
.	O

Multiple	O
angiofibromas	S-ALL
can	O
no	O
longer	O
be	O
considered	O
pathognomonic	O
for	O
tuberous	O
sclerosis	O
.	O

The	O
observation	O
of	O
angiofibromas	S-ALL
in	O
individuals	O
without	O
tuberous	O
sclerosis	O
necessitates	O
further	O
biochemical	O
testing	O
for	O
MEN1	O
.	O

The	O
child	O
was	O
hypotonic	B-ALL
at	I-ALL
birth	E-ALL
,	O
and	O
high	O
-	O
resolution	O
banding	O
failed	O
to	O
reveal	O
the	O
deletion	O
of	O
15q11	O
-	O
13	O
,	O
a	O
deletion	O
which	O
is	O
found	O
in	O
50	O
%	O
-	O
70	O
%	O
of	O
patients	O
with	O
PWS	O
.	O

The	O
results	O
of	O
a	O
systematic	O
study	O
of	O
the	O
otological	O
aspects	O
in	O
13	O
cases	O
of	O
earpit	S-ALL
-	O
deafness	S-ALL
syndrome	O
are	O
reported	O
.	O

A	O
convincing	O
explanation	O
of	O
the	O
poor	O
results	O
of	O
exploratory	O
tympanotomies	O
in	O
cases	O
with	O
mixed	B-ALL
hearing	B-ALL
loss	E-ALL
is	O
not	O
furnished	O
.	O

If	O
the	O
hearing	B-ALL
loss	E-ALL
is	O
confined	O
to	O
conduction	S-ALL
and	O
ankylosis	B-ALL
of	I-ALL
the	I-ALL
stapes	E-ALL
or	O
a	O
disconnection	B-ALL
of	I-ALL
the	I-ALL
ossicular	I-ALL
chain	E-ALL
is	O
suspected	O
,	O
exploratory	O
tympanotomy	O
can	O
be	O
expected	O
to	O
be	O
successful	O
.	O

Angelman	O
syndrome	O
-LRB-	O
AS	O
-RRB-	O
,	O
characterized	O
by	O
mental	B-ALL
retardation	S-ALL
,	O
seizures	S-ALL
,	O
frequent	B-ALL
smiling	I-ALL
and	I-ALL
laughter	S-ALL
,	O
and	O
abnormal	B-ALL
gait	E-ALL
,	O
is	O
one	O
of	O
the	O
best	O
examples	O
of	O
human	O
disease	O
in	O
which	O
genetic	O
imprinting	O
plays	O
a	O
role	O
.	O

In	O
about	O
70	O
%	O
of	O
cases	O
,	O
AS	O
is	O
caused	O
by	O
de	B-ALL
novo	E-ALL
maternal	O
deletions	O
at	O
15q11	O
-	O
q13	O
-LRB-	O
ref	O
.	O

We	O
have	O
looked	O
for	O
novel	O
UBE3A	O
mutations	O
in	O
nondeletion	O
/	O
non	O
-	O
UPD	O
/	O
non	O
-	O
imprinting	O
mutation	O
-LRB-	O
NDUI	O
-RRB-	O
AS	O
patients	O
and	O
have	O
found	O
one	O
patient	O
who	O
is	O
heterozygous	O
for	O
a	O
5	O
-	O
bp	O
de	B-ALL
novo	E-ALL
tandem	O
duplication	O
.	O

However	O
,	O
unilateral	B-ALL
renal	B-ALL
agenesis	E-ALL
was	O
present	O
in	O
the	O
first	O
child	O
,	O
a	O
defect	O
infrequently	O
found	O
in	O
the	O
BOF	O
syndrome	O
.	O

Both	O
the	O
mother	O
and	O
her	O
son	O
also	O
had	O
bilateral	B-ALL
supra	I-ALL
-	I-ALL
auricular	I-ALL
sinuses	E-ALL
.	O

The	O
BOFS	O
appears	O
to	O
represent	O
a	O
spectrum	O
involving	O
the	O
development	B-ALL
of	I-ALL
the	I-ALL
optic	I-ALL
vesicles	E-ALL
,	O
branchial	B-ALL
arches	E-ALL
,	O
eyes	O
,	O
face	O
,	O
lips	O
,	O
and	O
kidneys	O
.	O

The	O
variations	O
seen	O
in	O
this	O
disorder	O
and	O
the	O
overlap	O
between	O
this	O
condition	O
and	O
the	O
branchio	O
-	O
oto	O
-	O
renal	O
syndrome	O
may	O
represent	O
different	O
mutations	O
within	O
a	O
single	O
gene	O
or	O
may	O
be	O
a	O
contiguous	B-ALL
gene	I-ALL
deletion	I-ALL
syndrome	E-ALL
.	O

Brachydactyly	B-ALL
type	I-ALL
A1	E-ALL
-LRB-	O
BDA1	S-ALL
-RRB-	O
is	O
caused	O
by	O
mutations	O
in	O
the	O
Indian	O
hedgehog	O
gene	O
,	O
IHH	O
,	O
on	O
chromosome	O
2q35	O
-	O
36	O
.	O

All	O
affected	O
family	O
members	O
demonstrated	O
significant	B-ALL
homogeneous	I-ALL
phenotype	E-ALL
and	O
some	O
unique	O
clinical	O
features	O
different	O
from	O
those	O
associated	O
with	O
the	O
reported	O
BDA1	O
mutations	O
in	O
IHH	O
.	O

The	O
clinical	O
features	O
of	O
Angelman	O
syndrome	O
-LRB-	O
AS	O
-RRB-	O
comprise	O
severe	B-ALL
mental	B-ALL
retardation	S-ALL
,	O
postnatal	B-ALL
microcephaly	S-ALL
,	O
macrostomia	S-ALL
and	O
prognathia	S-ALL
,	O
absence	B-ALL
of	I-ALL
speech	E-ALL
,	O
ataxia	S-ALL
,	O
and	O
a	O
happy	B-ALL
disposition	E-ALL
.	O

We	O
report	O
on	O
seven	O
patients	O
who	O
lack	O
most	O
of	O
these	O
features	O
,	O
but	O
presented	O
with	O
obesity	S-ALL
,	O
muscular	B-ALL
hypotonia	S-ALL
and	O
mild	B-ALL
mental	B-ALL
retardation	S-ALL
.	O

Blood	O
samples	O
from	O
125	O
unrelated	O
families	O
with	O
classical	O
type	O
2	O
neurofibromatosis	S-ALL
-LRB-	O
NF2	O
-RRB-	O
with	O
bilateral	B-ALL
vestibular	B-ALL
schwannomas	S-ALL
have	O
been	O
analysed	O
for	O
mutations	O
in	O
the	O
NF2	O
gene	O
.	O

Subjects	O
with	O
truncating	O
mutations	O
were	O
significantly	O
more	O
likely	O
to	O
have	O
symptoms	O
before	O
20	O
years	O
of	O
age	O
-LRB-	O
p	O
-LRB-	O
0	O
.	O
001	O
-RRB-	O
and	O
to	O
develop	O
at	O
least	O
two	O
symptomatic	O
CNS	B-ALL
tumours	S-ALL
in	O
addition	O
to	O
vestibular	B-ALL
schwannoma	S-ALL
before	O
30	O
years	O
-LRB-	O
p	O
-LRB-	O
0	O
.	O
001	O
-RRB-	O
.	O

Four	O
further	O
truncating	O
mutations	O
were	O
in	O
mosaic	O
form	O
and	O
were	O
associated	B-ALL
with	I-ALL
milder	I-ALL
disease	I-ALL
than	I-ALL
other	I-ALL
similar	I-ALL
mutations	E-ALL
.	O

We	O
present	O
a	O
child	O
with	O
mild	B-ALL
to	I-ALL
moderate	B-ALL
global	B-ALL
developmental	B-ALL
delay	E-ALL
including	O
severe	O
speech	B-ALL
impairment	E-ALL
,	O
inappropriate	B-ALL
happy	B-ALL
demeanor	E-ALL
,	O
wide	B-ALL
-	I-ALL
based	I-ALL
gait	E-ALL
,	O
frequent	B-ALL
ear	I-ALL
infections	E-ALL
with	O
mild	O
hearing	B-ALL
loss	E-ALL
,	O
deep	B-ALL
-	I-ALL
set	I-ALL
eyes	E-ALL
,	O
a	O
wide	B-ALL
mouth	E-ALL
,	O
widely	B-ALL
-	I-ALL
spaced	I-ALL
teeth	E-ALL
,	O
normal	O
head	O
circumference	O
,	O
and	O
no	O
seizures	S-ALL
.	O

Therefore	O
,	O
mutations	O
in	O
Herc2	O
lead	O
to	O
the	O
neuromuscular	O
secretory	O
vesicle	O
and	O
sperm	O
acrosome	O
defects	O
,	O
other	O
developmental	B-ALL
abnormalities	E-ALL
and	O
juvenile	B-ALL
lethality	E-ALL
of	O
jdf2	O
mice	O
.	O

Fifteen	O
patients	O
with	O
bilateral	B-ALL
acoustic	B-ALL
neuromas	E-ALL
are	O
presented	O
.	O

Ten	O
patients	O
became	O
symptomatic	O
before	O
age	O
21	O
,	O
and	O
9	O
of	O
these	O
patients	O
developed	O
additional	O
central	B-ALL
nervous	B-ALL
system	I-ALL
tumors	S-ALL
.	O

Cutaneous	B-ALL
manifestations	E-ALL
of	O
neurofibromatosis	S-ALL
and	O
a	O
positive	O
family	O
history	O
of	O
this	O
disorder	O
were	O
absent	O
in	O
many	O
of	O
the	O
patients	O
.	O

The	O
pathogenesis	O
of	O
these	O
tumors	S-ALL
,	O
the	O
genetic	O
aspects	O
of	O
this	O
disorder	O
,	O
and	O
potential	O
treatment	O
alternatives	O
are	O
discussed	O
.	O

Prader	O
-	O
Willi	O
syndrome	O
-LRB-	O
PWS	O
-RRB-	O
and	O
Angelman	O
syndrome	O
-LRB-	O
AS	O
-RRB-	O
are	O
distinct	O
mental	B-ALL
retardation	S-ALL
disorders	O
associated	O
with	O
deletions	O
of	O
proximal	O
15q	O
-LRB-	O
q11	O
-	O
q13	O
-RRB-	O
of	O
different	O
parental	O
origin	O
.	O

FISH	O
analysis	O
on	O
a	O
previously	O
reported	O
case	O
of	O
familial	B-ALL
AS	E-ALL
confirmed	O
a	O
submicroscopic	O
deletion	O
including	O
YACs	O
corresponding	O
to	O
LS6	O
-	O
1	O
,	O
TD3	O
-	O
21	O
and	O
GABRB3	O
and	O
supports	O
the	O
separation	O
of	O
the	O
PWS	O
and	O
AS	O
critical	O
regions	O
.	O

The	O
authors	O
report	O
a	O
new	O
case	O
of	O
Townes	O
-	O
Brocks	O
syndrome	O
with	O
cardiac	B-ALL
defect	E-ALL
,	O
ossicular	B-ALL
anomalies	E-ALL
and	O
dominant	S-ALL
transmission	E-ALL
.	O

The	O
intrafamilial	B-ALL
variability	S-ALL
of	I-ALL
the	I-ALL
phenotype	E-ALL
and	O
the	O
difficulty	O
of	O
diagnosis	O
in	O
isolated	B-ALL
cases	E-ALL
are	O
underlined	O
.	O

Nevoid	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
syndrome	O
-LRB-	O
NBCCS	O
-RRB-	O
is	O
rare	O
in	O
black	O
persons	O
.	O

We	O
describe	O
an	O
11	O
-	O
year	O
-	O
old	O
black	O
boy	O
with	O
NBCCS	O
who	O
presented	O
with	O
exotropia	S-ALL
and	O
a	O
painful	O
,	O
expanding	O
,	O
cystic	B-ALL
mass	I-ALL
in	I-ALL
the	I-ALL
left	I-ALL
posterior	I-ALL
alveolar	I-ALL
ridge	E-ALL
.	O

Further	O
examination	O
revealed	O
odontogenic	B-ALL
keratocysts	E-ALL
with	O
palmar	B-ALL
and	I-ALL
plantar	I-ALL
pitting	E-ALL
.	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
report	O
of	O
a	O
black	O
patient	O
with	O
NBCCS	O
presenting	O
with	O
exotropia	S-ALL
and	O
an	O
impacted	O
molar	O
displaced	O
into	O
the	O
orbit	O
by	O
an	O
odontogenic	B-ALL
keratocyst	E-ALL
.	O

The	O
diagnosis	O
,	O
size	O
and	O
operation	O
results	O
in	O
41	O
acoustic	B-ALL
neurinomas	S-ALL
-LRB-	O
26	O
females	O
and	O
15	O
males	O
-RRB-	O
are	O
presented	O
.	O

In	O
one	O
case	O
the	O
tumor	S-ALL
was	O
bilateral	O
.	O

Out	O
of	O
the	O
total	O
of	O
41	O
tumors	S-ALL
,	O
12	O
.	O
5	O
%	O
were	O
small	O
acoustic	B-ALL
neurinomas	S-ALL
.	O

As	O
a	O
rule	O
,	O
at	O
diagnosis	O
the	O
tumors	S-ALL
were	O
larger	O
in	O
females	O
than	O
in	O
males	O
.	O

Ten	O
of	O
the	O
small	O
and	O
medium	O
size	O
acoustic	B-ALL
neurinomas	S-ALL
had	O
no	O
brain	O
stem	O
and	O
cerebellar	B-ALL
symptoms	E-ALL
or	O
signs	O
at	O
all	O
,	O
only	O
the	O
8th	B-ALL
cranial	I-ALL
nerve	E-ALL
was	O
affected	O
.	O

All	O
large	O
tumors	S-ALL
already	O
had	O
brain	B-ALL
stem	I-ALL
symptoms	E-ALL
and	O
one	O
-	O
third	O
of	O
them	O
also	O
had	O
cerebellar	B-ALL
symptoms	E-ALL
,	O
lesions	B-ALL
of	I-ALL
further	I-ALL
cranial	I-ALL
nerves	E-ALL
and	O
increasing	B-ALL
intracranial	I-ALL
pressure	E-ALL
.	O

All	O
these	O
findings	O
were	O
always	O
present	O
in	O
giant	O
tumors	S-ALL
.	O

Neurootological	O
functional	O
laboratory	O
examinations	O
can	O
not	O
be	O
replaced	O
by	O
CT	O
because	O
of	O
the	O
possibility	O
of	O
false	O
negative	O
findings	O
in	O
the	O
smallest	O
acoustic	B-ALL
neurinomas	S-ALL
.	O

As	O
regards	O
the	O
preservation	O
of	O
hearing	O
,	O
the	O
results	O
are	O
among	O
the	O
best	O
particularly	O
in	O
tumors	S-ALL
that	O
were	O
diagnosed	O
as	O
small	O
or	O
medium	O
in	O
this	O
series	O
.	O

Thus	O
it	O
is	O
apparent	O
that	O
the	O
size	O
of	O
a	O
diagnosed	O
acoustic	B-ALL
neurinoma	E-ALL
is	O
more	O
important	O
for	O
surgical	O
results	O
than	O
the	O
chosen	O
approach	O
to	O
the	O
tumor	S-ALL
.	O

We	O
have	O
investigated	O
the	O
incidence	O
of	O
Gorlin	O
syndrome	O
-LRB-	O
GS	O
-RRB-	O
in	O
patients	O
with	O
the	O
childhood	S-ALL
brain	B-ALL
tumour	S-ALL
,	O
medulloblastoma	S-ALL
.	O

One	O
hundred	O
and	O
seventy	O
-	O
three	O
consecutive	O
cases	O
of	O
medulloblastoma	S-ALL
in	O
the	O
North	O
-	O
West	O
Regional	O
Health	O
Authority	O
between	O
1954	O
and	O
1989	O
-LRB-	O
Manchester	O
Regional	O
Health	O
Board	O
before	O
1974	O
-RRB-	O
were	O
studied	O
.	O

A	O
further	O
case	O
at	O
50	O
%	O
risk	O
of	O
GS	O
died	O
of	O
a	O
brain	B-ALL
tumour	S-ALL
aged	O
4	O
years	O
.	O

The	O
incidence	O
of	O
GS	O
in	O
medulloblastoma	S-ALL
is	O
,	O
therefore	O
,	O
probably	O
between	O
1	O
-	O
2	O
%	O
.	O

A	O
population	O
based	O
study	O
of	O
GS	O
in	O
the	O
region	O
started	O
in	O
1983	O
was	O
used	O
to	O
assess	O
the	O
incidence	O
of	O
medulloblastoma	S-ALL
in	O
GS	O
,	O
which	O
was	O
found	O
to	O
be	O
between	O
3	O
-	O
5	O
%	O
.	O

In	O
view	O
of	O
the	O
early	B-ALL
age	I-ALL
of	I-ALL
onset	E-ALL
in	O
GS	O
-LRB-	O
mean	O
2	O
years	O
-RRB-	O
children	O
presenting	O
with	O
medulloblastoma	S-ALL
,	O
especially	O
under	O
5	O
years	O
,	O
should	O
be	O
examined	O
for	O
signs	O
of	O
the	O
syndrome	O
.	O

Those	O
at	O
high	O
risk	O
of	O
developing	O
multiple	O
invasive	O
basal	B-ALL
cell	I-ALL
carcinomata	E-ALL
will	O
then	O
be	O
identified	O
.	O

Townes	O
-	O
Brocks	O
syndrome	O
-LRB-	O
TBS	O
,	O
OMIM	O
#	O
107480	O
-RRB-	O
is	O
a	O
rare	O
autosomal	B-ALL
-	I-ALL
dominant	S-ALL
malformation	O
syndrome	O
with	O
a	O
combination	O
of	O
anal	B-ALL
,	I-ALL
renal	I-ALL
,	I-ALL
limb	I-ALL
and	I-ALL
ear	B-ALL
anomalies	E-ALL
.	O

Here	O
we	O
demonstrate	O
that	O
SALL1	O
mutations	O
cause	O
TBS	O
in	O
a	O
family	O
with	O
vertical	O
transmission	O
of	O
TBS	O
and	O
in	O
an	O
unrelated	O
family	O
with	O
a	O
sporadic	S-ALL
case	O
of	O
TBS	O
.	O

Angelman	O
syndrome	O
is	O
a	O
neurological	B-ALL
disorder	E-ALL
whose	O
symptoms	O
include	O
severe	B-ALL
mental	B-ALL
retardation	S-ALL
,	O
loss	B-ALL
of	I-ALL
motor	I-ALL
coordination	E-ALL
,	O
and	O
sleep	B-ALL
disturbances	E-ALL
.	O

Neurofibromatosis	S-ALL
includes	O
the	O
common	O
``	O
peripheral	O
''	O
form	O
and	O
a	O
recently	O
documented	O
``	O
central	O
''	O
form	O
.	O

Central	O
neurofibromatosis	S-ALL
with	O
bilateral	B-ALL
acoustic	B-ALL
neuroma	E-ALL
is	O
an	O
autosomal	B-ALL
dominant	S-ALL
disorder	E-ALL
beginning	O
about	O
20	O
years	O
of	O
age	O
,	O
accompanied	O
by	O
mild	O
skin	B-ALL
changes	E-ALL
.	O

In	O
three	O
kindreds	O
with	O
central	O
neurofibromatosis	S-ALL
,	O
we	O
measured	O
nerve	O
growth	O
factor	O
in	O
serum	O
by	O
radioimmunoassay	O
and	O
radioreceptor	O
assay	O
.	O

In	O
contrast	O
,	O
in	O
peripheral	O
neurofibromatosis	S-ALL
,	O
only	O
the	O
functional	O
activity	O
of	O
nerve	O
growth	O
factor	O
has	O
been	O
reported	O
increased	O
.	O

Central	O
and	O
peripheral	O
forms	O
of	O
neurofibromatosis	S-ALL
are	O
closely	O
related	O
but	O
discrete	O
diseases	O
which	O
appear	O
to	O
have	O
separate	O
alterations	O
in	O
nerve	O
growth	O
factor	O
activity	O
.	O

Popliteal	B-ALL
pterygium	S-ALL
syndrome	O
-LRB-	O
PPS	O
-RRB-	O
is	O
a	O
rare	O
autosomal	B-ALL
dominant	S-ALL
disorder	E-ALL
,	O
thought	O
to	O
occur	O
with	O
an	O
incidence	O
of	O
approximately	O
1	O
in	O
300	O
000	O
live	O
births	O
.	O

The	O
main	O
clinical	O
manifestations	O
are	O
popliteal	B-ALL
webbing	E-ALL
,	O
cleft	B-ALL
lip	E-ALL
,	I-ALL
cleft	B-ALL
palate	E-ALL
,	O
lower	B-ALL
lip	B-ALL
pits	S-ALL
,	O
syndactyly	S-ALL
,	O
and	O
genital	B-ALL
and	I-ALL
nail	B-ALL
anomalies	E-ALL
.	O

This	O
report	O
describes	O
the	O
clinical	O
features	O
in	O
two	O
families	O
with	O
PPS	O
and	O
one	O
isolated	B-ALL
case	E-ALL
,	O
showing	O
the	O
range	O
of	O
anomalies	O
found	O
both	O
within	O
and	O
between	O
the	O
families	O
.	O

PPS	O
has	O
some	O
features	O
in	O
common	O
with	O
Van	O
der	O
Woude	O
syndrome	O
-LRB-	O
VWS	O
-RRB-	O
,	O
also	O
inherited	O
as	O
an	O
autosomal	B-ALL
dominant	S-ALL
condition	O
,	O
with	O
cleft	B-ALL
lip	E-ALL
/	I-ALL
palate	E-ALL
and	O
,	O
more	O
distinctively	O
,	O
lower	B-ALL
lip	B-ALL
pits	S-ALL
.	O

The	O
nevoid	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
syndrome	O
-LRB-	O
NBCCS	O
-RRB-	O
is	O
an	O
autosomal	B-ALL
dominant	E-ALL
disorder	E-ALL
characterized	O
by	O
multiple	O
basal	B-ALL
cell	I-ALL
carcinomas	E-ALL
-LRB-	O
BCCs	O
-RRB-	O
,	O
pits	B-ALL
of	I-ALL
the	I-ALL
palms	I-ALL
and	I-ALL
soles	E-ALL
,	O
jaw	B-ALL
keratocysts	E-ALL
,	O
a	O
variety	O
of	O
other	B-ALL
tumors	S-ALL
,	O
and	O
developmental	B-ALL
abnormalities	E-ALL
.	O

Familial	O
and	O
sporadic	S-ALL
BCCs	O
display	O
loss	O
of	O
heterozygosity	O
in	O
this	O
region	O
,	O
consistent	O
with	O
the	O
gene	O
being	O
a	O
tumor	S-ALL
suppressor	O
.	O

Mutation	O
analysis	O
revealed	O
alterations	O
of	O
PTC	O
in	O
NBCCS	O
patients	O
and	O
in	O
related	O
tumors	S-ALL
.	O

We	O
propose	O
that	O
a	O
reduction	O
in	O
expression	O
of	O
the	O
patched	O
gene	O
can	O
lead	O
to	O
the	O
developmental	B-ALL
abnormalities	E-ALL
observed	O
in	O
the	O
syndrome	O
and	O
that	O
complete	O
loss	O
of	O
patched	O
function	O
contributes	O
to	O
transformation	O
of	O
certain	O
cell	O
types	O
.	O

Branchiootorenal	O
syndrome	O
is	O
an	O
autosomal	B-ALL
dominant	S-ALL
disorder	E-ALL
that	O
affects	O
an	O
estimated	O
2	O
%	O
of	O
profoundly	B-ALL
deaf	S-ALL
children	O
.	O

In	O
addition	O
to	O
hearing	B-ALL
impairment	E-ALL
,	O
it	O
is	O
characterized	O
by	O
a	O
lop	B-ALL
-	I-ALL
ear	I-ALL
deformity	E-ALL
,	O
preauricular	B-ALL
pits	S-ALL
,	O
branchial	B-ALL
cleft	I-ALL
sinus	I-ALL
tracts	E-ALL
,	O
and	O
renal	B-ALL
anomalies	E-ALL
.	O

Studies	O
of	O
Bmp5	O
mutations	O
in	O
short	B-ALL
ear	E-ALL
mice	O
have	O
shown	O
that	O
at	O
least	O
one	O
other	O
BMP	O
gene	O
is	O
also	O
required	O
for	O
normal	O
skeletal	O
development	O
.	O

The	O
highly	O
specific	O
skeletal	O
alterations	O
in	O
bp	O
and	O
short	B-ALL
ear	E-ALL
mice	O
suggest	O
that	O
different	O
members	O
of	O
the	O
BMP	O
family	O
control	O
the	O
formation	O
of	O
different	O
morphological	O
features	O
in	O
the	O
mammalian	O
skeleton	O
.	O

Mutations	O
in	O
SALL1	O
and	O
GLI3	O
are	O
responsible	O
for	O
human	O
limb	B-ALL
malformation	E-ALL
syndromes	O
.	O

We	O
identified	O
truncating	O
mutations	O
in	O
SALL1	O
and	O
GLI3	O
in	O
patients	O
with	O
limb	B-ALL
malformation	E-ALL
and	O
studied	O
the	O
contribution	O
of	O
nonsense	O
-	O
mediated	O
decay	O
-LRB-	O
NMD	O
-RRB-	O
to	O
the	O
expression	O
of	O
mutant	O
mRNA	O
in	O
patient	O
-	O
derived	O
fibroblasts	O
.	O

Stereotactic	O
radiosurgery	O
is	O
the	O
principal	O
alternative	O
to	O
microsurgical	O
resection	O
for	O
acoustic	B-ALL
neuromas	E-ALL
-LRB-	O
vestibular	B-ALL
schwannomas	S-ALL
-RRB-	O
.	O

The	O
goals	O
of	O
radiosurgery	O
are	O
the	O
long	O
-	O
term	O
prevention	O
of	O
tumor	S-ALL
growth	O
,	O
maintenance	O
of	O
neurologic	O
function	O
,	O
and	O
prevention	O
of	O
new	O
neurologic	O
deficits	O
.	O

We	O
evaluated	O
162	O
consecutive	O
patients	O
who	O
underwent	O
radiosurgery	O
for	O
acoustic	B-ALL
neuromas	E-ALL
between	O
1987	O
and	O
1992	O
by	O
means	O
of	O
serial	O
imaging	O
tests	O
,	O
clinical	O
evaluations	O
,	O
and	O
a	O
survey	O
between	O
5	O
and	O
10	O
years	O
after	O
the	O
procedure	O
.	O

The	O
average	O
dose	O
of	O
radiation	O
to	O
the	O
tumor	S-ALL
margin	O
was	O
16	O
Gy	O
,	O
and	O
the	O
mean	O
transverse	O
diameter	O
of	O
the	O
tumor	S-ALL
was	O
22	O
mm	O
-LRB-	O
range	O
,	O
8	O
to	O
39	O
-RRB-	O
.	O

Resection	O
had	O
been	O
performed	O
previously	O
in	O
42	O
patients	O
-LRB-	O
26	O
percent	O
-RRB-	O
;	O
in	O
13	O
patients	O
the	O
tumor	S-ALL
represented	O
a	O
recurrence	O
of	O
disease	O
after	O
a	O
previous	O
total	O
resection	O
.	O

The	O
rate	O
of	O
tumor	S-ALL
control	O
-LRB-	O
with	O
no	O
resection	O
required	O
-RRB-	O
was	O
98	O
percent	O
.	O

One	O
hundred	O
tumors	S-ALL
-LRB-	O
62	O
percent	O
-RRB-	O
became	O
smaller	O
,	O
53	O
-LRB-	O
33	O
percent	O
-RRB-	O
remained	O
unchanged	O
in	O
size	O
,	O
and	O
9	O
-LRB-	O
6	O
percent	O
-RRB-	O
became	O
slightly	O
larger	O
.	O

No	O
new	O
neurologic	B-ALL
deficits	E-ALL
appeared	O
more	O
than	O
28	O
months	O
after	O
radiosurgery	O
.	O

Radiosurgery	O
can	O
provide	O
long	O
-	O
term	O
control	O
of	O
acoustic	B-ALL
neuromas	E-ALL
while	O
preserving	O
neurologic	O
function	O
.	O

A	O
9	O
-	O
year	O
-	O
old	O
mentally	B-ALL
retarded	E-ALL
girl	O
with	O
multiple	O
congenital	O
anomalies	O
was	O
found	O
to	O
carry	O
a	O
balanced	O
13	O
/	O
14	O
Robertsonian	O
translocation	O
-	O
LSB	O
-	O
45	O
,	O
XX	O
,	O
t	O
-LRB-	O
13q14q	O
-RRB-	O
-	O
RSB	O
-	O
which	O
was	O
also	O
present	O
in	O
her	O
father	O
.	O

It	O
is	O
suggested	O
that	O
uniparental	O
disomy	O
may	O
be	O
the	O
basis	O
for	O
abnormal	B-ALL
development	E-ALL
in	O
at	O
least	O
some	O
phenotypically	O
abnormal	O
familial	O
balanced	O
-	O
translocation	O
carriers	O
.	O

Familial	O
Angelman	O
syndrome	O
-LRB-	O
AS	O
-RRB-	O
can	O
result	O
from	O
mutations	O
in	O
chromosome	O
15q11q13	O
that	O
,	O
when	O
transmitted	O
from	O
father	O
to	O
child	O
,	O
result	O
in	O
no	O
phenotypic	B-ALL
abnormality	E-ALL
but	O
,	O
when	O
transmitted	O
from	O
mother	O
to	O
child	O
,	O
cause	O
AS	O
.	O

These	O
mutations	O
therefore	O
behave	O
neither	O
as	O
dominant	S-ALL
nor	O
as	O
recessive	O
mutations	O
but	O
,	O
rather	O
,	O
show	O
an	O
imprinted	O
mode	B-ALL
of	I-ALL
inheritance	E-ALL
.	O

A	O
mother	O
and	O
son	O
with	O
bilateral	B-ALL
branchial	S-ALL
sinuses	E-ALL
,	O
intrauterine	B-ALL
and	I-ALL
postnatal	B-ALL
growth	B-ALL
retardation	S-ALL
,	O
unusual	B-ALL
facial	B-ALL
appearance	E-ALL
,	O
and	O
premature	B-ALL
aging	E-ALL
in	O
the	O
mother	O
are	O
reported	O
.	O

No	O
hormonal	O
or	O
systemic	O
cause	O
of	O
growth	B-ALL
retardation	S-ALL
was	O
identified	O
.	O

It	O
is	O
suggested	O
that	O
this	O
syndrome	O
is	O
a	O
dominant	S-ALL
trait	E-ALL
,	O
the	O
mother	O
being	O
the	O
initial	O
mutant	O
.	O

In	O
this	O
report	O
we	O
present	O
a	O
subject	O
affected	O
by	O
nevoid	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
syndrome	O
-LRB-	O
NBCCS	O
-RRB-	O
,	O
showing	O
also	O
bilateral	B-ALL
mandibular	I-ALL
coronoid	I-ALL
processes	I-ALL
hyperplasia	E-ALL
,	O
a	O
hitherto	O
unreported	O
association	O
.	O

Our	O
observation	O
of	O
bilateral	B-ALL
hyperplasia	I-ALL
of	I-ALL
the	I-ALL
mandibular	I-ALL
coronoid	I-ALL
processes	E-ALL
in	O
a	O
boy	O
with	O
NBCCS	O
may	O
prompt	O
a	O
retrospective	O
and	O
prospective	O
review	O
of	O
other	O
patients	O
affected	O
by	O
this	O
syndrome	O
in	O
order	O
to	O
establish	O
if	O
this	O
anomaly	O
is	O
part	O
of	O
it	O
.	O

We	O
report	O
a	O
man	O
who	O
had	O
the	O
branchio	O
-	O
oto	O
-	O
renal	O
-LRB-	O
BOR	O
-RRB-	O
syndrome	O
with	O
crossed	O
renal	B-ALL
ectopia	E-ALL
.	O

His	O
three	O
children	O
were	O
born	O
with	O
bilateral	B-ALL
renal	B-ALL
agenesis	E-ALL
and	O
the	O
so	O
-	O
called	O
Potter	B-ALL
syndrome	E-ALL
.	O

This	O
case	O
illustrates	O
the	O
potential	O
severity	O
of	O
the	O
renal	B-ALL
anomalies	E-ALL
in	O
the	O
BOR	O
syndrome	O
and	O
the	O
inadequacy	O
of	O
oligohydramnios	S-ALL
and	O
maternal	O
serum	O
alpha	O
-	O
fetoprotein	O
as	O
screening	O
methods	O
for	O
renal	B-ALL
agenesis	E-ALL
.	O

This	O
case	O
also	O
implies	O
strongly	O
the	O
necessity	O
for	O
meticulous	O
search	O
for	O
renal	B-ALL
anomalies	E-ALL
in	O
individuals	O
with	O
the	O
BOR	O
syndrome	O
and	O
proper	O
counseling	O
regarding	O
the	O
possibility	O
of	O
lethal	O
bilateral	B-ALL
renal	B-ALL
agenesis	E-ALL
.	O

Chromosome	O
region	O
15q	O
is	O
thought	O
to	O
contain	O
one	O
or	O
more	O
genes	O
that	O
are	O
important	O
for	O
melanin	B-ALL
pigment	I-ALL
synthesis	I-ALL
in	I-ALL
the	I-ALL
hair	I-ALL
,	I-ALL
skin	I-ALL
,	I-ALL
and	I-ALL
eyes	E-ALL
.	O

Hypopigmentation	S-ALL
has	O
been	O
identified	O
in	O
the	O
Prader	O
-	O
Willi	O
-LRB-	O
PWS	O
-RRB-	O
and	O
Angelman	O
-LRB-	O
AS	O
-RRB-	O
syndromes	O
.	O

None	O
had	O
obvious	O
albinism	S-ALL
.	O

Eye	O
changes	O
included	O
nystagmus	S-ALL
in	O
2	O
,	O
strabismus	S-ALL
in	O
4	O
,	O
and	O
reduced	B-ALL
retinal	I-ALL
pigment	E-ALL
in	O
5	O
.	O

Hypopigmentation	S-ALL
characterized	O
by	O
light	O
skin	O
,	O
reduced	O
retinal	O
pigment	O
,	O
low	O
hairbulb	O
tyrosinase	O
activity	O
,	O
and	O
incomplete	O
melanization	O
of	O
melanosomes	O
is	O
part	O
of	O
the	O
phenotype	O
of	O
AS	O
,	O
and	O
is	O
similar	O
to	O
that	O
found	O
in	O
PWS	O
.	O

We	O
have	O
reviewed	O
a	O
series	O
of	O
36	O
patients	O
with	O
the	O
basal	B-ALL
cell	I-ALL
nevus	E-ALL
syndrome	O
seen	O
at	O
Roswell	O
Park	O
Memorial	O
Institute	O
from	O
1950	O
to	O
1978	O
.	O

These	O
include	O
extensive	O
uncontrolled	O
basal	B-ALL
cell	I-ALL
epithelioma	I-ALL
of	I-ALL
the	I-ALL
face	E-ALL
resulting	O
in	O
one	O
death	O
from	O
direct	O
cerebral	O
invasion	O
via	O
the	O
orbit	O
,	O
one	O
facial	B-ALL
nerve	I-ALL
palsy	E-ALL
,	O
two	O
bilateral	O
and	O
two	O
unilateral	O
eye	B-ALL
enucleations	E-ALL
,	O
and	O
several	O
severe	O
facial	B-ALL
mutilations	E-ALL
in	O
young	B-ALL
patients	E-ALL
.	O

There	O
were	O
three	O
patients	O
who	O
developed	O
severe	O
bradycardia	S-ALL
and	O
hypotension	S-ALL
during	O
induction	O
of	O
general	O
anesthesia	O
required	O
postponement	O
of	O
the	O
intended	O
operation	O
,	O
and	O
one	O
patient	O
with	O
congenital	B-ALL
hemiparesis	S-ALL
who	O
on	O
investigation	O
was	O
found	O
to	O
have	O
an	O
absent	B-ALL
internal	I-ALL
carotid	I-ALL
artery	E-ALL
.	O

Most	O
patients	O
of	O
this	O
age	O
group	O
show	O
at	O
least	O
8	O
of	O
the	O
major	O
characteristics	O
-LRB-	O
bursts	B-ALL
of	I-ALL
laughter	E-ALL
,	O
happy	B-ALL
disposition	E-ALL
,	O
hyperactive	B-ALL
behaviour	E-ALL
,	O
microcephaly	S-ALL
,	O
brachycephaly	S-ALL
,	O
macrostomia	S-ALL
,	O
tongue	B-ALL
protrusion	E-ALL
,	O
mandibular	B-ALL
prognathism	S-ALL
,	O
widely	B-ALL
spaced	I-ALL
teeth	E-ALL
,	O
stiff	O
and	O
puppetlike	B-ALL
movements	E-ALL
,	O
typical	O
stature	O
,	O
wide	B-ALL
based	I-ALL
gait	E-ALL
-RRB-	O
beside	O
the	O
mental	B-ALL
retardation	S-ALL
and	O
-LRB-	O
almost	O
-RRB-	O
absence	B-ALL
of	I-ALL
speech	E-ALL
,	O
which	O
is	O
a	O
universal	O
trait	O
.	O

The	O
diagnosis	B-ALL
in	I-ALL
infants	E-ALL
is	O
based	O
on	O
only	O
a	O
limited	O
number	O
of	O
clinical	O
characteristics	O
or	O
on	O
anamnestic	O
data	O
.	O

In	O
older	O
patients	O
,	O
the	O
diagnosis	O
may	O
be	O
hampered	O
in	O
part	O
because	O
of	O
the	O
changing	O
behavioral	B-ALL
characteristics	E-ALL
and	O
the	O
decreasing	O
frequency	O
of	O
fits	O
.	O

Other	O
manifestations	O
,	O
such	O
as	O
scoliosis	S-ALL
,	O
may	O
become	O
more	O
pronounced	O
with	O
age	O
.	O

Branchiootorenal	O
-LRB-	O
BOR	O
-RRB-	O
syndrome	O
is	O
a	O
common	O
autosomal	B-ALL
dominant	S-ALL
form	E-ALL
of	O
hearing	B-ALL
impairment	E-ALL
previously	O
mapped	O
to	O
8q	O
.	O

Brachydactyly	B-ALL
type	I-ALL
A	I-ALL
-	I-ALL
1	E-ALL
-LRB-	O
BDA	B-ALL
-	I-ALL
1	E-ALL
;	O
MIM	O
112500	O
-RRB-	O
is	O
characterized	O
by	O
shortening	B-ALL
or	I-ALL
missing	B-ALL
of	I-ALL
the	I-ALL
middle	I-ALL
phalanges	E-ALL
-LRB-	O
Fig	O
.	O

2	O
-RRB-	O
,	O
is	O
the	O
first	O
recorded	O
example	O
of	O
a	O
human	O
anomaly	O
with	O
Mendelian	O
autosomal	B-ALL
-	I-ALL
dominant	B-ALL
inheritance	E-ALL
and	O
,	O
as	O
such	O
,	O
is	O
cited	O
in	O
most	O
genetic	O
and	O
biological	O
textbooks	O
.	O

A	O
woman	O
with	O
the	O
autosomal	B-ALL
dominant	S-ALL
syndrome	O
of	O
preauricular	B-ALL
pits	S-ALL
,	O
cervical	B-ALL
fistulae	E-ALL
,	O
and	O
partial	B-ALL
deafness	S-ALL
gave	O
birth	O
to	O
two	O
children	O
with	O
preauricular	B-ALL
pits	S-ALL
and	O
severe	B-ALL
renal	I-ALL
dysgenesis	E-ALL
.	O

The	O
facies	O
had	O
some	O
features	O
of	O
the	O
Potter	B-ALL
facies	E-ALL
of	O
renal	B-ALL
agenesis	E-ALL
.	O

One	O
child	O
died	B-ALL
soon	I-ALL
after	I-ALL
birth	E-ALL
because	O
of	O
pneumothorax	S-ALL
and	O
immature	B-ALL
development	I-ALL
of	I-ALL
the	I-ALL
lungs	E-ALL
.	O

We	O
suggest	O
that	O
all	O
infants	O
with	O
renal	B-ALL
agenesis	I-ALL
or	I-ALL
dysgenesis	E-ALL
be	O
examined	O
for	O
preauricular	B-ALL
pits	S-ALL
because	O
of	O
the	O
high	O
recurrence	O
risk	O
of	O
renal	B-ALL
anomalies	E-ALL
in	O
families	O
with	O
this	O
syndrome	O
.	O

Neurofibromatosis	S-ALL
2	O
or	O
bilateral	B-ALL
acoustic	I-ALL
neurofibromatosis	S-ALL
-LRB-	O
NF2	O
-RRB-	O
is	O
a	O
severe	O
autosomal	B-ALL
dominant	S-ALL
disorder	E-ALL
characterized	O
by	O
the	O
development	O
of	O
multiple	O
tumors	B-ALL
of	I-ALL
the	I-ALL
nervous	I-ALL
system	E-ALL
,	O
including	O
meningiomas	S-ALL
,	O
gliomas	S-ALL
,	O
neurofibromas	S-ALL
,	O
ependymomas	S-ALL
,	O
and	O
particularly	O
acoustic	B-ALL
neuromas	E-ALL
.	O

Polymorphic	O
DNA	O
markers	O
have	O
revealed	O
frequent	O
loss	O
of	O
one	O
copy	O
of	O
chromosome	O
22	O
in	O
the	O
tumor	S-ALL
types	O
associated	O
with	O
NF2	O
.	O

Family	O
studies	O
have	O
demonstrated	O
that	O
the	O
primary	O
defect	O
in	O
NF2	O
is	O
linked	O
to	O
DNA	O
markers	O
on	O
chromosome	O
22	O
,	O
suggesting	O
that	O
it	O
involves	O
inactivation	O
of	O
a	O
tumor	S-ALL
suppressor	O
gene	O
.	O

We	O
have	O
employed	O
a	O
combination	O
of	O
multipoint	O
linkage	O
analysis	O
and	O
examination	O
of	O
deletions	O
in	O
primary	O
tumor	S-ALL
specimens	O
to	O
precisely	O
map	O
the	O
NF2	O
locus	O
between	O
flanking	O
polymorphic	O
DNA	O
markers	O
on	O
chromosome	O
22	O
.	O

Gorlin	O
syndrome	O
is	O
an	O
autosomal	B-ALL
dominant	I-ALL
disorder	E-ALL
characterized	O
by	O
multiple	O
basal	B-ALL
cell	I-ALL
carcinomas	E-ALL
,	O
medulloblastomas	S-ALL
,	O
ovarian	B-ALL
fibromas	E-ALL
,	O
and	O
a	O
variety	O
of	O
developmental	B-ALL
defects	E-ALL
.	O

All	O
affected	O
individuals	O
share	O
certain	O
key	O
features	O
,	O
but	O
there	O
is	O
significant	B-ALL
phenotypic	B-ALL
variability	S-ALL
within	I-ALL
and	I-ALL
among	I-ALL
kindreds	E-ALL
with	O
respect	O
to	O
malformations	O
.	O

The	O
gene	O
-LRB-	O
NBCCS	O
-RRB-	O
maps	O
to	O
chromosome	O
9q22	O
,	O
and	O
allelic	O
loss	O
at	O
this	O
location	O
is	O
common	O
in	O
tumors	S-ALL
from	O
Gorlin	O
syndrome	O
patients	O
.	O

Two	O
recessive	O
cancer	S-ALL
-	O
predisposition	O
syndromes	O
,	O
xeroderma	O
pigmentosum	O
group	O
A	O
-LRB-	O
XPAC	O
-RRB-	O
and	O
Fanconi	O
anemia	O
group	O
C	O
-LRB-	O
FACC	O
-RRB-	O
,	O
map	O
to	O
the	O
NBCCS	O
region	O
;	O
and	O
unusual	O
,	O
dominant	O
mutations	O
in	O
these	O
genes	O
have	O
been	O
proposed	O
as	O
the	O
cause	O
of	O
Gorlin	O
syndrome	O
.	O

Both	O
have	O
typical	O
features	O
of	O
Gorlin	O
syndrome	O
plus	O
additional	O
findings	O
,	O
including	O
mental	B-ALL
retardation	S-ALL
,	O
conductive	B-ALL
hearing	B-ALL
loss	E-ALL
,	O
and	O
failure	B-ALL
to	I-ALL
thrive	E-ALL
.	O

First	O
,	O
in	O
conjunction	O
with	O
previous	O
analyses	O
of	O
allelic	O
loss	O
in	O
tumors	S-ALL
,	O
this	O
study	O
provides	O
evidence	O
that	O
associated	O
neoplasms	S-ALL
arise	O
with	O
homozygous	O
inactivation	O
of	O
the	O
gene	O
.	O

Finally	O
,	O
phenotypic	O
features	O
that	O
show	O
variable	B-ALL
expression	E-ALL
must	O
be	O
influenced	O
by	O
genetic	O
background	O
,	O
epigenetic	O
effects	O
,	O
somatic	O
mutations	O
,	O
or	O
environmental	O
factors	O
,	O
since	O
these	O
two	O
patients	O
with	O
identical	O
alterations	O
-LRB-	O
deletions	O
-RRB-	O
of	O
the	O
Gorlin	O
syndrome	O
gene	O
have	O
somewhat	O
different	O
manifestations	O
of	O
Gorlin	O
syndrome	O
.	O

This	O
paper	O
reports	O
on	O
a	O
family	O
with	O
popliteal	B-ALL
pterygium	S-ALL
syndrome	O
-LRB-	O
PPS	O
-RRB-	O
,	O
which	O
was	O
ascertained	O
through	O
a	O
baby	O
with	O
most	O
of	O
the	O
major	O
signs	O
of	O
the	O
syndrome	O
.	O

The	O
mother	O
,	O
who	O
had	O
a	O
repaired	O
cleft	B-ALL
palate	E-ALL
and	O
toe	B-ALL
syndactyly	S-ALL
,	O
had	O
been	O
aware	O
that	O
her	O
syndactyly	S-ALL
was	O
familial	O
,	O
but	O
her	O
unpreparedness	O
for	O
the	O
birth	O
of	O
a	O
child	O
with	O
PPS	O
led	O
to	O
interest	O
in	O
,	O
and	O
a	O
subsequent	O
review	O
of	O
,	O
the	O
differnetial	O
diagnosis	O
and	O
the	O
variable	B-ALL
expression	E-ALL
of	O
the	O
clinical	O
manifestations	O
of	O
this	O
syndrome	O
.	O

Neurofibromatosis	S-ALL
type	O
2	O
-LRB-	O
NF2	O
-RRB-	O
is	O
a	O
monogenic	O
dominantly	B-ALL
inherited	E-ALL
disease	O
predisposing	O
carriers	O
to	O
develop	O
nervous	B-ALL
system	I-ALL
tumours	S-ALL
.	O

One	O
is	O
the	O
site	O
of	O
germ	O
-	O
line	O
mutations	O
in	O
NF2	O
patients	O
and	O
of	O
somatic	O
mutations	O
in	O
NF2	O
-	O
related	O
tumours	S-ALL
.	O

Its	O
deduced	O
product	O
has	O
homology	O
with	O
proteins	O
at	O
the	O
plasma	O
membrane	O
and	O
cytoskeleton	O
interface	O
,	O
a	O
previously	O
unknown	O
site	O
of	O
action	O
of	O
tumour	S-ALL
suppressor	O
genes	O
in	O
humans	O
.	O

Apparently	O
,	O
most	O
patients	O
are	O
sporadic	S-ALL
cases	E-ALL
.	O

The	O
genetic	O
mechanism	O
underlying	O
familial	B-ALL
AS	E-ALL
has	O
remained	O
enigmatic	O
for	O
a	O
long	O
time	O
.	O

Recently	O
,	O
evidence	O
has	O
been	O
emerging	O
suggesting	O
autosomal	B-ALL
dominant	B-ALL
inheritance	E-ALL
of	O
a	O
detectable	O
or	O
undetectable	O
defect	O
in	O
a	O
gene	O
or	O
genes	O
at	O
15q11	O
-	O
13	O
,	O
subject	O
to	O
genomic	O
imprinting	O
.	O

The	O
nevoid	O
basal	B-ALL
-	I-ALL
cell	I-ALL
carcinoma	E-ALL
syndrome	O
is	O
characterized	O
by	O
major	O
manifestations	O
,	O
such	O
as	O
multiple	O
basal	B-ALL
-	I-ALL
cell	I-ALL
carcinomata	E-ALL
,	O
cysts	B-ALL
of	I-ALL
the	I-ALL
jaws	E-ALL
,	O
and	O
skeletal	B-ALL
-	I-ALL
-	I-ALL
specifically	E-ALL
,	O
rib	B-ALL
-	I-ALL
-	I-ALL
abnormalities	E-ALL
.	O

The	O
odontogenic	B-ALL
keratocyst	E-ALL
,	O
which	O
usually	O
appears	B-ALL
during	I-ALL
adolescence	S-ALL
,	O
has	O
a	O
marked	O
tendency	O
to	O
recur	O
.	O

In	O
addition	O
to	O
the	O
skin	B-ALL
tumors	S-ALL
,	O
milia	S-ALL
,	O
epidermoid	B-ALL
cysts	E-ALL
,	O
chalazia	S-ALL
,	O
comedones	S-ALL
,	O
and	O
palmar	B-ALL
and	I-ALL
plantar	B-ALL
pits	S-ALL
are	O
frequent	O
.	O

The	O
skin	B-ALL
tumors	S-ALL
,	O
originally	O
thought	O
to	O
be	O
independent	O
of	O
sun	O
exposure	O
,	O
are	O
more	O
common	O
in	O
sun	O
-	O
exposed	O
areas	O
and	O
are	O
far	O
less	O
frequent	O
and	O
occur	O
at	O
a	O
much	O
later	O
age	O
in	O
blacks	O
than	O
in	O
whites	O
.	O

There	O
is	O
some	O
evidence	O
that	O
radiation	O
of	O
the	O
skin	O
promotes	O
the	O
appearance	O
of	O
skin	B-ALL
cancers	E-ALL
in	O
this	O
disorder	O
.	O

Unilateral	O
linear	O
nevoid	O
basal	B-ALL
-	I-ALL
cell	I-ALL
carcinomas	E-ALL
with	O
comedones	S-ALL
may	O
represent	O
postzygotic	O
somatic	B-ALL
mutation	E-ALL
.	O

A	O
proclivity	O
to	O
other	O
forms	O
of	O
neoplasia	S-ALL
exists	O
.	O

Patients	O
with	O
this	O
syndrome	O
have	O
had	O
medulloblastoma	S-ALL
,	O
meningioma	S-ALL
,	O
ovarian	B-ALL
fibroma	E-ALL
,	O
ovarian	B-ALL
fibrosarcoma	S-ALL
,	O
fibrosarcoma	B-ALL
of	I-ALL
the	I-ALL
jaws	E-ALL
,	O
cardiac	B-ALL
fibroma	E-ALL
,	O
fetal	O
rhabdomyoma	S-ALL
,	O
and	O
lymphatic	O
or	O
chylous	O
cysts	O
of	O
the	O
mesentery	O
.	O

The	O
independent	O
observations	O
of	O
increased	O
prostaglandin	O
levels	O
associated	O
both	O
with	O
odontogenic	B-ALL
keratocyst	E-ALL
expansion	O
and	O
aggression	S-ALL
of	O
basal	B-ALL
cell	I-ALL
cancers	E-ALL
merit	O
further	O
investigation	O
both	O
as	O
a	O
fundamental	O
cellular	O
mechanism	O
and	O
as	O
a	O
possible	O
basis	O
for	O
treatment	O
-LRB-	O
e	O
.	O
g	O
.	O
,	O
with	O
antiprostaglandins	O
-RRB-	O
.	O

The	O
nevoid	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
syndrome	O
-LRB-	O
NBCC	O
-RRB-	O
is	O
an	O
autosomal	B-ALL
dominant	S-ALL
multisystem	O
disorder	O
with	O
variable	B-ALL
expressivity	E-ALL
.	O

The	O
2	O
new	O
families	O
,	O
as	O
well	O
as	O
those	O
previously	O
reported	O
,	O
suggest	O
minimal	O
expression	O
of	O
the	O
basal	B-ALL
cell	I-ALL
carcinomas	E-ALL
and	O
full	O
expression	O
of	O
the	O
other	O
components	O
of	O
the	O
syndrome	O
.	O

The	O
3	O
most	O
common	O
findings	O
in	O
the	O
11	O
cases	O
were	O
jaw	B-ALL
cysts	E-ALL
,	O
palmar	B-ALL
and	I-ALL
/	I-ALL
or	I-ALL
plantar	B-ALL
pits	S-ALL
,	O
and	O
calcification	B-ALL
of	I-ALL
the	I-ALL
falx	I-ALL
cerebri	E-ALL
.	O

Only	O
44	O
%	O
-LRB-	O
4	O
/	O
11	O
-RRB-	O
of	O
these	O
cases	O
had	O
one	O
or	O
more	O
confirmed	O
basal	B-ALL
cell	I-ALL
carcinomas	E-ALL
.	O

This	O
frequency	O
is	O
substantially	O
less	O
than	O
that	O
observed	O
in	O
whites	O
-LRB-	O
90	O
%	O
with	O
basal	B-ALL
cell	I-ALL
carcinomas	E-ALL
-RRB-	O
.	O

The	O
relative	O
lack	O
of	O
these	O
skin	B-ALL
tumors	S-ALL
in	O
African	O
-	O
Americans	O
partly	O
reflects	O
ultraviolet	O
radiation	O
protection	O
resulting	O
from	O
increased	B-ALL
skin	I-ALL
pigmentation	E-ALL
.	O

Neurofibromatosis	S-ALL
1	O
and	O
neurofibromatosis	S-ALL
2	O
are	O
autosomal	B-ALL
dominant	S-ALL
genetic	O
disorders	O
in	O
which	O
affected	O
individuals	O
develop	O
both	O
benign	O
and	O
malignant	O
tumors	S-ALL
at	O
an	O
increased	O
frequency	O
.	O

Since	O
the	O
original	O
National	O
Institutes	O
of	O
Health	O
Consensus	O
Development	O
Conference	O
in	O
1987	O
,	O
there	O
has	O
been	O
significant	O
progress	O
toward	O
a	O
more	O
complete	O
understanding	O
of	O
the	O
molecular	O
bases	O
for	O
neurofibromatosis	S-ALL
1	O
and	O
neurofibromatosis	S-ALL
2	O
.	O

Our	O
objective	O
was	O
to	O
determine	O
the	O
diagnostic	O
criteria	O
for	O
neurofibromatosis	S-ALL
1	O
and	O
neurofibromatosis	S-ALL
2	O
,	O
recommendations	O
for	O
the	O
care	O
of	O
patients	O
and	O
their	O
families	O
at	O
diagnosis	O
and	O
during	O
routine	O
follow	O
-	O
up	O
,	O
and	O
the	O
role	O
of	O
DNA	O
diagnostic	O
testing	O
in	O
the	O
evaluation	O
of	O
these	O
disorders	O
.	O

The	O
main	O
results	O
of	O
the	O
review	O
were	O
qualitative	O
and	O
were	O
reviewed	O
by	O
neurofibromatosis	S-ALL
clinical	O
directors	O
worldwide	O
through	O
an	O
Internet	O
Web	O
site	O
.	O

On	O
the	O
basis	O
of	O
the	O
information	O
presented	O
in	O
this	O
review	O
,	O
we	O
propose	O
a	O
comprehensive	O
approach	O
to	O
the	O
diagnosis	O
and	O
treatment	O
of	O
individuals	O
with	O
neurofibromatosis	S-ALL
1	O
and	O
neurofibromatosis	S-ALL
2	O
.	O

Neurofibromatosis	S-ALL
type	O
2	O
is	O
an	O
autosomal	B-ALL
-	I-ALL
dominant	S-ALL
multiple	B-ALL
neoplasia	S-ALL
syndrome	O
that	O
results	O
from	O
mutations	O
in	O
the	O
NF2	O
tumour	S-ALL
suppressor	O
gene	O
located	O
on	O
chromosome	O
22q	O
.	O

Half	O
of	O
patients	O
inherit	O
a	O
germline	O
mutation	O
from	O
an	O
affected	O
parent	O
and	O
the	O
remainder	O
acquire	O
a	O
de	B-ALL
novo	I-ALL
mutation	E-ALL
for	O
neurofibromatosis	S-ALL
type	O
2	O
.	O

Patients	O
develop	O
nervous	B-ALL
system	I-ALL
tumours	S-ALL
-LRB-	O
schwannomas	S-ALL
,	O
meningiomas	S-ALL
,	O
ependymomas	S-ALL
,	O
astrocytomas	S-ALL
,	O
and	O
neurofibromas	S-ALL
-RRB-	O
,	O
peripheral	B-ALL
neuropathy	S-ALL
,	O
ophthalmological	B-ALL
lesions	E-ALL
-LRB-	O
cataracts	S-ALL
,	O
epiretinal	B-ALL
membranes	E-ALL
,	O
and	O
retinal	B-ALL
hamartomas	E-ALL
-RRB-	O
,	O
and	O
cutaneous	B-ALL
lesions	E-ALL
-LRB-	O
skin	B-ALL
tumours	S-ALL
-RRB-	O
.	O

We	O
review	O
the	O
molecular	O
pathogenesis	O
,	O
genetics	O
,	O
clinical	O
findings	O
,	O
and	O
management	O
strategies	O
for	O
neurofibromatosis	S-ALL
type	O
2	O
.	O

A	O
family	O
with	O
the	O
Popliteal	B-ALL
Pterygium	E-ALL
Syndrome	O
is	O
presented	O
.	O

The	O
father	O
was	O
born	O
with	O
a	O
cleft	B-ALL
of	I-ALL
the	I-ALL
palate	E-ALL
and	O
lower	B-ALL
lip	B-ALL
pits	S-ALL
.	O

Two	O
of	O
the	O
three	O
offspring	O
showed	O
extensive	O
involvement	B-ALL
of	I-ALL
the	I-ALL
palate	E-ALL
,	I-ALL
gums	I-ALL
,	I-ALL
and	I-ALL
lips	E-ALL
with	O
minimal	O
involvement	B-ALL
of	I-ALL
the	I-ALL
lower	I-ALL
limbs	I-ALL
,	I-ALL
genitalia	E-ALL
,	I-ALL
and	I-ALL
nails	E-ALL
.	O

The	O
present	O
report	O
concerns	O
a	O
two	O
-	O
generation	O
family	O
of	O
nine	O
individuals	O
in	O
which	O
the	O
father	O
and	O
three	O
of	O
the	O
six	O
living	O
children	O
all	O
had	O
:	O
-LRB-	O
1	O
-RRB-	O
a	O
mixed	B-ALL
hearing	B-ALL
loss	E-ALL
with	O
a	O
Mondini	B-ALL
type	I-ALL
cochlear	B-ALL
malformation	E-ALL
and	O
stapes	B-ALL
fixation	E-ALL
;	O
-LRB-	O
2	O
-RRB-	O
cup	B-ALL
-	I-ALL
shaped	I-ALL
,	I-ALL
anteverted	I-ALL
pinnae	E-ALL
with	O
bilateral	O
prehelical	B-ALL
pits	S-ALL
:	O
-LRB-	O
3	O
-RRB-	O
bilateral	O
branchial	B-ALL
cleft	E-ALL
fistulas	S-ALL
;	O
and	O
-LRB-	O
4	O
-RRB-	O
bilateral	B-ALL
renal	B-ALL
dysplasia	E-ALL
and	O
anomalies	B-ALL
of	I-ALL
the	I-ALL
collecting	I-ALL
system	E-ALL
.	O

The	O
father	O
and	O
one	O
affected	O
son	O
also	O
had	O
aplasia	B-ALL
of	I-ALL
the	I-ALL
lacrimal	I-ALL
ducts	E-ALL
.	O

A	O
fourth	O
child	O
who	O
died	O
at	O
5	O
months	O
of	O
age	O
was	O
reported	O
to	O
have	O
branchial	B-ALL
cleft	E-ALL
fistulas	S-ALL
and	O
bilateral	B-ALL
polycystic	B-ALL
kidneys	E-ALL
at	O
autopsy	O
.	O

This	O
concept	O
is	O
illustrated	O
with	O
a	O
group	O
of	O
branchial	S-ALL
arch	I-ALL
syndromes	E-ALL
that	O
are	O
related	O
in	O
this	O
way	O
.	O

The	O
distal	B-ALL
arthrogryposes	E-ALL
-LRB-	O
DAs	O
-RRB-	O
are	O
a	O
group	O
of	O
disorders	O
characterized	O
by	O
multiple	B-ALL
congenital	B-ALL
contractures	B-ALL
of	I-ALL
the	I-ALL
limbs	E-ALL
.	O

Because	O
the	O
DAs	O
are	O
genetically	O
heterogeneous	S-ALL
,	O
we	O
sought	O
additional	O
candidate	O
genes	O
by	O
examining	O
modifiers	O
of	O
mutant	O
Drosophila	O
isoforms	O
of	O
TnI	O
.	O

This	O
provides	O
a	O
new	O
opportunity	O
to	O
directly	O
study	O
the	O
etiology	O
and	O
pathogenesis	O
of	O
multiple	B-ALL
-	I-ALL
congenital	B-ALL
-	I-ALL
contracture	S-ALL
syndromes	O
.	O

Townes	O
-	O
Brocks	O
syndrome	O
-LRB-	O
TBS	O
-RRB-	O
is	O
a	O
condition	O
with	O
imperforate	B-ALL
anus	E-ALL
,	O
hand	B-ALL
anomalies	E-ALL
,	O
and	O
ear	B-ALL
malformations	E-ALL
with	O
sensorineural	B-ALL
hearing	B-ALL
loss	E-ALL
.	O

Many	O
cases	O
are	O
sporadic	S-ALL
.	O

Within	B-ALL
and	I-ALL
between	I-ALL
families	I-ALL
,	I-ALL
the	I-ALL
phenotype	I-ALL
displays	I-ALL
striking	I-ALL
variability	S-ALL
.	O

Unique	O
cardiac	B-ALL
anomalies	E-ALL
seen	O
in	O
this	O
family	O
include	O
lethal	O
truncus	B-ALL
arteriosus	E-ALL
in	O
one	O
patient	O
and	O
a	O
lethal	O
complicated	O
defect	O
,	O
including	O
pulmonary	B-ALL
valve	I-ALL
atresia	E-ALL
,	O
in	O
a	O
second	O
patient	O
.	O

These	O
severe	O
cardiac	B-ALL
anomalies	E-ALL
have	O
not	O
previously	O
been	O
reported	O
in	O
a	O
familial	O
case	O
of	O
TBS	O
.	O

In	O
addition	O
,	O
hypoplastic	B-ALL
thumbs	E-ALL
were	O
seen	O
in	O
two	O
individuals	O
in	O
this	O
family	O
and	O
should	O
,	O
therefore	O
,	O
be	O
considered	O
a	O
true	O
feature	O
of	O
TBS	O
.	O

To	O
evaluate	O
the	O
ocular	B-ALL
abnormalities	E-ALL
in	O
patients	O
with	O
clinically	O
diagnosed	O
neurofibromatosis	S-ALL
2	O
and	O
asymptomatic	O
gene	O
carriers	O
.	O

In	O
a	O
cross	O
-	O
sectional	O
study	O
,	O
we	O
examined	O
49	O
patients	O
with	O
neurofibromatosis	S-ALL
2	O
,	O
30	O
offspring	O
of	O
patients	O
,	O
and	O
,	O
as	O
a	O
comparison	O
group	O
,	O
18	O
parents	O
and	O
siblings	O
of	O
patients	O
with	O
sporadic	S-ALL
neurofibromatosis	S-ALL
2	O
.	O

The	O
most	O
common	O
ocular	B-ALL
abnormalities	E-ALL
were	O
posterior	B-ALL
subcapsular	I-ALL
or	I-ALL
capsular	B-ALL
,	I-ALL
cortical	B-ALL
,	I-ALL
or	I-ALL
mixed	I-ALL
lens	B-ALL
opacities	E-ALL
in	O
33	O
-LRB-	O
67	O
%	O
-RRB-	O
of	O
49	O
patients	O
with	O
neurofibromatosis	S-ALL
2	O
and	O
retinal	B-ALL
hamartomas	E-ALL
in	O
11	O
-LRB-	O
22	O
%	O
-RRB-	O
.	O

Three	O
asymptomatic	O
mutation	O
carriers	O
had	O
cataracts	S-ALL
,	O
whereas	O
those	O
who	O
were	O
predicted	O
not	O
to	O
carry	O
the	O
mutation	O
did	O
not	O
have	O
cataracts	S-ALL
.	O

Asymptomatic	O
mutation	O
carriers	O
may	O
have	O
developmental	B-ALL
abnormalities	B-ALL
of	I-ALL
the	I-ALL
eye	E-ALL
that	O
are	O
detectable	O
in	O
childhood	S-ALL
or	O
adolescence	S-ALL
,	O
a	O
finding	O
that	O
may	O
assist	O
in	O
early	O
diagnosis	O
of	O
the	O
disease	O
.	O

A	O
variety	O
of	O
ocular	B-ALL
abnormalities	E-ALL
are	O
present	O
in	O
neurofibromatosis	S-ALL
2	O
,	O
including	O
cataracts	S-ALL
,	O
retinal	B-ALL
hamartomas	E-ALL
,	O
and	O
ocular	B-ALL
motor	I-ALL
deficits	E-ALL
.	O

For	O
screening	O
at	O
-	O
risk	O
relatives	O
of	O
patients	O
with	O
neurofibromatosis	S-ALL
2	O
,	O
the	O
types	O
of	O
cataract	S-ALL
that	O
are	O
most	O
suggestive	O
of	O
neurofibromatosis	S-ALL
2	O
are	O
plaque	O
-	O
like	O
posterior	B-ALL
subcapsular	I-ALL
or	I-ALL
capsular	B-ALL
cataract	S-ALL
and	O
cortical	B-ALL
cataract	S-ALL
with	O
onset	O
under	O
the	O
age	O
of	O
30	O
years	O
.	O

Thirty	O
six	O
children	O
with	O
typical	O
features	O
of	O
Angelman	O
's	O
syndrome	O
,	O
including	O
global	B-ALL
developmental	B-ALL
delay	E-ALL
,	O
ataxia	S-ALL
,	O
episodes	B-ALL
of	I-ALL
paroxysmal	B-ALL
laughter	S-ALL
,	O
seizures	S-ALL
,	O
and	O
microcephaly	S-ALL
were	O
studied	O
.	O

The	O
facial	B-ALL
appearance	E-ALL
is	O
characterised	O
by	O
a	O
prominent	B-ALL
jaw	E-ALL
,	O
a	O
wide	B-ALL
mouth	E-ALL
,	O
and	O
a	O
pointed	B-ALL
chin	E-ALL
.	O

Tongue	B-ALL
thrusting	E-ALL
is	O
common	O
.	O

The	O
movement	B-ALL
disorder	E-ALL
consists	O
of	O
a	O
wide	B-ALL
based	I-ALL
,	I-ALL
ataxic	B-ALL
gait	E-ALL
with	O
frequent	O
jerky	B-ALL
limb	I-ALL
movements	E-ALL
and	O
flapping	B-ALL
of	I-ALL
the	I-ALL
hands	E-ALL
.	O

Tone	O
is	O
variable	S-ALL
in	O
the	O
limbs	O
with	O
normal	O
reflexes	O
,	O
and	O
the	O
plantar	O
responses	O
are	O
usually	O
flexor	O
.	O

Angelman	O
syndrome	O
-LRB-	O
AS	O
-RRB-	O
results	O
from	O
a	O
lack	O
of	O
maternal	O
contribution	O
from	O
chromosome	O
15q11	O
-	O
13	O
,	O
arising	O
from	O
de	B-ALL
novo	E-ALL
deletion	O
in	O
most	O
cases	O
or	O
rarely	O
from	O
uniparental	O
disomy	O
.	O

The	O
mode	B-ALL
of	I-ALL
inheritance	E-ALL
in	O
these	O
families	O
is	O
autosomal	B-ALL
dominant	S-ALL
modified	O
by	O
imprinting	O
.	O

Sporadic	B-ALL
cases	E-ALL
,	O
with	O
no	O
observable	O
deletion	O
,	O
therefore	O
pose	O
a	O
counselling	O
dilemma	O
as	O
there	O
could	O
be	O
a	O
recurrence	O
risk	O
as	O
high	O
as	O
50	O
%	O
.	O

Eighty	O
-	O
one	O
AS	O
patients	O
were	O
sporadic	S-ALL
cases	E-ALL
while	O
12	O
cases	O
came	O
from	O
six	O
families	O
.	O

Ten	O
sporadic	S-ALL
cases	E-ALL
plus	O
all	O
12	O
familial	B-ALL
cases	E-ALL
had	O
no	O
detectable	O
deletion	O
.	O

In	O
familial	B-ALL
cases	E-ALL
,	O
all	O
affected	O
sibs	O
inherited	O
the	O
same	O
maternal	O
chromosome	O
15	O
markers	O
for	O
the	O
region	O
15q11	O
-	O
13	O
.	O

The	O
case	O
of	O
a	O
seriously	O
disabled	O
and	O
retarded	S-ALL
female	O
patient	O
with	O
neurofibromatosis	S-ALL
type	O
2	O
-LRB-	O
NF2	O
-RRB-	O
is	O
reported	O
.	O

She	O
suffered	O
from	O
bilateral	B-ALL
vestibular	B-ALL
schwannomas	S-ALL
,	O
multiple	B-ALL
intracranial	B-ALL
meningiomas	S-ALL
and	O
neurinomas	S-ALL
.	O

The	O
instability	O
of	O
the	O
ring	O
chromosome	O
22	O
with	O
the	O
associated	O
loss	O
of	O
tumor	S-ALL
suppressor	O
genes	O
on	O
chromosome	O
22	O
,	O
in	O
particular	O
the	O
loss	O
of	O
the	O
NF2	O
gene	O
,	O
are	O
assumed	O
to	O
have	O
caused	O
multiple	B-ALL
tumorigenesis	E-ALL
in	O
this	O
patient	O
.	O

Brachydactyly	B-ALL
type	I-ALL
A1	E-ALL
is	O
a	O
limb	B-ALL
malformation	E-ALL
characterized	O
by	O
a	O
uniform	O
shortening	B-ALL
of	I-ALL
the	I-ALL
middle	I-ALL
phalanges	I-ALL
in	I-ALL
all	I-ALL
digits	E-ALL
.	O

Mutations	O
in	O
the	O
Indian	O
hedgehog	O
-LRB-	O
IHH	O
-RRB-	O
gene	O
were	O
shown	O
to	O
be	O
the	O
cause	O
of	O
this	O
autosomal	B-ALL
dominant	I-ALL
disorder	E-ALL
.	O

Townes	O
-	O
Brocks	O
syndrome	O
-LRB-	O
TBS	O
-RRB-	O
is	O
an	O
autosomal	B-ALL
dominant	S-ALL
disorder	E-ALL
with	O
multiple	O
malformations	O
and	O
variable	S-ALL
expression	E-ALL
.	O

Major	O
findings	O
include	O
external	B-ALL
ear	B-ALL
anomalies	E-ALL
,	O
hearing	B-ALL
loss	E-ALL
,	O
preaxial	B-ALL
polydactyly	S-ALL
and	O
triphalangeal	B-ALL
thumbs	E-ALL
,	O
imperforate	B-ALL
anus	E-ALL
,	O
and	O
renal	B-ALL
malformations	E-ALL
.	O

Most	O
patients	O
with	O
Townes	O
-	O
Brocks	O
syndrome	O
have	O
normal	O
intelligence	O
,	O
although	O
mental	B-ALL
retardation	S-ALL
has	O
been	O
noted	O
in	O
a	O
few	O
.	O

We	O
observed	O
an	O
autosomal	B-ALL
dominant	S-ALL
disorder	E-ALL
of	O
abnormal	B-ALL
upper	I-ALL
lip	E-ALL
,	O
which	O
resembles	O
a	O
poorly	O
repaired	O
cleft	B-ALL
lip	E-ALL
,	O
malformed	B-ALL
nose	E-ALL
with	O
broad	B-ALL
bridge	E-ALL
and	O
flattened	B-ALL
tip	E-ALL
,	O
lacrimal	B-ALL
duct	I-ALL
obstruction	E-ALL
,	O
malformed	B-ALL
ears	E-ALL
,	O
and	O
branchial	B-ALL
cleft	E-ALL
sinuses	E-ALL
and	O
/	O
or	O
linear	B-ALL
skin	B-ALL
lesions	E-ALL
behind	I-ALL
the	I-ALL
ears	E-ALL
in	O
several	O
persons	O
in	O
3	O
families	O
.	O

Father	O
-	O
to	O
-	O
son	O
transmission	O
in	O
one	O
of	O
these	O
families	O
ruled	O
out	O
X	B-ALL
-	I-ALL
linked	I-ALL
inheritance	E-ALL
.	O

Other	O
anomalies	O
include	O
coloboma	S-ALL
,	O
microphthalmia	S-ALL
,	O
auricular	B-ALL
pits	S-ALL
,	O
lip	B-ALL
pits	S-ALL
,	O
highly	B-ALL
arched	I-ALL
plate	E-ALL
,	O
dental	B-ALL
anomalies	E-ALL
,	O
and	O
subcutaneous	B-ALL
cysts	B-ALL
of	I-ALL
the	I-ALL
scalp	E-ALL
.	O

Premature	B-ALL
graying	I-ALL
of	I-ALL
hair	E-ALL
occurred	O
in	O
the	O
affected	O
adults	O
.	O

Growth	B-ALL
retardation	S-ALL
,	O
developmental	B-ALL
delay	E-ALL
,	O
and	O
hand	B-ALL
anomalies	E-ALL
are	O
variable	S-ALL
components	O
of	O
the	O
syndrome	O
.	O

Mutations	O
in	O
the	O
GDF5	O
gene	O
can	O
cause	O
different	O
types	O
of	O
skeletal	B-ALL
dysplasia	E-ALL
,	O
including	O
brachydactyly	B-ALL
type	I-ALL
C	E-ALL
-LRB-	O
BDC	S-ALL
-RRB-	O
and	O
proximal	B-ALL
symphalangism	S-ALL
-LRB-	O
SYM1	O
-RRB-	O
.	O

We	O
report	O
two	O
novel	O
mutations	O
in	O
the	O
GDF5	O
gene	O
in	O
Chinese	O
families	O
with	O
distinct	O
limb	B-ALL
malformations	E-ALL
.	O

Two	O
unrelated	O
children	O
-LRB-	O
one	O
male	O
,	O
the	O
other	O
female	O
-RRB-	O
had	O
unusual	B-ALL
craniofacial	B-ALL
anomalies	E-ALL
consisting	O
of	O
hemangiomatous	B-ALL
branchial	B-ALL
clefts	S-ALL
,	O
lip	B-ALL
pseudoclefts	E-ALL
,	O
and	O
identical	O
unusual	B-ALL
facial	B-ALL
appearance	E-ALL
.	O

One	O
also	O
had	O
unilateral	O
microphthalmia	S-ALL
and	O
both	O
had	O
congenital	O
nasolacrimal	B-ALL
duct	I-ALL
obstruction	E-ALL
.	O

Two	O
similar	O
,	O
sporadic	B-ALL
cases	E-ALL
from	O
the	O
literature	O
were	O
also	O
identified	O
.	O

Two	O
unrelated	O
females	O
,	O
age	O
15	O
and	O
5	O
years	O
respectively	O
,	O
were	O
studied	O
cytogenetically	O
because	O
of	O
severe	B-ALL
mental	B-ALL
retardation	E-ALL
,	O
seizures	S-ALL
and	O
ataxia	S-ALL
-	O
like	O
incoordination	S-ALL
.	O

Re	O
-	O
evaluation	O
showed	O
no	O
voracious	B-ALL
appetite	E-ALL
or	O
obesity	S-ALL
;	O
normal	O
size	O
of	O
hands	O
and	O
feet	O
,	O
minimal	O
to	O
no	O
hypotonia	S-ALL
by	O
history	O
or	O
examination	O
and	O
facial	O
features	O
not	O
typical	O
of	O
the	O
Prader	O
-	O
Willi	O
syndrome	O
.	O

However	O
,	O
the	O
facial	B-ALL
appearance	E-ALL
of	O
the	O
girls	O
was	O
similar	O
to	O
each	O
other	O
with	O
mild	O
hypertelorism	S-ALL
.	O

The	O
findings	O
of	O
ataxic	B-ALL
-	I-ALL
like	I-ALL
movements	E-ALL
,	O
frequent	B-ALL
,	I-ALL
unprovoked	I-ALL
and	I-ALL
prolonged	I-ALL
bouts	I-ALL
of	I-ALL
laughter	S-ALL
and	O
facial	B-ALL
appearance	E-ALL
are	O
more	O
compatible	O
with	O
the	O
diagnosis	O
of	O
Angelman	O
syndrome	O
.	O

Three	O
families	O
are	O
presented	O
,	O
one	O
with	O
branchio	O
-	O
oto	O
-	O
renal	B-ALL
dysplasia	E-ALL
-LRB-	O
BOR	O
-RRB-	O
and	O
two	O
with	O
branchio	O
-	O
oto	O
dysplasia	O
-LRB-	O
BO	O
-RRB-	O
.	O

The	O
former	O
syndrome	O
is	O
characterized	O
by	O
external	B-ALL
ear	B-ALL
malformations	E-ALL
,	O
cervical	B-ALL
fistulae	E-ALL
,	O
mixed	B-ALL
hearing	B-ALL
loss	E-ALL
and	O
renal	B-ALL
anomalies	E-ALL
of	O
varying	O
severity	O
.	O

The	O
latter	O
syndrome	O
differs	O
in	O
that	O
there	O
are	O
no	O
renal	B-ALL
anomalies	E-ALL
and	O
that	O
the	O
sensorineural	O
component	O
of	O
the	O
hearing	B-ALL
loss	E-ALL
may	O
be	O
absent	O
.	O

The	O
external	B-ALL
ear	B-ALL
malformations	E-ALL
are	O
quite	O
variable	S-ALL
in	O
both	O
syndromes	O
.	O

Evidence	O
is	O
presented	O
which	O
supports	O
the	O
idea	O
that	O
these	O
two	O
syndromes	O
are	O
not	O
phenotypic	O
variants	O
of	O
the	O
same	O
autosomal	B-ALL
dominant	S-ALL
mutation	O
but	O
distinct	O
disease	O
entities	O
.	O

The	O
BOR	O
syndrome	O
appears	O
to	O
belong	O
to	O
a	O
larger	O
group	O
of	O
hereditary	O
ear	B-ALL
dysplasia	E-ALL
-	O
renal	B-ALL
adysplasia	E-ALL
syndromes	O
that	O
must	O
be	O
carefully	O
ruled	O
out	O
in	O
all	O
patients	O
with	O
familial	O
branchial	B-ALL
arch	I-ALL
malformations	E-ALL
as	O
well	O
as	O
in	O
the	O
parents	O
and	O
siblings	O
of	O
infants	O
with	O
``	O
Potter	B-ALL
facies	E-ALL
''	O
in	O
the	O
presence	O
of	O
auricular	B-ALL
malformation	E-ALL
and	O
renal	B-ALL
adysplasia	E-ALL
.	O

The	O
syndrome	O
's	O
main	O
features	O
are	O
microbrachycephaly	S-ALL
and	O
peculiar	B-ALL
face	E-ALL
,	O
mental	B-ALL
deficiency	E-ALL
with	O
euphoria	S-ALL
and	O
laughter	S-ALL
,	O
ataxia	S-ALL
and	O
epilepsy	S-ALL
consisting	O
in	O
infantile	B-ALL
spasms	E-ALL
and	O
grand	B-ALL
-	I-ALL
mal	I-ALL
attacks	E-ALL
.	O

In	O
situ	O
hybridization	O
with	O
a	O
c	O
-	O
sis	O
probe	O
was	O
performed	O
on	O
peripheral	O
lymphocytes	O
of	O
a	O
man	O
with	O
neurofibromatosis	S-ALL
and	O
a	O
ring	O
22	O
chromosome	O
.	O

The	O
implications	O
of	O
a	O
ring	O
22	O
constitution	O
and	O
the	O
neurofibromatosis	S-ALL
phenotype	O
are	O
discussed	O
.	O

Whenever	O
multiple	O
basal	B-ALL
cell	I-ALL
carcinomas	E-ALL
plus	O
the	O
typical	O
jaw	B-ALL
lesions	E-ALL
are	O
found	O
in	O
a	O
patient	O
,	O
the	O
diagnosis	O
is	O
easy	O
.	O

A	O
minimum	O
diagnostic	O
criterion	O
is	O
the	O
combination	O
of	O
either	O
the	O
skin	B-ALL
tumours	S-ALL
or	O
multiple	O
odontogenic	B-ALL
keratocysts	E-ALL
plus	O
a	O
positive	O
family	O
history	O
for	O
this	O
disorder	O
,	O
bifid	B-ALL
ribs	E-ALL
,	O
lamellar	O
calcification	B-ALL
of	I-ALL
the	I-ALL
falx	I-ALL
cerebri	E-ALL
or	O
any	O
one	O
of	O
the	O
skeletal	B-ALL
abnormalities	E-ALL
typical	O
of	O
this	O
syndrome	O
.	O

A	O
father	O
and	O
son	O
are	O
described	O
with	O
an	O
autosomal	B-ALL
dominant	S-ALL
branchial	B-ALL
cleft	E-ALL
syndrome	O
resembling	O
both	O
the	O
branchio	O
-	O
oto	O
-	O
renal	O
and	O
the	O
branchio	O
-	O
oculo	O
-	O
facial	O
syndrome	O
.	O

Both	O
syndromes	O
may	O
represent	O
variant	O
expressions	O
of	O
the	O
same	O
autosomal	B-ALL
dominant	S-ALL
gene	O
.	O

These	O
rearrangements	O
involve	O
deletions	O
found	O
in	O
approximately	O
70	O
%	O
of	O
Prader	O
-	O
Willi	O
or	O
Angelman	O
's	O
syndrome	O
patients	O
-LRB-	O
PWS	O
,	O
AS	O
-RRB-	O
,	O
duplications	O
detected	O
in	O
some	O
cases	O
of	O
autism	S-ALL
,	O
triplications	O
and	O
inverted	O
duplications	O
.	O

The	O
E6	O
-	O
AP	O
ubiquitin	O
ligase	O
-LRB-	O
human	O
/	O
mouse	O
gene	O
UBE3A	O
/	O
Ube3a	O
-RRB-	O
promotes	O
the	O
degradation	O
of	O
p53	O
in	O
association	O
with	O
papilloma	S-ALL
E6	O
protein	O
,	O
and	O
maternal	O
deficiency	O
causes	O
human	O
Angelman	O
syndrome	O
-LRB-	O
AS	O
-RRB-	O
.	O

We	O
found	O
that	O
the	O
phenotype	O
of	O
mice	O
with	O
maternal	O
deficiency	O
-LRB-	O
m	O
-	O
/	O
p	O
+	O
-RRB-	O
for	O
Ube3a	O
resembles	O
human	O
AS	O
with	O
motor	B-ALL
dysfunction	E-ALL
,	O
inducible	O
seizures	S-ALL
,	O
and	O
a	O
context	O
-	O
dependent	O
learning	B-ALL
deficit	E-ALL
.	O

Prader	O
-	O
Willi	O
syndrome	O
-LRB-	O
PWS	O
-RRB-	O
and	O
Angelman	O
syndrome	O
-LRB-	O
AS	O
-RRB-	O
are	O
distinct	O
neurobehavioral	B-ALL
disorders	E-ALL
that	O
most	O
often	O
arise	O
from	O
a	O
4	O
-	O
Mb	O
deletion	O
of	O
chromosome	O
15q11	O
-	O
q13	O
during	O
paternal	O
or	O
maternal	O
gametogenesis	O
,	O
respectively	O
.	O

At	O
a	O
de	B-ALL
novo	E-ALL
frequency	O
of	O
approximately	O
.	O
67	O
-	O
1	O
/	O
10	O
,	O
000	O
births	O
,	O
these	O
deletions	O
represent	O
a	O
common	O
structural	O
chromosome	O
change	O
in	O
the	O
human	O
genome	O
.	O

DNA	O
deletion	O
studies	O
using	O
5	O
DNA	O
markers	O
localized	O
at	O
15q11	O
-	O
q12	O
were	O
performed	O
in	O
14	O
Angelman	O
syndrome	O
-LRB-	O
AS	O
-RRB-	O
patients	O
-LRB-	O
9	O
sporadic	S-ALL
and	O
5	O
familial	B-ALL
cases	E-ALL
-RRB-	O
.	O

A	O
deletion	O
of	O
only	O
the	O
D15S11	O
locus	O
was	O
detected	O
in	O
one	O
sporadic	S-ALL
patient	O
,	O
that	O
involving	O
only	O
the	O
D15S10	O
in	O
3	O
familial	O
patients	O
-LRB-	O
sibs	O
in	O
a	O
family	O
-RRB-	O
,	O
that	O
spanning	O
3	O
loci	O
-LRB-	O
D15S11	O
,	O
D15S10	O
,	O
D15S12	O
-RRB-	O
in	O
one	O
sporadic	S-ALL
patient	O
,	O
and	O
that	O
spanning	O
4	O
loci	O
-LRB-	O
D15S9	O
,	O
D15S11	O
,	O
D15S10	O
,	O
D15S12	O
-RRB-	O
in	O
the	O
other	O
3	O
sporadic	S-ALL
patients	O
.	O

We	O
studied	O
two	O
families	O
with	O
an	O
unusual	O
variant	O
of	O
neurofibromatosis	S-ALL
-LRB-	O
NF	O
-RRB-	O
.	O

The	O
first	O
family	O
had	O
spinal	B-ALL
neurofibromas	S-ALL
and	O
caf?	B-ALL
au	I-ALL
lait	I-ALL
spots	E-ALL
-LRB-	I-ALL
CLS	I-ALL
-RRB-	E-ALL
,	O
the	O
second	O
spinal	B-ALL
neurofibromas	S-ALL
without	O
CLS	O
.	O

Other	O
signs	O
of	O
NF1	O
or	O
NF2	O
,	O
such	O
as	O
cutaneous	B-ALL
tumors	S-ALL
,	O
Lisch	B-ALL
nodules	E-ALL
,	O
or	O
acoustic	B-ALL
tumors	S-ALL
,	O
were	O
absent	O
.	O

The	O
inheritance	O
pattern	O
in	O
both	O
pedigrees	O
was	O
consistent	O
with	O
autosomal	B-ALL
dominant	B-ALL
inheritance	E-ALL
.	O

Branchio	O
-	O
oto	O
-	O
renal	O
-LRB-	O
BOR	O
-RRB-	O
and	O
Stickler	O
-LRB-	O
STL	O
-RRB-	O
syndromes	O
are	O
disorders	O
that	O
include	O
hearing	B-ALL
loss	E-ALL
among	O
their	O
clinical	O
features	O
.	O

STL	O
syndrome	O
type	O
I	O
-LRB-	O
STL1	O
-RRB-	O
is	O
a	O
combination	O
of	O
ophthalmic	B-ALL
,	I-ALL
orofacial	B-ALL
,	I-ALL
articular	B-ALL
,	I-ALL
and	I-ALL
auditory	B-ALL
manifestations	E-ALL
,	O
caused	O
by	O
mutations	O
in	O
the	O
COL2A1	O
.	O

BOR	O
syndrome	O
is	O
an	O
autosomal	B-ALL
dominant	B-ALL
trait	E-ALL
encompassing	O
branchial	S-ALL
,	I-ALL
otic	B-ALL
and	I-ALL
renal	B-ALL
anomalies	E-ALL
because	O
of	O
mutations	O
in	O
EYA1	O
,	O
SIX1	O
and	O
SIX5	O
.	O

This	O
patient	O
and	O
his	O
younger	O
brother	O
exhibited	O
hearing	B-ALL
loss	E-ALL
and	O
cleft	B-ALL
palate	E-ALL
.	O

Both	O
siblings	O
and	O
their	O
mother	O
also	O
showed	O
myopia	S-ALL
,	O
congenital	O
non	O
-	O
progressive	O
vitreous	B-ALL
anomaly	E-ALL
and	O
a	O
flat	B-ALL
face	E-ALL
.	O

The	O
proband	O
also	O
displayed	O
pre	B-ALL
-	I-ALL
auricular	B-ALL
pits	S-ALL
,	O
branchial	B-ALL
fistulae	E-ALL
and	O
renal	B-ALL
agenesis	E-ALL
that	O
define	O
BOR	O
syndrome	O
.	O

Interestingly	O
,	O
this	O
patient	O
carries	O
an	O
EYA1	O
mutation	O
,	O
p	O
.	O
R328X	O
,	O
which	O
was	O
not	O
present	O
in	O
the	O
two	O
other	O
patients	O
or	O
in	O
his	O
healthy	O
father	O
,	O
supporting	O
that	O
the	O
mutation	O
arose	O
de	B-ALL
novo	E-ALL
.	O

To	O
describe	O
the	O
ophthalmic	O
and	O
systemic	O
features	O
in	O
a	O
series	O
of	O
patients	O
initially	O
seen	O
with	O
eyelid	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
associated	O
with	O
Gorlin	O
-	O
Goltz	O
syndrome	O
.	O

Of	O
105	O
consecutive	O
patients	O
with	O
eyelid	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
managed	O
at	O
an	O
Ocular	O
Oncology	O
Center	O
between	O
January	O
1973	O
and	O
December	O
1999	O
,	O
four	O
patients	O
with	O
Gorlin	O
-	O
Goltz	O
syndrome	O
were	O
identified	O
.	O

The	O
ophthalmic	O
and	O
systemic	O
features	O
,	O
management	O
,	O
and	O
outcome	O
of	O
patients	O
with	O
eyelid	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
associated	O
with	O
Gorlin	O
-	O
Goltz	O
syndrome	O
were	O
analyzed	O
.	O

Response	O
of	O
the	O
eyelid	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
to	O
treatment	O
and	O
the	O
final	O
systemic	O
condition	O
were	O
the	O
main	O
outcome	O
measures	O
.	O

The	O
systemic	O
manifestations	O
included	O
multiple	O
basal	B-ALL
cell	I-ALL
carcinomas	E-ALL
in	O
all	O
the	O
patients	O
,	O
frontal	B-ALL
bossing	E-ALL
or	O
increased	B-ALL
occipitofrontal	I-ALL
circumference	E-ALL
in	O
three	O
patients	O
,	O
palmar	B-ALL
pits	S-ALL
in	O
two	O
patients	O
,	O
odontogenic	B-ALL
keratocyst	E-ALL
in	O
one	O
patient	O
,	O
ectopic	B-ALL
calcification	E-ALL
in	O
one	O
patient	O
,	O
and	O
bifid	B-ALL
rib	E-ALL
in	O
one	O
patient	O
.	O

The	O
mean	O
age	O
at	O
the	O
detection	O
of	O
the	O
first	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
was	O
30	O
years	O
-LRB-	O
range	O
,	O
16	O
-	O
38	O
years	O
-RRB-	O
.	O

All	O
four	O
patients	O
had	O
multiple	O
basal	B-ALL
cell	I-ALL
carcinomas	I-ALL
on	I-ALL
the	I-ALL
face	E-ALL
and	O
elsewhere	O
.	O

The	O
eyelid	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
was	O
advanced	O
with	O
orbital	O
infiltration	O
in	O
three	O
patients	O
,	O
one	O
of	O
whom	O
opted	O
for	O
palliative	O
radiotherapy	O
,	O
whereas	O
the	O
other	O
two	O
underwent	O
orbital	O
exenteration	O
.	O

The	O
fourth	O
patient	O
,	O
who	O
had	O
localized	O
recurrent	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
in	O
the	O
upper	O
eyelid	O
,	O
was	O
treated	O
with	O
excision	O
and	O
eyelid	O
reconstruction	O
.	O

At	O
the	O
final	O
follow	O
-	O
up	O
-LRB-	O
mean	O
,	O
41	O
months	O
-RRB-	O
,	O
eyelid	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
was	O
cured	O
in	O
three	O
patients	O
and	O
stable	O
in	O
one	O
patient	O
.	O

Gorlin	O
-	O
Goltz	O
syndrome	O
is	O
a	O
rare	O
autosomal	B-ALL
dominant	E-ALL
cancer	S-ALL
predisposition	O
syndrome	O
that	O
may	O
be	O
associated	O
with	O
eyelid	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
.	O

It	O
is	O
important	O
to	O
recognize	O
Gorlin	O
-	O
Goltz	O
syndrome	O
when	O
a	O
patient	O
has	O
multiple	O
basal	B-ALL
cell	I-ALL
carcinomas	E-ALL
or	O
when	O
a	O
young	S-ALL
patient	O
with	O
eyelid	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
is	O
seen	O
by	O
an	O
ophthalmologist	O
,	O
because	O
lifelong	O
monitoring	O
is	O
essential	O
for	O
patient	O
management	O
.	O

Branchio	O
-	O
oculo	O
-	O
facial	O
syndrome	O
-LRB-	O
BOFS	O
-RRB-	O
is	O
a	O
rare	O
autosomal	B-ALL
-	I-ALL
dominant	S-ALL
cleft	B-ALL
palate	E-ALL
-	O
craniofacial	B-ALL
disorder	E-ALL
with	O
variable	B-ALL
expressivity	E-ALL
.	O

The	O
major	O
features	O
include	O
cutaneous	B-ALL
anomalies	E-ALL
-LRB-	O
cervical	O
,	O
infra	B-ALL
-	I-ALL
and	I-ALL
/	I-ALL
or	I-ALL
supra	I-ALL
-	I-ALL
auricular	I-ALL
defects	E-ALL
,	O
often	O
with	O
dermal	O
thymus	O
-RRB-	O
,	O
ocular	B-ALL
anomalies	E-ALL
,	O
characteristic	O
facial	B-ALL
appearance	E-ALL
-LRB-	O
malformed	B-ALL
pinnae	E-ALL
,	O
oral	B-ALL
clefts	S-ALL
-RRB-	O
,	O
and	O
,	O
less	O
commonly	O
,	O
renal	B-ALL
and	I-ALL
ectodermal	B-ALL
-LRB-	I-ALL
dental	I-ALL
and	I-ALL
hair	I-ALL
-RRB-	I-ALL
anomalies	E-ALL
.	O

Four	O
additional	O
BOFS	O
patients	O
were	O
found	O
to	O
have	O
de	B-ALL
novo	E-ALL
missense	O
mutations	O
in	O
the	O
highly	O
conserved	O
exons	O
4	O
and	O
5	O
-LRB-	O
basic	O
region	O
of	O
the	O
DNA	O
binding	O
domain	O
-RRB-	O
of	O
the	O
TFAP2A	O
gene	O
in	O
the	O
candidate	O
deleted	O
region	O
.	O

More	O
patients	O
need	O
to	O
be	O
studied	O
to	O
determine	O
possible	O
genetic	B-ALL
heterogeneity	S-ALL
and	O
to	O
establish	O
whether	O
there	O
are	O
genotype	O
-	O
phenotype	O
correlations	O
.	O

Branchio	O
-	O
oto	O
-	O
renal	O
syndrome	O
-LRB-	O
BOR	O
-RRB-	O
is	O
an	O
autosomal	B-ALL
dominant	S-ALL
disorder	E-ALL
characterized	O
by	O
the	O
association	O
of	O
branchial	S-ALL
and	I-ALL
external	B-ALL
ear	B-ALL
malformations	E-ALL
,	O
hearing	B-ALL
loss	E-ALL
,	O
and	O
renal	B-ALL
anomalies	E-ALL
.	O

The	O
phenotype	O
varies	O
from	O
ear	B-ALL
pits	S-ALL
to	O
profound	B-ALL
hearing	B-ALL
loss	E-ALL
,	O
branchial	B-ALL
fistulae	E-ALL
,	O
and	O
kidney	B-ALL
agenesis	E-ALL
.	O

We	O
report	O
studies	O
of	O
six	O
patients	O
with	O
the	O
Angelman	O
``	O
Happy	B-ALL
Puppet	E-ALL
''	O
syndrome	O
and	O
compare	O
the	O
data	O
with	O
those	O
from	O
previous	O
reports	O
.	O

The	O
results	O
confirm	O
the	O
classic	O
findings	O
of	O
severe	B-ALL
mental	B-ALL
retardation	S-ALL
,	O
``	B-ALL
puppet	I-ALL
-	I-ALL
like	I-ALL
''	I-ALL
gait	E-ALL
,	O
characteristic	O
craniofacial	B-ALL
abnormalities	E-ALL
,	O
and	O
frequent	B-ALL
episodes	I-ALL
of	I-ALL
laughter	S-ALL
and	O
suggest	O
that	O
this	O
syndrome	O
is	O
more	O
common	O
than	O
previously	O
thought	O
.	O

Computerized	O
axial	O
tomographs	O
of	O
the	O
brain	O
demonstrating	O
unilateral	B-ALL
cerebellar	B-ALL
atrophy	E-ALL
in	O
one	O
patient	O
constitute	O
the	O
first	O
direct	O
evidence	O
of	O
cerebellar	B-ALL
abnormalities	E-ALL
in	O
this	O
syndrome	O
.	O

Nevoid	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
syndrome	O
-LRB-	O
NBCCS	O
-RRB-	O
is	O
a	O
hereditary	O
condition	O
transmitted	O
as	O
an	O
autosomal	B-ALL
dominant	S-ALL
trait	E-ALL
with	O
complete	O
penetrance	O
and	O
variable	S-ALL
expressivity	E-ALL
.	O

The	O
syndrome	O
is	O
characterised	O
by	O
numerous	O
basal	B-ALL
cell	I-ALL
carcinomas	E-ALL
-LRB-	O
BCCs	O
-RRB-	O
,	O
odontogenic	B-ALL
keratocysts	B-ALL
of	I-ALL
the	I-ALL
jaws	E-ALL
,	O
palmar	B-ALL
and	I-ALL
/	I-ALL
or	I-ALL
plantar	B-ALL
pits	S-ALL
,	O
skeletal	B-ALL
abnormalities	E-ALL
and	O
intracranial	B-ALL
calcifications	E-ALL
.	O

Jaw	B-ALL
cysts	E-ALL
and	O
calcification	B-ALL
of	I-ALL
falx	I-ALL
cerebri	E-ALL
were	O
the	O
most	O
frequently	O
observed	O
anomalies	O
,	O
followed	O
by	O
BCCs	S-ALL
and	O
palmar	B-ALL
/	I-ALL
plantar	B-ALL
pits	S-ALL
.	O

The	O
association	O
between	O
ear	B-ALL
and	I-ALL
kidney	B-ALL
anomalies	E-ALL
is	O
not	O
usually	O
due	O
to	O
an	O
insult	O
to	O
the	O
embryo	O
.	O

Here	O
,	O
we	O
describe	O
ear	B-ALL
and	I-ALL
kidney	B-ALL
clinical	I-ALL
syndromes	E-ALL
and	O
their	O
molecular	O
expression	O
.	O

We	O
present	O
the	O
case	O
of	O
a	O
14	O
-	O
year	O
-	O
old	O
Japanese	O
girl	O
who	O
had	O
both	O
Gorlin	O
syndrome	O
and	O
ulcerative	B-ALL
colitis	S-ALL
.	O

She	O
had	O
complained	O
of	O
blood	B-ALL
stools	E-ALL
for	O
6	O
months	O
and	O
severe	O
scoliosis	S-ALL
from	O
her	O
infancy	S-ALL
.	O

Physical	O
examination	O
revealed	O
multiple	B-ALL
nevi	E-ALL
,	O
palmar	B-ALL
and	I-ALL
plantar	B-ALL
pits	S-ALL
,	O
jaw	B-ALL
cysts	E-ALL
,	O
and	O
calcification	B-ALL
of	I-ALL
the	I-ALL
falx	I-ALL
cerebri	E-ALL
,	O
leading	O
to	O
the	O
diagnosis	O
of	O
Gorlin	O
syndrome	O
.	O

Total	O
colonoscopy	O
revealed	O
an	O
edematous	B-ALL
and	I-ALL
spotty	I-ALL
bleeding	I-ALL
mucosa	E-ALL
extending	O
from	O
the	O
anus	O
to	O
the	O
transverse	O
colon	O
.	O

Histological	O
examination	O
was	O
also	O
compatible	O
with	O
ulcerative	B-ALL
colitis	S-ALL
.	O

Thus	O
,	O
we	O
diagnosed	O
her	O
as	O
having	O
Gorlin	O
syndrome	O
with	O
ulcerative	B-ALL
colitis	S-ALL
.	O

Since	O
Gorlin	O
syndrome	O
and	O
ulcerative	B-ALL
colitis	S-ALL
are	O
rare	O
disorders	O
in	O
childhood	S-ALL
,	O
this	O
association	O
is	O
interesting	O
,	O
suggesting	O
a	O
correlation	O
between	O
the	O
hedgehog	O
signaling	O
and	O
intestinal	B-ALL
disorders	E-ALL
.	O

Basal	B-ALL
cell	I-ALL
nevus	E-ALL
syndrome	O
-LRB-	O
BCNS	O
or	O
Gorlin	O
syndrome	O
,	O
OMIM	O
:	O
109400	O
-RRB-	O
is	O
a	O
rare	O
autosomal	B-ALL
dominant	I-ALL
disorder	E-ALL
with	O
high	O
penetrance	O
.	O

It	O
is	O
characterized	O
by	O
developmental	O
anomalies	O
and	O
predisposition	O
to	O
tumors	S-ALL
-LRB-	O
for	O
example	O
,	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
-LRB-	O
BCC	O
-RRB-	O
and	O
medulloblastoma	S-ALL
-RRB-	O
.	O

UBE3A	O
mutations	O
are	O
more	O
frequent	O
in	O
familial	O
than	O
in	O
sporadic	S-ALL
patients	O
and	O
the	O
mutations	O
described	O
so	O
far	O
seem	O
to	O
cause	O
similar	O
phenotypes	O
in	O
the	O
familial	O
affected	O
cases	O
.	O

Her	O
affected	O
cousin	O
shows	O
a	O
more	O
severe	O
phenotype	O
,	O
with	O
asymmetric	O
spasticity	S-ALL
that	O
led	O
originally	O
to	O
a	O
diagnosis	O
of	O
cerebral	B-ALL
palsy	E-ALL
.	O

Proband	O
's	O
brain	O
MRI	O
shows	O
mild	O
cerebral	B-ALL
atrophy	E-ALL
while	O
her	O
cousin	O
's	O
brain	O
MRI	O
shows	O
severe	O
brain	O
malformation	O
.	O

This	O
family	O
demonstrates	O
that	O
,	O
although	O
brain	B-ALL
malformation	E-ALL
is	O
unusual	O
in	O
AS	O
,	O
presence	O
of	O
a	O
brain	O
malformation	O
does	O
not	O
exclude	O
the	O
diagnosis	O
of	O
AS	O
.	O

At	O
least	O
eight	O
provisional	O
categories	O
of	O
neurofibromatosis	S-ALL
have	O
been	O
proposed	O
.	O

Among	O
these	O
,	O
neurofibromatosis	S-ALL
1	O
-LRB-	O
von	O
Recklinghausen	O
's	O
disease	O
or	O
peripheral	O
neurofibromatosis	S-ALL
-RRB-	O
and	O
neurofibromatosis	S-ALL
2	O
-LRB-	O
central	O
or	O
bilateral	B-ALL
acoustic	I-ALL
neurofibromatosis	S-ALL
-RRB-	O
have	O
been	O
established	O
as	O
distinct	O
disorders	O
.	O

We	O
studied	O
15	O
affected	O
male	O
and	O
8	O
affected	O
female	O
members	O
of	O
one	O
large	O
kindred	O
with	O
neurofibromatosis	S-ALL
2	O
.	O

None	O
of	O
the	O
patients	O
met	O
the	O
diagnostic	O
criteria	O
for	O
neurofibromatosis	S-ALL
1	O
.	O

Between	O
the	O
ages	O
of	O
15	O
and	O
53	O
years	O
,	O
the	O
patients	O
had	O
multiple	O
central	B-ALL
nervous	B-ALL
system	I-ALL
tumors	S-ALL
of	O
various	O
types	O
-	O
-	O
mainly	O
,	O
bilateral	B-ALL
acoustic	B-ALL
neuromas	E-ALL
.	O

Two	O
or	O
more	O
tumors	S-ALL
eventually	O
developed	O
in	O
20	O
of	O
the	O
patients	O
;	O
9	O
had	O
evidence	O
of	O
only	O
bilateral	B-ALL
acoustic	B-ALL
neuromas	E-ALL
.	O

Meningiomas	S-ALL
and	O
ependymomas	S-ALL
were	O
more	O
common	O
among	O
the	O
young	S-ALL
patients	E-ALL
;	O
those	O
who	O
initially	O
presented	O
with	O
acoustic	B-ALL
neuromas	E-ALL
were	O
nearly	O
a	O
decade	O
older	O
.	O

Intracranial	B-ALL
nontumoral	I-ALL
calcifications	E-ALL
were	O
present	O
in	O
most	O
patients	O
and	O
were	O
also	O
found	O
in	O
symptom	O
-	O
free	O
children	O
.	O

The	O
presence	O
of	O
such	O
lesions	O
is	O
probably	O
a	O
prodromic	O
feature	O
of	O
neurofibromatosis	S-ALL
2	O
.	O

Simultaneous	O
analysis	O
of	O
D22S1	O
and	O
IGLV	O
DNA	O
markers	O
for	O
coinheritance	O
with	O
neurofibromatosis	S-ALL
2	O
indicates	O
that	O
the	O
locus	O
for	O
the	O
disease	O
is	O
near	O
the	O
center	O
of	O
the	O
long	O
arm	O
of	O
chromosome	O
22	O
-LRB-	O
22q11	O
.	O
1	O
-	O
-	O
22q13	O
.	O
1	O
-RRB-	O
.	O

The	O
eventual	O
isolation	O
of	O
this	O
disease	O
gene	O
may	O
reveal	O
a	O
cause	O
of	O
the	O
most	O
common	O
intracranial	B-ALL
tumors	S-ALL
in	O
humans	O
.	O

Four	O
patients	O
with	O
deleted	O
15q	O
were	O
all	O
sporadic	B-ALL
cases	E-ALL
,	O
whereas	O
in	O
the	O
sib	O
cases	O
we	O
could	O
not	O
detect	O
a	O
visible	O
deletion	O
in	O
the	O
long	O
arm	O
of	O
chromosome	O
15	O
.	O

However	O
,	O
there	O
was	O
no	O
clinical	O
difference	O
between	O
sporadic	B-ALL
cases	E-ALL
and	O
sib	O
cases	O
.	O

There	O
seemed	O
to	O
be	O
heterogeneity	S-ALL
for	O
the	O
molecular	O
deletion	O
within	O
AS	O
individuals	O
.	O

Naevoid	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
syndrome	O
-LRB-	O
NBCCS	O
-RRB-	O
is	O
a	O
pleiotropic	O
,	O
autosomal	B-ALL
dominant	S-ALL
disease	O
.	O

Schwannomas	B-ALL
in	I-ALL
the	I-ALL
skin	E-ALL
are	O
frequently	O
observed	O
in	O
neurofibromatosis	S-ALL
2	O
patients	O
.	O

In	O
about	O
one	O
-	O
quarter	O
of	O
the	O
cases	O
,	O
skin	B-ALL
tumors	S-ALL
are	O
the	O
first	O
clinical	O
symptoms	O
of	O
this	O
disease	O
.	O

Recognizing	O
neurofibromatosis	S-ALL
-	O
2	O
-	O
related	O
skin	B-ALL
tumors	S-ALL
is	O
therefore	O
important	O
for	O
early	O
diagnosis	O
of	O
neurofibromatosis	S-ALL
2	O
,	O
especially	O
in	O
pediatric	O
patients	O
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
40	O
skin	B-ALL
tumors	S-ALL
-LRB-	O
36	O
schwannomas	S-ALL
and	O
four	O
neurofibromas	S-ALL
-RRB-	O
from	O
20	O
neurofibromatosis	S-ALL
2	O
patients	O
for	O
NF2	O
mutations	O
and	O
allelic	O
loss	O
.	O

We	O
found	O
NF2	O
mutations	O
in	O
five	O
-LRB-	O
13	O
%	O
-RRB-	O
and	O
NF2	O
allelic	O
loss	O
in	O
18	O
-LRB-	O
45	O
%	O
-RRB-	O
of	O
the	O
40	O
analyzed	O
tumors	S-ALL
.	O

In	O
17	O
-LRB-	O
43	O
%	O
-RRB-	O
tumors	S-ALL
,	O
alterations	O
were	O
found	O
on	O
both	O
NF2	O
alleles	O
.	O

These	O
results	O
suggest	O
that	O
,	O
as	O
in	O
the	O
case	O
of	O
vestibular	B-ALL
schwannomas	S-ALL
and	O
meningiomas	S-ALL
,	O
loss	O
of	O
functional	O
NF2	O
gene	O
product	O
is	O
also	O
the	O
critical	O
event	O
in	O
the	O
development	O
of	O
skin	B-ALL
schwannomas	S-ALL
.	O

Identification	O
of	O
genetic	O
alterations	O
of	O
the	O
NF2	O
gene	O
in	O
skin	B-ALL
tumors	S-ALL
may	O
help	O
to	O
identify	O
neurofibromatosis	S-ALL
-	O
2	O
-	O
associated	O
skin	B-ALL
tumors	S-ALL
,	O
thus	O
assisting	O
in	O
the	O
diagnosis	O
of	O
neurofibromatosis	S-ALL
2	O
in	O
ambiguous	O
cases	O
,	O
and	O
excluding	O
neurofibromatosis	S-ALL
1	O
in	O
unclear	O
cases	O
.	O

We	O
also	O
report	O
that	O
the	O
detection	O
rate	O
of	O
constitutional	O
mutations	O
was	O
higher	O
in	O
patients	O
with	O
skin	B-ALL
tumors	S-ALL
-LRB-	O
65	O
%	O
-RRB-	O
than	O
in	O
patients	O
without	O
skin	B-ALL
tumors	S-ALL
-LRB-	O
40	O
%	O
-RRB-	O
.	O

Type	B-ALL
A1	I-ALL
brachydactyly	S-ALL
in	O
humans	O
is	O
a	O
recognisable	O
syndrome	O
characterised	O
by	O
shortening	B-ALL
of	I-ALL
the	I-ALL
middle	I-ALL
phalanx	I-ALL
of	I-ALL
all	I-ALL
digits	E-ALL
with	O
occasional	O
fusion	B-ALL
of	I-ALL
the	I-ALL
middle	I-ALL
and	I-ALL
terminal	I-ALL
phalanges	E-ALL
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
candidate	O
genes	O
for	O
type	B-ALL
A1	I-ALL
brachydactyly	S-ALL
in	O
two	O
families	O
with	O
multiple	O
affected	O
members	O
.	O

The	O
brachydactyly	S-ALL
type	I-ALL
A1	E-ALL
gene	O
or	O
locus	O
was	O
not	O
found	O
in	O
either	O
of	O
the	O
two	O
families	O
studied	O
.	O

The	O
index	O
case	O
was	O
a	O
Maori	O
bushman	O
who	O
presented	O
with	O
severe	O
congenital	O
spinal	B-ALL
stenosis	E-ALL
and	O
manifestations	O
of	O
distal	B-ALL
arthrogryposis	S-ALL
.	O

Of	O
those	O
examined	O
7	O
individuals	O
with	O
definite	O
and	O
2	O
with	O
probable	O
distal	B-ALL
arthrogryposis	S-ALL
were	O
identified	O
in	O
4	O
of	O
the	O
families	O
.	O

A	O
tenth	O
relative	O
with	O
distal	B-ALL
arthrogryposis	S-ALL
and	O
contractural	B-ALL
arachnodactyly	S-ALL
had	O
died	O
.	O

There	O
was	O
marked	B-ALL
variability	S-ALL
in	I-ALL
the	I-ALL
severity	I-ALL
and	I-ALL
nature	I-ALL
of	I-ALL
manifestations	E-ALL
with	O
2	O
having	O
severe	O
hand	B-ALL
and	I-ALL
foot	B-ALL
involvement	E-ALL
in	O
addition	O
to	O
craniofacial	B-ALL
changes	E-ALL
compatible	O
with	O
a	O
diagnosis	O
of	O
Freeman	O
-	O
Sheldon	O
syndrome	O
.	O

Other	O
apparently	O
unrelated	O
hereditary	O
disorders	O
in	O
the	O
family	O
included	O
ectrodactyly	S-ALL
,	O
biliary	B-ALL
atresia	E-ALL
,	O
and	O
Brachmann	O
-	O
de	O
Lange	O
syndrome	O
.	O

This	O
is	O
the	O
first	O
report	O
of	O
arthrogryposis	S-ALL
in	O
a	O
Maori	O
family	O
.	O

Nine	O
children	O
with	O
the	O
``	O
happy	B-ALL
puppet	E-ALL
''	O
syndrome	O
are	O
presented	O
here	O
and	O
19	O
previously	O
reported	O
cases	O
are	O
reviewed	O
.	O

A	O
characteristic	O
psychological	O
profile	O
is	O
suggested	O
by	O
the	O
children	O
's	O
``	B-ALL
unfocused	I-ALL
''	I-ALL
activities	E-ALL
and	O
inconsistent	O
responsiveness	O
to	O
their	O
surroundings	O
.	O

Behavioral	B-ALL
characteristics	E-ALL
are	O
atypical	O
for	O
mental	O
age	O
and	O
do	O
not	O
appear	O
to	O
represent	O
unusual	O
seizure	S-ALL
equivalents	O
.	O

Recognition	O
of	O
such	O
non	B-ALL
-	I-ALL
adaptive	I-ALL
behavior	E-ALL
may	O
be	O
of	O
importance	O
in	O
selecting	O
specific	O
treatment	O
and	O
management	O
techniques	O
to	O
modify	O
the	O
characteristics	O
of	O
this	O
syndrome	O
at	O
an	O
early	B-ALL
age	E-ALL
.	O

Hereditary	O
isolated	O
brachydactyly	B-ALL
type	I-ALL
C	E-ALL
-LRB-	O
OMIM	O
113100	O
-RRB-	O
mostly	O
follows	O
an	O
autosomal	B-ALL
dominant	S-ALL
pattern	O
of	O
inheritance	O
with	O
a	O
marked	B-ALL
variability	S-ALL
in	I-ALL
expression	E-ALL
.	O

The	O
latter	O
locus	O
contains	O
the	O
cartilage	O
-	O
derived	O
morphogenetic	O
protein	O
-LRB-	O
CDMP	O
-RRB-	O
1	O
gene	O
,	O
in	O
which	O
a	O
null	O
mutation	O
has	O
been	O
found	O
in	O
patients	O
with	O
malformations	B-ALL
restricted	I-ALL
to	I-ALL
the	I-ALL
upper	I-ALL
limbs	E-ALL
.	O

A	O
more	O
complex	O
brachydactyly	B-ALL
type	I-ALL
C	E-ALL
phenotype	O
has	O
been	O
mapped	O
to	O
chromosome	O
12q24	O
.	O

Differences	O
in	O
complexity	O
of	O
these	O
phenotypes	O
have	O
been	O
attributed	O
to	O
locus	B-ALL
heterogeneity	S-ALL
.	O

We	O
present	O
patients	O
with	O
a	O
complex	O
brachydactyly	S-ALL
type	I-ALL
C	E-ALL
phenotype	O
in	O
whom	O
there	O
is	O
considerable	B-ALL
intra	I-ALL
-	I-ALL
and	I-ALL
interfamilial	B-ALL
variability	S-ALL
in	I-ALL
expression	E-ALL
.	O

We	O
show	O
that	O
clinical	O
subclassification	O
based	O
on	O
the	O
complexity	O
of	O
the	O
brachydactyly	B-ALL
type	I-ALL
C	E-ALL
phenotype	O
related	O
to	O
the	O
genetic	O
defect	O
is	O
not	O
feasible	O
.	O

We	O
present	O
evidence	O
that	O
differences	O
in	O
complexity	O
are	O
not	O
only	O
due	O
to	O
locus	B-ALL
heterogeneity	S-ALL
,	O
but	O
that	O
genetic	O
modifiers	O
and	O
/	O
or	O
environmental	O
factors	O
must	O
also	O
play	O
a	O
role	O
.	O

Older	O
paternal	O
age	O
has	O
previously	O
been	O
documented	O
as	O
a	O
factor	O
in	O
sporadic	S-ALL
fresh	O
mutational	O
cases	O
of	O
several	O
autosomal	B-ALL
dominant	S-ALL
disorders	O
.	O

In	O
this	O
collaborative	O
study	O
,	O
an	O
older	O
mean	O
paternal	O
age	O
has	O
been	O
documented	O
in	O
sporadic	S-ALL
cases	E-ALL
of	O
at	O
least	O
five	O
additional	O
dominantly	B-ALL
inheritable	I-ALL
disorders	E-ALL
;	O
the	O
basal	B-ALL
cell	I-ALL
nevus	E-ALL
syndrome	E-ALL
,	O
the	O
Waardenburg	O
syndrome	O
,	O
the	O
Crouzon	O
syndrome	O
,	O
the	O
oculo	O
-	O
dental	O
-	O
digital	O
sysdrome	O
,	O
and	O
the	O
Treacher	O
-	O
Collins	O
syndrome	O
.	O

It	O
was	O
also	O
found	O
to	O
be	O
a	O
factor	O
in	O
acrodysostosis	O
and	O
progeria	O
,	O
suggesting	O
a	O
fresh	O
mutant	O
gene	O
etiology	O
for	O
these	O
two	O
conditions	O
in	O
which	O
virtually	O
all	O
cases	O
have	O
been	O
sporadic	S-ALL
and	O
the	O
mode	O
of	O
genetic	O
etiology	O
has	O
been	O
unknown	O
.	O

We	O
describe	O
a	O
new	O
family	O
with	O
the	O
Townes	O
-	O
Brocks	O
syndrome	O
,	O
a	O
dominantly	B-ALL
inherited	E-ALL
syndrome	O
of	O
anal	B-ALL
,	I-ALL
urorenal	B-ALL
,	I-ALL
ear	B-ALL
and	I-ALL
limb	B-ALL
malformations	E-ALL
.	O

The	O
proband	O
shows	O
the	O
full	O
spectrum	O
of	O
anomalies	O
,	O
including	O
imperforate	B-ALL
anus	E-ALL
,	O
prominent	B-ALL
perineal	I-ALL
raphe	E-ALL
,	O
rectoperineal	B-ALL
fistula	E-ALL
,	O
triphalangeal	B-ALL
thumb	E-ALL
,	O
preaxial	B-ALL
hexadactyly	E-ALL
,	O
syndactyly	S-ALL
,	O
clinodactyly	S-ALL
,	O
preauricular	B-ALL
protuberances	E-ALL
,	O
hypoplastic	B-ALL
satyr	I-ALL
ears	E-ALL
,	O
sensorineural	B-ALL
hearing	B-ALL
loss	E-ALL
and	O
urorenal	B-ALL
anomalies	E-ALL
.	O

In	O
contrast	O
,	O
the	O
father	O
shows	O
only	O
limb	B-ALL
anomalies	E-ALL
,	O
sensorineural	B-ALL
hearing	B-ALL
loss	E-ALL
and	O
renal	B-ALL
anomalies	E-ALL
.	O

Anorectal	B-ALL
malformations	E-ALL
,	O
which	O
are	O
present	O
in	O
almost	O
every	O
patient	O
with	O
the	O
Townes	O
-	O
Brocks	O
syndrome	O
,	O
were	O
absent	O
in	O
the	O
father	O
.	O

This	O
case	O
report	O
illustrates	O
the	O
intrafamilial	B-ALL
variability	S-ALL
of	O
the	O
Townes	O
-	O
Brocks	O
syndrome	O
.	O

Brachydactyly	B-ALL
type	I-ALL
A	I-ALL
-	I-ALL
1	E-ALL
-LRB-	O
BDA1	S-ALL
-RRB-	O
was	O
,	O
in	O
1903	O
,	O
the	O
first	O
recorded	O
example	O
of	O
a	O
human	O
anomaly	O
with	O
Mendelian	O
autosomal	B-ALL
dominant	S-ALL
inheritance	E-ALL
.	O

Homozygous	O
CDMP	O
-	O
1	O
mutations	O
cause	O
Hunter	O
-	O
Thompson	O
and	O
Grebe	O
types	O
of	O
acromesomelic	O
chondrodysplasia	O
and	O
DuPan	O
syndrome	O
in	O
humans	O
,	O
as	O
well	O
as	O
brachypodism	O
in	O
mice	O
,	O
while	O
heterozygous	O
mutations	O
cause	O
brachydactyly	B-ALL
type	I-ALL
C	E-ALL
-LRB-	O
BDC	O
-RRB-	O
.	O

Although	O
eight	O
mutation	O
carriers	O
display	O
BDC	O
,	O
four	O
have	O
normal	O
hands	O
and	O
feet	O
,	O
confirming	O
nonpenetrance	S-ALL
of	O
BDC	O
with	O
CDMP	O
-	O
1	O
mutations	O
.	O

In	O
addition	O
,	O
several	O
carriers	O
have	O
other	O
skeletal	B-ALL
abnormalities	E-ALL
,	O
including	O
severe	O
bilateral	O
vertical	B-ALL
talus	E-ALL
-LRB-	O
in	O
two	O
-RRB-	O
,	O
developmental	B-ALL
hip	B-ALL
dysplasia	E-ALL
-LRB-	O
in	O
one	O
-RRB-	O
,	O
and	O
short	B-ALL
stature	E-ALL
-LRB-	O
in	O
two	O
,	O
who	O
are	O
otherwise	O
unaffected	O
-RRB-	O
.	O

Premature	B-ALL
vertebral	I-ALL
end	I-ALL
-	I-ALL
plate	I-ALL
disease	E-ALL
was	O
observed	O
in	O
four	O
mutation	O
carriers	O
and	O
was	O
associated	O
with	O
spondylolysis	S-ALL
and	O
spondylolisthesis	S-ALL
in	O
three	O
of	O
these	O
.	O

Axial	B-ALL
skeletal	I-ALL
involvement	E-ALL
has	O
not	O
been	O
previously	O
reported	O
in	O
association	O
with	O
CDMP	O
-	O
1	O
mutations	O
.	O

Phenotypic	B-ALL
variation	E-ALL
in	O
BDC	O
has	O
previously	O
been	O
attributed	O
either	O
to	O
locus	B-ALL
heterogeneity	S-ALL
or	O
to	O
the	O
varied	O
functional	O
effects	O
of	O
different	O
CDMP	O
-	O
1	O
mutations	O
.	O

Our	O
findings	O
illustrate	O
that	O
nonpenetrance	S-ALL
for	O
the	O
typical	O
features	O
of	O
BDC	O
can	O
be	O
appreciable	O
and	O
that	O
atypical	O
skeletal	O
features	O
that	O
have	O
been	O
reported	O
in	O
some	O
patients	O
with	O
BDC	O
-LRB-	O
i	O
.	O
e	O
.	O
,	O
clubfoot	S-ALL
,	O
short	B-ALL
stature	E-ALL
,	O
spondylolysis	S-ALL
-RRB-	O
may	O
also	O
result	O
from	O
CDMP	O
-	O
1	O
mutation	O
.	O

RFLP	O
typing	O
of	O
members	O
of	O
a	O
neurofibromatosis	S-ALL
type	O
2	O
-LRB-	O
NF2	O
-RRB-	O
family	O
suggested	O
that	O
affected	O
individuals	O
were	O
hemizygous	O
at	O
the	O
neurofilament	O
heavy	O
chain	O
-LRB-	O
NEFH	O
-RRB-	O
locus	O
,	O
possibly	O
as	O
a	O
result	O
of	O
a	O
disease	O
-	O
associated	O
deletion	O
.	O

FISH	O
analysis	O
confirmed	O
a	O
disease	O
-	O
associated	O
germinal	O
deletion	O
on	O
22q	O
which	O
encompassed	O
the	O
NEFH	O
locus	O
,	O
which	O
is	O
known	O
to	O
be	O
very	O
closely	O
linked	O
to	O
NF2	O
,	O
but	O
did	O
not	O
extend	O
as	O
far	O
as	O
the	O
proximal	O
Ewing	O
sarcoma	S-ALL
region	O
or	O
the	O
distal	O
leukaemia	O
factor	O
-LRB-	O
LIF	O
-RRB-	O
locus	O
.	O

These	O
include	O
calcification	B-ALL
of	I-ALL
the	I-ALL
falx	I-ALL
cerebri	E-ALL
and	I-ALL
tentorium	I-ALL
cerebelli	E-ALL
and	O
dysgenesis	B-ALL
of	I-ALL
the	I-ALL
corpus	I-ALL
callosum	E-ALL
and	I-ALL
vermis	E-ALL
.	O

Vermian	B-ALL
dysgenesis	E-ALL
was	O
detected	O
in	O
both	O
mother	O
and	O
daughter	O
suggesting	O
a	O
previously	O
unrecognized	O
finding	O
associated	O
with	O
Gorlin	O
syndrome	O
.	O

A	O
young	S-ALL
girl	O
12	O
old	O
,	O
sent	O
to	O
us	O
for	O
obesity	S-ALL
,	O
and	O
coxa	B-ALL
-	I-ALL
epiphysiolysis	E-ALL
showed	O
signs	O
of	O
mental	B-ALL
retardation	E-ALL
and	O
bilateral	O
thumb	B-ALL
ankylosis	E-ALL
.	O

The	O
latter	O
revealed	O
that	O
not	O
only	O
the	O
daughter	O
,	O
the	O
mother	O
,	O
but	O
also	O
their	O
own	O
mother	O
and	O
may	O
be	O
,	O
the	O
sister	O
,	O
the	O
grand	O
-	O
mother	O
and	O
the	O
great	O
-	O
aunt	O
of	O
the	O
patient	O
had	O
a	O
retardation	S-ALL
,	O
a	O
slight	B-ALL
dysmorphia	E-ALL
,	O
a	O
type	B-ALL
A	I-ALL
brachydactylia	I-ALL
,	E-ALL
signs	O
of	O
obesity	S-ALL
and	O
an	O
identical	O
ankylosis	B-ALL
of	I-ALL
both	I-ALL
thumbs	E-ALL
.	O

Short	B-ALL
stature	E-ALL
may	O
be	O
a	O
component	O
of	O
the	O
brachydactyly	S-ALL
C	E-ALL
syndrome	O
.	O

A	O
family	O
is	O
presented	O
in	O
which	O
the	O
propositus	O
has	O
brachydactyly	S-ALL
C	E-ALL
,	O
short	B-ALL
stature	E-ALL
,	O
and	O
hip	B-ALL
dysplasia	E-ALL
.	O

The	O
causal	O
heterogeneity	S-ALL
of	O
Angelman	O
syndrome	O
-LRB-	O
AS	O
-RRB-	O
makes	O
providing	O
information	O
regarding	O
recurrence	O
risk	O
both	O
important	O
and	O
challenging	O
,	O
and	O
may	O
have	O
a	O
dramatic	O
impact	O
on	O
reproductive	O
decision	O
-	O
making	O
for	O
the	O
nuclear	O
and	O
extended	O
family	O
.	O

Most	O
cases	O
of	O
AS	O
result	O
from	O
typical	O
large	O
de	B-ALL
novo	E-ALL
deletions	O
of	O
15q11	O
-	O
q13	O
,	O
and	O
are	O
expected	O
to	O
have	O
a	O
low	O
-LRB-	O
-LRB-	O
1	O
%	O
-RRB-	O
risk	O
of	O
recurrence	O
.	O

Nevoid	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
syndrome	O
-LRB-	O
NBCCS	O
;	O
basal	B-ALL
cell	I-ALL
nevus	I-ALL
syndrome	E-ALL
or	O
Gorlin	O
syndrome	O
-RRB-	O
is	O
a	O
cancer	S-ALL
-	O
predisposition	O
syndrome	O
characterized	O
by	O
multiple	O
basal	B-ALL
cell	I-ALL
carcinomas	E-ALL
-LRB-	O
BCCs	O
-RRB-	O
and	O
diverse	O
developmental	B-ALL
defects	E-ALL
.	O

In	O
addition	O
,	O
loss	O
of	O
heterozygosity	O
-LRB-	O
LOH	O
-RRB-	O
for	O
genetic	O
markers	O
in	O
this	O
region	O
has	O
been	O
detected	O
in	O
sporadic	S-ALL
BCCs	O
,	O
indicating	O
that	O
the	O
NBCCS	O
gene	O
is	O
probably	O
a	O
tumor	S-ALL
-	O
suppressor	O
gene	O
.	O

In	O
this	O
study	O
we	O
have	O
determined	O
that	O
the	O
NBCCS	O
gene	O
is	O
also	O
linked	O
to	O
this	O
region	O
in	O
Australasian	O
pedigrees	O
and	O
that	O
there	O
is	O
no	O
significant	O
evidence	O
of	O
heterogeneity	S-ALL
.	O

LOH	O
at	O
these	O
loci	O
was	O
detected	O
in	O
50	O
%	O
of	O
sporadic	S-ALL
BCCs	O
,	O
a	O
rate	O
that	O
is	O
significantly	O
higher	O
than	O
that	O
in	O
other	O
skin	B-ALL
lesions	E-ALL
used	O
as	O
controls	O
.	O

We	O
report	O
9	O
subjects	O
from	O
2	O
families	O
with	O
the	O
syndrome	O
of	O
cerebral	B-ALL
gigantism	E-ALL
,	O
seven	O
of	O
the	O
patients	O
also	O
had	O
jaw	B-ALL
cyst	E-ALL
basal	B-ALL
cell	I-ALL
naevoid	E-ALL
syndrome	O
.	O

Neurological	O
symptoms	O
included	O
mild	O
hydrocephalus	S-ALL
,	O
ventricular	B-ALL
malformation	E-ALL
,	O
cerebellar	B-ALL
syndrome	E-ALL
,	O
intracranial	B-ALL
calcification	E-ALL
,	O
oculomotor	B-ALL
disturbances	E-ALL
,	O
EEG	B-ALL
abnormalities	E-ALL
and	O
rarely	O
,	O
mild	O
peripheral	B-ALL
nervous	I-ALL
disorders	E-ALL
.	O

A	O
disturbance	O
of	O
calcium	B-ALL
metabolism	E-ALL
appears	O
to	O
be	O
a	O
prominent	O
feature	O
of	O
the	O
genetically	O
determined	O
nonprogressive	S-ALL
syndrome	O
.	O

The	O
basal	B-ALL
cell	I-ALL
nevus	I-ALL
syndrome	E-ALL
-LRB-	O
BCNS	O
-RRB-	O
is	O
characterized	O
by	O
developmental	B-ALL
abnormalities	E-ALL
and	O
by	O
the	O
postnatal	O
occurrence	O
of	O
cancers	O
,	O
especially	O
basal	B-ALL
cell	I-ALL
carcinomas	E-ALL
-LRB-	O
BCCs	O
-RRB-	O
,	O
the	O
most	O
common	O
human	O
cancer	S-ALL
.	O

Heritable	O
mutations	O
in	O
BCNS	O
patients	O
and	O
a	O
somatic	B-ALL
mutation	E-ALL
in	O
a	O
sporadic	S-ALL
BCC	O
were	O
identified	O
in	O
a	O
human	O
homolog	O
of	O
the	O
Drosophila	O
patched	O
-LRB-	O
ptc	O
-RRB-	O
gene	O
.	O

The	O
human	O
PTC	O
gene	O
appears	O
to	O
be	O
crucial	O
for	O
proper	O
embryonic	O
development	O
and	O
for	O
tumor	S-ALL
suppression	O
.	O

The	O
neurofibromatosis	S-ALL
type	O
2	O
-LRB-	O
NF2	O
-RRB-	O
gene	O
has	O
been	O
hypothesized	O
to	O
be	O
a	O
recessive	O
tumor	S-ALL
suppressor	O
,	O
with	O
mutations	O
at	O
the	O
same	O
locus	O
on	O
chromosome	O
22	O
that	O
lead	O
to	O
NF2	O
also	O
leading	O
to	O
sporadic	S-ALL
tumors	S-ALL
of	O
the	O
types	O
seen	O
in	O
NF2	O
.	O

Identification	O
of	O
subregions	O
of	O
this	O
interval	O
that	O
are	O
consistently	O
rearranged	O
in	O
the	O
NF2	O
-	O
related	O
tumors	S-ALL
would	O
aid	O
in	O
better	O
defining	O
the	O
disease	O
locus	O
.	O

To	O
this	O
end	O
,	O
we	O
have	O
compared	O
tumor	S-ALL
and	O
constitutional	O
DNAs	O
,	O
isolated	O
from	O
39	O
unrelated	O
patients	O
with	O
sporadic	S-ALL
and	O
NF2	O
-	O
associated	O
acoustic	B-ALL
neuromas	E-ALL
,	O
meningiomas	S-ALL
,	O
schwannomas	S-ALL
,	O
and	O
ependymomas	S-ALL
,	O
at	O
eight	O
polymorphic	O
loci	O
on	O
chromosome	O
22	O
.	O

Two	O
of	O
the	O
tumors	S-ALL
studied	O
revealed	O
loss	O
-	O
of	O
-	O
heterozygosity	O
patterns	O
,	O
which	O
is	O
consistent	O
with	O
the	O
presence	O
of	O
chromosome	O
22	O
terminal	O
deletions	O
.	O

By	O
using	O
additional	O
polymorphic	O
markers	O
,	O
the	O
terminal	O
deletion	O
breakpoint	O
found	O
in	O
one	O
of	O
the	O
tumors	S-ALL
,	O
an	O
acoustic	B-ALL
neuroma	E-ALL
from	O
an	O
NF2	O
patient	O
,	O
was	O
mapped	O
within	O
the	O
previously	O
defined	O
NF2	O
region	O
.	O

In	O
addition	O
,	O
we	O
identified	O
a	O
sporadic	S-ALL
acoustic	B-ALL
neuroma	E-ALL
that	O
reveals	O
a	O
loss	O
-	O
of	O
-	O
heterozygosity	O
pattern	O
consistent	O
with	O
mitotic	O
recombination	O
or	O
deletion	O
and	O
reduplication	O
,	O
which	O
are	O
mechanisms	O
not	O
previously	O
seen	O
in	O
studies	O
of	O
these	O
tumors	S-ALL
.	O

This	O
finding	O
,	O
while	O
inconsistent	O
with	O
models	O
of	O
tumorigenesis	O
that	O
invoke	O
single	O
deletions	O
and	O
their	O
gene	O
-	O
dosage	O
effects	O
,	O
lends	O
further	O
support	O
to	O
the	O
recessive	O
tumor	S-ALL
-	O
suppressor	O
model	O
.	O

Neurofibromatosis	S-ALL
type	O
2	O
-LRB-	O
NF2	O
-RRB-	O
is	O
an	O
autosomal	B-ALL
dominant	S-ALL
syndrome	O
characterized	O
by	O
the	O
development	O
of	O
vestibular	B-ALL
schwannomas	S-ALL
and	O
other	B-ALL
tumors	B-ALL
of	I-ALL
the	I-ALL
nervous	I-ALL
system	E-ALL
,	O
including	O
cranial	B-ALL
and	I-ALL
spinal	B-ALL
meningiomas	S-ALL
,	O
schwannomas	S-ALL
,	O
and	O
ependymomas	S-ALL
.	O

The	O
presence	O
of	O
bilateral	B-ALL
vestibular	B-ALL
schwannomas	S-ALL
is	O
sufficient	O
for	O
the	O
diagnosis	O
.	O

Skin	B-ALL
manifestations	E-ALL
are	O
less	O
common	O
than	O
in	O
neurofibromatosis	S-ALL
type	O
1	O
-LRB-	O
NF1	O
;	O
von	O
Recklinghausen	O
disease	O
-RRB-	O
.	O

Our	O
results	O
confirm	O
the	O
assignment	O
of	O
the	O
gene	O
for	O
NF2	O
to	O
chromosome	O
22	O
and	O
do	O
not	O
support	O
the	O
hypothesis	O
of	O
genetic	B-ALL
heterogeneity	S-ALL
.	O

We	O
report	O
on	O
a	O
woman	O
who	O
was	O
diagnosed	O
with	O
branchio	O
-	O
oto	O
-	O
renal	O
-LRB-	O
BOR	O
-RRB-	O
syndrome	O
after	O
2	O
pregnancies	O
complicated	O
by	O
oligohydramnios	S-ALL
due	O
to	O
renal	B-ALL
hypoplasia	I-ALL
and	I-ALL
agenesis	E-ALL
.	O

Both	O
babies	O
died	B-ALL
neonatally	E-ALL
of	O
pulmonary	B-ALL
hypoplasia	E-ALL
.	O

Histopathology	O
of	O
the	O
temporal	O
bones	O
of	O
the	O
second	O
child	O
showed	O
marked	O
immaturity	B-ALL
of	I-ALL
the	I-ALL
middle	I-ALL
ear	I-ALL
cleft	E-ALL
,	I-ALL
ossicles	I-ALL
,	I-ALL
facial	I-ALL
nerve	I-ALL
and	I-ALL
canal	I-ALL
,	I-ALL
and	I-ALL
cochlear	I-ALL
nerve	E-ALL
.	O

Maternal	O
renal	O
ultrasound	O
study	O
was	O
normal	O
although	O
intravenous	O
pyelography	O
indicated	O
renal	B-ALL
hypoplasia	E-ALL
.	O

The	O
frequency	O
of	O
BOR	O
syndrome	O
among	O
cases	O
of	O
recurrent	O
fetal	O
renal	B-ALL
hypoplasia	I-ALL
/	I-ALL
dysplasia	I-ALL
or	I-ALL
agenesis	E-ALL
is	O
unknown	O
,	O
and	O
parental	O
renal	O
ultrasonography	O
may	O
not	O
identify	O
a	O
heritable	O
renal	B-ALL
defect	E-ALL
.	O

Investigations	O
should	O
include	O
a	O
family	O
history	O
,	O
and	O
examination	O
of	O
relatives	O
to	O
look	O
for	O
preauricular	B-ALL
pits	S-ALL
,	O
lacrimal	B-ALL
duct	I-ALL
stenosis	E-ALL
,	O
and	O
branchial	S-ALL
fistulae	I-ALL
and	I-ALL
/	I-ALL
or	I-ALL
cysts	E-ALL
.	O

Hearing	B-ALL
studies	E-ALL
and	O
IVP	O
may	O
be	O
indicated	O
.	O

Bilateral	B-ALL
acoustic	I-ALL
neurofibromatosis	S-ALL
-LRB-	O
BANF	S-ALL
-RRB-	O
is	O
a	O
genetic	O
defect	O
associated	O
with	O
multiple	B-ALL
tumors	S-ALL
of	I-ALL
neural	I-ALL
crest	E-ALL
origin	O
.	O

Specific	O
loss	O
of	O
alleles	O
from	O
chromosome	O
22	O
was	O
detected	O
with	O
polymorphic	O
DNA	O
markers	O
in	O
two	O
acoustic	B-ALL
neuromas	E-ALL
,	O
two	O
neurofibromas	S-ALL
,	O
and	O
one	O
meningioma	S-ALL
from	O
BANF	O
patients	O
.	O

This	O
indicates	O
a	O
common	O
pathogenetic	O
mechanism	O
for	O
all	O
three	O
tumor	S-ALL
types	O
.	O

The	O
two	O
neurofibromas	S-ALL
were	O
among	O
three	O
taken	O
from	O
the	O
same	O
patient	O
,	O
and	O
both	O
showed	O
loss	O
of	O
identical	O
alleles	O
demonstrating	O
that	O
the	O
same	O
chromosome	O
suffered	O
deletion	O
in	O
both	O
tumors	S-ALL
.	O

The	O
third	O
neurofibroma	S-ALL
from	O
this	O
patient	O
showed	O
no	O
detectable	O
loss	O
of	O
heterozygosity	O
,	O
which	O
suggests	O
the	O
possibility	O
of	O
a	O
more	O
subtle	O
mutational	O
event	O
that	O
affects	O
chromosome	O
22	O
.	O

In	O
the	O
two	O
acoustic	B-ALL
neuromas	E-ALL
,	O
only	O
a	O
portion	O
of	O
chromosome	O
22	O
was	O
deleted	O
,	O
narrowing	O
the	O
possible	O
chromosomal	O
location	O
of	O
the	O
gene	O
that	O
causes	O
BANF	O
to	O
the	O
region	O
distal	O
to	O
the	O
D22S9	O
locus	O
in	O
band	O
22q11	O
.	O

The	O
identification	O
of	O
progressively	O
smaller	O
deletions	O
on	O
chromosome	O
22	O
in	O
these	O
tumor	S-ALL
types	O
may	O
well	O
provide	O
a	O
means	O
to	O
clone	O
and	O
characterize	O
the	O
defect	O
.	O

Comparing	O
the	O
clinical	O
data	O
from	O
our	O
and	O
published	O
UPD	O
patients	O
with	O
those	O
with	O
deletions	O
we	O
observed	O
the	O
following	O
:	O
the	O
age	O
of	O
diagnosis	O
is	O
higher	O
in	O
UPD	O
group	O
-LRB-	O
average	O
7	O
?	O
3	O
/	O
12	O
years	O
-RRB-	O
,	O
microcephaly	S-ALL
is	O
more	O
frequent	O
among	O
deletion	O
patients	O
,	O
UPD	O
children	O
start	O
walking	O
earlier	O
-LRB-	O
average	O
age	O
2	O
?	O
9	O
/	O
12	O
years	O
-RRB-	O
,	O
whereas	O
in	O
deletion	O
patients	O
the	O
average	O
is	O
4	O
-LRB-	O
1	O
/	O
2	O
-RRB-	O
years	O
,	O
epilepsy	S-ALL
started	O
later	O
in	O
UPD	O
patients	O
-LRB-	O
average	O
5	O
?	O
10	O
/	O
12	O
years	O
-RRB-	O
than	O
in	O
deletion	O
patients	O
-LRB-	O
average	O
1	O
?	O
11	O
/	O
12	O
years	O
-RRB-	O
,	O
weight	O
above	O
the	O
75th	O
centile	O
is	O
reported	O
mainly	O
in	O
UPD	O
patients	O
,	O
complete	O
absence	B-ALL
of	I-ALL
speech	E-ALL
is	O
more	O
common	O
in	O
the	O
deleted	O
-LRB-	O
88	O
.	O
9	O
%	O
-RRB-	O
than	O
in	O
the	O
UPD	O
patients	O
because	O
half	O
of	O
the	O
children	O
are	O
able	O
to	O
say	O
few	O
words	O
.	O

Branchio	O
-	O
oto	O
-	O
renal	O
-LRB-	O
BOR	O
-RRB-	O
syndrome	O
is	O
an	O
autosomal	B-ALL
dominant	S-ALL
condition	O
of	O
branchial	S-ALL
arch	I-ALL
anomalies	E-ALL
,	O
deafness	S-ALL
and	O
renal	B-ALL
dysplasia	E-ALL
.	O

Clinical	O
manifestations	O
tend	O
to	O
have	O
considerable	O
intrafamilial	B-ALL
and	I-ALL
interfamilial	B-ALL
variability	S-ALL
.	O

To	O
gain	O
insight	O
into	O
the	O
pathogenesis	O
of	O
neurofibromatosis	S-ALL
type	O
2	O
-LRB-	O
NF2	O
-RRB-	O
by	O
investigating	O
the	O
ocular	B-ALL
manifestations	E-ALL
of	O
this	O
disease	O
.	O

Using	O
standard	O
histologic	O
techniques	O
,	O
immunohistochemistry	O
,	O
and	O
electron	O
microscopy	O
,	O
we	O
described	O
the	O
ocular	B-ALL
pathologic	I-ALL
findings	E-ALL
of	O
a	O
34	O
-	O
year	O
-	O
old	O
woman	O
who	O
died	O
from	O
complications	O
of	O
NF2	O
.	O

We	O
identified	O
3	O
types	O
of	O
NF2	O
-	O
associated	O
lesions	O
:	O
juvenile	O
posterior	B-ALL
subcapsular	B-ALL
cataracts	S-ALL
,	O
epiretinal	B-ALL
membranes	E-ALL
,	O
and	O
an	O
intrascleral	B-ALL
schwannoma	S-ALL
.	O

Our	O
analysis	O
indicated	O
that	O
dysplastic	O
lens	O
cells	O
accumulate	O
just	O
anterior	O
to	O
the	O
posterior	O
lens	O
capsule	O
in	O
juvenile	O
posterior	B-ALL
subcapsular	B-ALL
cataracts	S-ALL
and	O
that	O
dysplastic	O
M	O
?	O
ller	O
cells	O
may	O
be	O
a	O
major	O
component	O
of	O
NF2	O
-	O
associated	O
epiretinal	B-ALL
membranes	B-ALL
.	E-ALL

Distal	B-ALL
arthrogryposis	S-ALL
type	O
1	O
-LRB-	O
DA1	O
-RRB-	O
and	O
Freeman	O
-	O
Sheldon	O
syndrome	O
-LRB-	O
FSS	O
-RRB-	O
are	O
the	O
two	O
most	O
common	O
known	O
causes	O
of	O
inherited	O
multiple	B-ALL
congenital	B-ALL
contractures	S-ALL
.	O

We	O
report	O
two	O
families	O
in	O
which	O
propositi	O
had	O
severe	O
bilateral	B-ALL
sensorineural	B-ALL
hearing	B-ALL
loss	E-ALL
,	O
a	O
preauricular	B-ALL
pit	E-ALL
or	I-ALL
tag	E-ALL
,	O
and	O
duplication	B-ALL
of	I-ALL
the	I-ALL
ureters	E-ALL
or	O
bifid	B-ALL
renal	I-ALL
pelvices	E-ALL
.	O

Other	O
relatives	O
had	O
one	O
or	O
more	O
of	O
these	O
anomalies	O
in	O
a	O
pattern	O
suggesting	O
autosomal	B-ALL
dominant	B-ALL
inheritance	E-ALL
with	O
reduced	B-ALL
penetrance	E-ALL
and	O
variable	S-ALL
expressivity	E-ALL
.	O

Club	B-ALL
foot	E-ALL
is	O
one	O
of	O
the	O
most	O
common	O
human	O
congenital	O
malformations	O
.	O

Distal	B-ALL
arthrogryposis	S-ALL
type	O
I	O
-LRB-	O
DA	O
-	O
1	O
-RRB-	O
is	O
a	O
frequent	O
cause	O
of	O
dominantly	B-ALL
inherited	E-ALL
club	B-ALL
foot	E-ALL
.	O

Analysis	O
of	O
an	O
additional	O
family	O
demonstrated	O
no	O
linkage	O
to	O
the	O
same	O
locus	O
,	O
indicating	O
likely	O
locus	B-ALL
heterogeneity	S-ALL
.	O

Of	O
the	O
autosomal	O
congenital	B-ALL
contracture	S-ALL
disorders	O
causing	O
positional	B-ALL
foot	B-ALL
deformities	E-ALL
,	O
this	O
is	O
the	O
first	O
to	O
be	O
mapped	O
.	O

Two	O
very	O
preterm	B-ALL
infants	E-ALL
-LRB-	O
born	O
at	O
29	O
and	O
25	O
weeks	O
,	O
respectively	O
-RRB-	O
were	O
found	O
to	O
have	O
abnormal	B-ALL
ribs	E-ALL
.	O

Though	O
this	O
was	O
thought	O
unimportant	O
at	O
the	O
time	O
,	O
it	O
was	O
subsequently	O
shown	O
to	O
indicate	O
that	O
some	O
members	O
of	O
their	O
families	O
had	O
a	O
dominantly	B-ALL
inherited	E-ALL
risk	O
of	O
developing	O
skin	B-ALL
cancer	S-ALL
and	O
other	O
serious	O
problems	O
.	O

Angelman	O
syndrome	O
-LRB-	O
AS	O
-RRB-	O
is	O
a	O
neurogenetic	O
disorder	O
characterized	O
by	O
severe	B-ALL
mental	B-ALL
retardation	S-ALL
,	O
speech	B-ALL
disorder	E-ALL
,	O
stereotyped	B-ALL
jerky	B-ALL
movements	E-ALL
,	O
and	O
a	O
peculiar	O
behavioral	B-ALL
profile	E-ALL
,	O
with	O
a	O
happy	B-ALL
disposition	E-ALL
and	O
outbursts	B-ALL
of	I-ALL
laughter	S-ALL
.	O

Most	O
patients	O
with	O
AS	O
present	O
with	O
epilepsy	S-ALL
and	O
suggestive	O
electroencephalographic	B-ALL
patterns	E-ALL
,	O
which	O
may	O
be	O
used	O
as	O
diagnostic	O
criteria	O
.	O

To	O
study	O
epilepsy	S-ALL
and	O
response	O
to	O
treatment	O
in	O
a	O
series	O
of	O
patients	O
with	O
AS	O
determined	O
by	O
deletion	O
.	O

Epilepsy	S-ALL
Center	O
at	O
the	O
University	O
of	O
S	O
?	O
o	O
Paulo	O
.	O

Epilepsy	S-ALL
severity	O
,	O
epilepsy	S-ALL
evolution	O
,	O
and	O
response	O
to	O
antiepileptic	O
drug	O
treatment	O
.	O

All	O
patients	O
with	O
AS	O
in	O
this	O
group	O
had	O
generalized	O
epilepsy	S-ALL
,	O
and	O
10	O
-LRB-	O
53	O
%	O
-RRB-	O
also	O
had	O
partial	O
epilepsy	S-ALL
.	O

Main	O
seizure	S-ALL
types	O
were	O
atypical	B-ALL
absences	E-ALL
and	O
myoclonic	S-ALL
and	I-ALL
tonic	B-ALL
-	I-ALL
clonic	I-ALL
seizures	S-ALL
.	O

Epilepsy	S-ALL
aggravated	O
by	O
fever	S-ALL
occurred	O
in	O
10	O
patients	O
-LRB-	O
53	O
%	O
-RRB-	O
and	O
status	B-ALL
epilepticus	E-ALL
in	O
16	O
-LRB-	O
84	O
%	O
-RRB-	O
.	O

Eighteen	O
patients	O
-LRB-	O
95	O
%	O
-RRB-	O
had	O
previous	O
or	O
current	O
history	O
of	O
daily	O
seizures	S-ALL
,	O
of	O
which	O
14	O
-LRB-	O
64	O
%	O
-RRB-	O
had	O
disabling	O
seizures	S-ALL
.	O

Multiple	O
seizure	S-ALL
types	O
were	O
observed	O
in	O
13	O
patients	O
-LRB-	O
53	O
%	O
-RRB-	O
.	O

History	O
of	O
refractory	O
epilepsy	S-ALL
was	O
reported	O
in	O
16	O
patients	O
-LRB-	O
84	O
%	O
-RRB-	O
.	O

Parents	O
reported	O
improvement	O
,	O
characterized	O
by	O
decrease	O
in	O
seizure	S-ALL
frequency	O
or	O
seizure	S-ALL
control	O
,	O
at	O
the	O
mean	O
age	O
of	O
5	O
.	O
3	O
years	O
.	O

Therefore	O
,	O
most	O
of	O
these	O
patients	O
had	O
a	O
period	O
of	O
refractory	O
epilepsy	S-ALL
;	O
however	O
,	O
improvement	O
occurred	O
during	O
late	O
childhood	S-ALL
and	O
puberty	O
.	O

Epilepsy	S-ALL
was	O
aggravated	O
by	O
carbamazepine	O
,	O
oxcarbazepine	O
,	O
and	O
vigabatrin	O
.	O

Patients	O
with	O
AS	O
with	O
deletion	O
have	O
epilepsy	S-ALL
with	O
early	B-ALL
onset	E-ALL
and	O
stereotyped	O
electroclinical	B-ALL
profile	E-ALL
regarding	O
seizure	S-ALL
type	O
,	O
severity	O
,	O
and	O
response	O
to	O
antiepileptic	O
drug	O
treatment	O
.	O

Another	O
feature	O
of	O
AS	O
is	O
the	O
age	O
-	O
related	O
improvement	O
,	O
even	O
in	O
refractory	O
cases	O
,	O
during	O
late	O
childhood	S-ALL
and	O
puberty	O
.	O

We	O
believe	O
that	O
AS	O
should	O
be	O
considered	O
a	O
differential	O
diagnosis	O
in	O
developmentally	B-ALL
delayed	E-ALL
infants	O
with	O
severe	O
,	O
generalized	O
,	O
cryptogenic	O
epilepsy	S-ALL
;	O
however	O
,	O
a	O
proper	O
electroclinical	O
delineation	O
of	O
each	O
genetic	O
group	O
is	O
mandatory	O
.	O

This	O
study	O
of	O
47	O
patients	O
from	O
11	O
families	O
with	O
neurofibromatosis	S-ALL
type	O
2	O
-LRB-	O
NF	O
2	O
-RRB-	O
confirms	O
our	O
previously	O
reported	O
association	O
between	O
posterior	B-ALL
capsular	B-ALL
cataract	S-ALL
and	O
NF	O
2	O
.	O

A	O
highly	O
significant	O
statistical	O
association	O
was	O
found	O
between	O
the	O
presence	O
of	O
posterior	B-ALL
capsular	I-ALL
lens	B-ALL
opacities	E-ALL
and	O
the	O
presence	O
of	O
NF	O
2	O
as	O
determined	O
by	O
magnetic	O
resonance	O
imaging	O
or	O
pathologic	O
diagnosis	O
.	O

This	O
association	O
was	O
not	O
present	O
for	O
other	O
types	O
of	O
lens	B-ALL
opacities	E-ALL
that	O
could	O
be	O
the	O
result	O
of	O
age	O
-	O
related	O
or	O
nonspecific	O
changes	O
.	O

When	O
considering	O
the	O
diagnosis	O
of	O
NF	O
2	O
,	O
this	O
finding	O
now	O
makes	O
it	O
essential	O
to	O
use	O
a	O
careful	O
dilated	O
biomicroscopic	O
examination	O
of	O
the	O
lens	O
to	O
evaluate	O
known	O
,	O
suspected	O
,	O
or	O
at	O
-	O
risk	O
individuals	O
for	O
this	O
potentially	O
early	B-ALL
associated	I-ALL
manifestation	E-ALL
.	O

We	O
had	O
previously	O
described	O
a	O
patient	O
with	O
an	O
overgrowth	S-ALL
syndrome	O
and	O
the	O
chromosome	O
constitution	O
45	O
,	O
XY	O
,	O
t	O
-LRB-	O
15q15q	O
-RRB-	O
-LRB-	O
Wajntal	O
et	O
al	O
.	O
,	O
DNA	O
Cell	O
Biol	O
1993	O
:	O
12	O
:	O
227	O
-	O
231	O
-RRB-	O
.	O

Our	O
findings	O
suggest	O
that	O
some	O
patients	O
with	O
clinical	O
features	O
of	O
AS	O
have	O
hyperphagia	S-ALL
and	O
obesity	S-ALL
with	O
overgrowth	S-ALL
,	O
and	O
that	O
these	O
features	O
should	O
not	O
rule	O
out	O
a	O
diagnosis	O
of	O
AS	O
.	O

One	O
hundred	O
eighteen	O
cases	O
of	O
nevoid	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
syndrome	O
-LRB-	O
NBCCS	O
,	O
Gorlin	O
's	O
syndrome	O
or	O
basal	B-ALL
cell	I-ALL
nevus	E-ALL
syndrome	O
-RRB-	O
are	O
presented	O
in	O
this	O
study	O
.	O

However	O
,	O
one	O
major	O
difference	O
is	O
that	O
the	O
multiple	O
basal	B-ALL
cell	I-ALL
carcinomas	E-ALL
are	O
manifest	O
from	O
an	O
earlier	O
age	O
in	O
the	O
Australian	O
population	O
,	O
which	O
probably	O
reflects	O
greater	O
exposure	O
to	O
ultraviolet	O
radiation	O
.	O

We	O
report	O
a	O
type	B-ALL
C	I-ALL
brachydactyly	S-ALL
transmitted	O
through	O
four	O
generations	O
,	O
with	O
incomplete	B-ALL
penetrance	E-ALL
and	O
feet	B-ALL
abnormalities	E-ALL
in	O
the	O
proposita	O
.	O

Of	O
note	O
is	O
his	O
normal	O
intelligence	O
,	O
regular	O
class	O
placement	O
,	O
hypernasal	B-ALL
speech	E-ALL
,	O
and	O
continued	B-ALL
growth	I-ALL
along	I-ALL
the	I-ALL
third	I-ALL
centile	E-ALL
.	O

Patients	O
who	O
present	O
with	O
unilateral	B-ALL
vestibular	B-ALL
schwannomas	S-ALL
either	O
at	O
a	O
young	S-ALL
age	E-ALL
or	O
with	O
additional	O
features	O
of	O
type	O
2	O
neurofibromatosis	S-ALL
-LRB-	O
NF2	O
-RRB-	O
are	O
at	O
risk	O
of	O
developing	O
bilateral	B-ALL
disease	E-ALL
and	O
transmitting	O
a	O
risk	O
of	O
neurogenic	B-ALL
tumours	S-ALL
to	O
their	O
offspring	O
.	O

We	O
have	O
identified	O
15	O
patients	O
from	O
a	O
series	O
of	O
537	O
with	O
unilateral	B-ALL
vestibular	B-ALL
schwannomas	S-ALL
who	O
also	O
had	O
one	O
or	O
more	O
of	O
the	O
following	O
:	O
other	O
tumours	S-ALL
-LRB-	O
10	O
/	O
15	O
-RRB-	O
,	O
features	O
of	O
NF2	O
-LRB-	O
3	O
/	O
15	O
-RRB-	O
,	O
or	O
a	O
family	O
history	O
of	O
neurogenic	B-ALL
tumours	S-ALL
-LRB-	O
5	O
/	O
15	O
-RRB-	O
.	O

No	O
germline	O
NF2	O
mutations	O
were	O
detected	O
and	O
in	O
7	O
/	O
9	O
cases	O
where	O
tumour	S-ALL
material	O
was	O
available	O
for	O
analysis	O
a	O
germline	O
mutation	O
in	O
the	O
NF2	O
gene	O
has	O
been	O
excluded	O
.	O

We	O
suggest	O
a	O
general	O
strategy	O
,	O
based	O
on	O
analysis	O
of	O
tumour	S-ALL
DNA	O
,	O
for	O
distinguishing	O
sporadic	S-ALL
and	O
familial	B-ALL
cases	E-ALL
of	O
tumours	S-ALL
caused	O
by	O
two	O
hit	O
mechanisms	O
.	O

Application	O
of	O
this	O
strategy	O
suggests	O
that	O
most	O
instances	O
of	O
unilateral	B-ALL
vestibular	B-ALL
schwannoma	S-ALL
which	O
do	O
not	O
fulfil	O
criteria	O
for	O
NF2	O
represent	O
chance	O
occurrences	O
.	O

No	O
difference	O
in	O
survival	O
was	O
observed	O
between	O
cultured	O
cells	O
from	O
basal	B-ALL
cell	I-ALL
naevus	E-ALL
syndrome	O
-LRB-	O
BCNS	O
-RRB-	O
patients	O
and	O
normal	O
controls	O
following	O
exposure	O
of	O
fibroblasts	O
to	O
ionizing	O
radiation	O
.	O

Three	O
successive	O
generations	O
in	O
two	O
families	O
affected	O
with	O
the	O
popliteal	B-ALL
pterygium	S-ALL
syndrome	O
are	O
reported	O
.	O

Differential	O
diagnosis	O
between	O
mildly	O
affected	O
patients	O
with	O
the	O
popliteal	B-ALL
pterygium	S-ALL
syndrome	O
and	O
those	O
with	O
Van	O
der	O
Woude	O
syndrome	O
is	O
difficult	O
and	O
may	O
even	O
be	O
impossible	O
.	O

There	O
are	O
many	O
potential	O
complications	O
which	O
have	O
been	O
reported	O
in	O
association	O
with	O
the	O
naevoid	O
basal	B-ALL
cell	I-ALL
carcinoma	E-ALL
syndrome	O
.	O

The	O
major	O
complications	O
of	O
basal	B-ALL
cell	I-ALL
carcinomas	E-ALL
and	O
jaw	B-ALL
cysts	E-ALL
occur	O
in	O
over	O
90	O
%	O
of	O
patients	O
by	O
40	O
years	O
of	O
age	O
,	O
but	O
may	O
both	O
occur	O
before	O
10	O
years	O
of	O
age	O
.	O

Less	O
well	O
described	O
complications	O
are	O
ovarian	B-ALL
calcification	I-ALL
or	I-ALL
fibroma	E-ALL
-LRB-	O
24	O
%	O
-RRB-	O
,	O
medulloblastoma	S-ALL
-LRB-	O
5	O
%	O
-RRB-	O
,	O
cardiac	B-ALL
fibroma	E-ALL
-LRB-	O
3	O
%	O
-RRB-	O
,	O
cleft	B-ALL
palate	E-ALL
-LRB-	O
5	O
%	O
-RRB-	O
,	O
and	O
ophthalmic	B-ALL
abnormalities	E-ALL
such	O
as	O
squint	S-ALL
or	O
cataract	S-ALL
-LRB-	O
26	O
%	O
-RRB-	O
.	O

